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Targeting cancer cells has been the primary focus of most cancer therapies, and only recently has 
the interaction of cancer cells with host stroma been recognized as a driving force for cancer evolution. In 
the presence of tumor-derived physicochemical cues, the host stroma fails to fulfill its primary role – the 
maintenance of tissue or organ homeostasis – and in fact aids in shaping a pro-tumorigenic 
microenvironment, ultimately promoting tumor progression. This interaction of cancer cells with the host 
stroma often complicates conventional cancer therapy and ultimately leads to unfavorable outcomes. 
The mammary stroma is largely composed of adipose tissue, and upon the onset of mammary 
tumors, the residing stromal vascular cells and adipocytes possibly partake in extracellular matrix (ECM) 
remodeling and blood vessel recruitment. Both tumor-associated ECM remodeling and neovascularization 
are typically mediated by myofibroblasts, which are known to be recruited or differentiated from other 
stromal cells. However, whether tumor-derived biochemical and mechanical cues can induce the 
conversion of adipose-derived stem cells (ASCs) or adipocytes into myofibroblastic cells is yet unknown.  
Furthermore, obesity has been highlighted as a risk factor for breast cancer possibly due to its role 
in modulating the mammary microenvironment. Nevertheless, whether obesity influences the phenotype 
of host cells in the mammary stroma in a manner similar to tumors, thereby advancing tumorigenesis, has 
yet to be determined. The goal of this dissertation is to find answers to these aforementioned unanswered 
questions by leveraging in vivo and in vitro engineering techniques. 
The results presented here demonstrate that implanted or host ASCs and adipocytes indeed 
possess pro-tumorigenic potential to stimulate breast tumor malignancy in part due to their ability to 
convert into myofibroblastic lineages upon tumor or obesity-associated microenvironmental cues. The 
  
 
 
 
 
 
findings of this work emphasize the importance of contextual cues and their roles in inducing the 
participation of the host stroma in regulating mammary tumor progression. Finally, the conclusions of this 
work potentially provide new insight for the development of therapeutic approaches for cancer and tissue 
regeneration.
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CHAPTER 1 
 
INTRODUCTION 
 
1.1. Cancer 
Cancer is one of the most life-threatening diseases, causing an estimated 7.5 million deaths and 
nearly $900 billion economic losses worldwide in 20081,2. These socioeconomic impacts highlight the 
urgency of cancer research with the ultimate goal to aid in developing better therapeutic approaches to 
this disease. Cancer is a malignant mass of neoplastic cells, arising from a sequential process of 
transformation, selection, and uncontrollable expansion of a single or few cells3. A profound 
understanding of several oncogenes (i.e. src and myc), tumor-suppressing genes (i.e.TP53), and pro-
tumorigenic molecules have contributed to advancing therapeutic approaches as well as improving 
clinical outcomes4,5. However, such therapeutic methods are effective only for limited types of cancer or 
primary cancer patients6,7. This is partially because i) cancer is an organ-, stage-, and patient-specific 
disease and ii) it often becomes resistant against any given therapies over time through its own 
surveillance system but also through an interaction with host stromal cellular and extracellular 
components8,9. 
In the healthy condition, host stromal cells maintain a fine balance in their microenvironment 
which constrains outgrowth of abnormal cancerous cells10. However, during the course of tumorigenesis 
host cells lose their phenotypic integrity upon prolonged exposure to tumor-derived cues and in turn 
contribute to constructing an increasingly pro-tumorigenic microenvironment that favors tumor 
progression, invasion, and metastasis10. The tumor microenvironment has tissue-specific features in 
accordance with the architecture, cellular, and extracellular composition of each tissue, and it also evolve 
during the course of tumor progression11,12. Therefore, understanding the dynamics of cancer cell and host 
stroma interaction in a specific cancer type will aid in developing better therapeutic approaches overall. 
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1.2. Breast cancer 
Breast cancer is one of the leading threats to women’s health worldwide13. The transformation of 
normal mammary epithelial cells (and/or myoepithelial cells) can be initiated by various risk factors 
including genetic mutation (BRCA1, BRCA2 and TP53, etc.), menopausal status, aging, obesity, 
mammographic density, health complications, and lifestyle habits13. The aforementioned risk factors are 
quite important as they play critical roles in shaping a pro-tumorigenic microenvironment, which 
ultimately regulates tumor malignancy.  In addition, breast cancer has various subtypes and each subtype 
is classified by its unique molecular and histologic patterns, which ultimately influence the tumor 
microenvironment. Since these unique patterns have a strong association with the etiology as well as 
clinical outcomes of cancer, accurate classification of breast cancer is prognostically and clinically 
important for choosing appropriate treatment strategies14.  
For molecular classification, estrogen receptor (ER), progesterone (PR), and epidermal growth 
factor-2 (HER2/neu) are key markers to delineate the 5 subtypes of breast cancers: Basal-like/triple 
negative (ER-, PR-, HER2-), luminal A (ER+, PR+, HER2-) luminal B (ER+, PR+, HER2+), HER2-enriched 
(HER2+, PR+/-, ER+/-), and normal breast-like breast cancer 15,16. In the United States, luminal A (45%) 
occurs most prevalently but is relatively curable. In contrast, basal-like breast cancer patients (5 to 15%) 
are rare yet they exhibit the poorest clinical outcomes and survival rate15. Subtypes classified by the 
receptor status are treated through their respective receptor inhibitors. For example, Trastuzumab and 
Tamoxifen have been used for HER2+ and for ER+, respectively17. However, receptor-based treatment is 
not effective for all breast cancer subtypes. For example, triple negative breast cancer does not respond to 
receptor inhibitors or endocrine therapy18. Also, although the receptor-based treatments have been shown 
to positively affect their respective cancer types, what is often unaccounted for is the dynamic interaction 
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between cancer and host stroma and its resulting tumor microenvironment. This interaction complicates 
therapy by providing a niche where cancer cells can escape from the given cancer drugs8.  
 In addition, histopathological analysis has also been used clinically to diagnose tumor stage and 
grade via characterization of morphological changes of cellular components as well as overall tumor 
stroma structure16. For example, breast tumor stroma progressively changes from in-situ, invasive, to 
metastatic exhibiting distinct features in each stage, so analysis by a trained pathologist is useful for a 
prompt diagnosis of tumor stage. However, the specific molecular mechanism underlying the 
development of unique histopathological pattern in each breast cancer subtype is not fully understood. 
Due to the lack of understanding, still there is a gap between diagnostic results from histopathological 
analysis and their corresponding treatment. In addition, as briefly stated, risk factors play pivotal roles in 
forming unique tumor microenvironment, so a better understanding of mammary tumor stroma dynamics 
in conjunction with breast cancer risk factors and the resulting impacts on tumor malignancy and 
recurrence will ultimately help to develop better diagnostic tools as well as therapeutic methods. 
 
1.3. The tumor microenvironment: An emerging hallmark of cancer 
Since Paget’s “seed and soil” hypothesis, a growing number of studies supporting his seminal 
proposal have emphasized the significance of the tumor microenvironment19,20. The dynamic tumor 
microenvironment is modulated by key processes, which have been defined as hallmarks of cancer,: 
genomic mutation and instability, unlimited replicative capability, disrupted control of mitogenesis, cell 
death resistance, induced angiogenesis (blood vessel branching), activated invasion and metastasis, pro-
tumoral inflammation, and anabolic metabolism21. Each of aforementioned processes occurs while 
affecting the other processes, and these interwoven processes require the collaboration of cancer cells 
with host stromal cells. For example, unlimited replication of cancerous epithelial cells leads to formation 
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of a tumor mass. The mass creates a hypoxic core where blood vessels are not able to reach out and 
stimulates chronic inflammation, which in turn recruits inflammatory cells into tumor stroma. The 
resulting inflammatory cell-mediated factors activate surrounding stromal cells such as fibroblast or 
progenitor cells to partake in fibrotic reaction, a part of innate wound healing process. The fibrotic 
reaction consequently densifies and then stiffens tumor stroma, which explains why tumors typically 
appear as rigid lumps, which are easily palpable. Thus, tumor stiffness has been recognized as a hallmark 
of cancer and often used as diagnostic marker. However, tumor stiffness is not just a passive outcome of 
tumorigenesis, but it, in turn, actively promotes tumor progression by stimulating cancer cell growth as 
well as promoting some of the aforementioned key processes such as angiogenesis22-25.  
 
Tumor desmoplasia 
(Published in Adv Drug Deliv Rev (2014))9 
 
Fig. 1.1. Normal and tumor mammary microenvironment 
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As described briefly, one of the key features of tumor microenvironment is the dynamics of tumor 
stroma. As tumors progress from a benign to malignant stage, tumor stroma structure changes facilitate 
tumor growth, invasion and metastasis. The change is mediated by tumor-associated fibrosis, called as 
tumor desmolasia. Tumor desmoplasia is initiated by the recruitment of cancer-associated fibroblasts 
(CAFs). The recruited CAFs, which include myofibroblasts, deposit abundant amounts of fibrillar ECM 
molecules including collagen I and fibronectin26. These ECM compositional changes entail structural and 
mechanical alterations of the ECM27-29. For example, CAFs mediate the partial unfolding of fibronectin, 
which increases both the stiffness of individual fibronectin fibers30,31 and their ability to bind other ECM 
molecules such as glycosaminoglycans (GAGs) and collagen32. Along with elevated collagen crosslinking 
(e.g., by lysyl oxidase, non-enzymatic glycation, or transglutamination33,34) and GAG concentration28, 
these pronounced changes in ECM density and intermolecular interactions globally enhance tumor 
stiffness with direct consequences for tumor progression. Despite this overall increase in matrix 
deposition and cross-linking, tumor cells simultaneously mediate the degradation of the ECM, in part by 
secreting enzymes such as matrix metalloproteinases (MMPs). In addition to generating tumorigenic 
ECM fragments35, elevated MMP activity affects the local (micro-scale) physical properties of the tumor 
ECM. For example, MMPs can govern degradation and reorganization of fibrillar collagen, while 
enhancing interactions with other ECM components through exposure of cryptic binding sites36-38. 
Nevertheless, it has to be kept in mind that non-proteolytic functions of MMPs may be similarly 
important. For example, MMP-9 has been associated with smooth muscle cell adhesion, migration, and 
cell-mediated collagen contraction, independent of its proteolytic function38,39. The diverse roles of MMPs 
in tumorigenesis have previously been reviewed by Egeblad40 and Page-McCaw41. Such alterations of 
ECM composition, structure, and mechanics stimulate malignancy and drug resistance by inducing 
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manifold changes in cell signaling42-45, which governs cell fate decisions, tumor angiogenesis, progression, 
and drug resistance (e.g., Rho/Rock, ERK/MAPK, and PI3K) 46-49 
 
Tumor angiogenesis 
Angiogenesis is a multi-step process of new blood vessel formation from existing endothelial 
cells (ECs): EC activation, ECM remodeling, EC migration and branching and neo-vessel stabilization50. 
Angiogenesis requires collaborative efforts of surrounding stromal cells with ECs acting upon the pro- 
and anti-angiogenic signaling, which is typically well-balanced50. However, any induced imbalance 
between pro- and anti-angiogenic signals modulates the interaction between ECs, their neighboring cells, 
and ECM, consequently slanting the vasculature homeostasis toward avascularity or dysfunctional 
hypervascularity51,52.  
During tumorigenesis, tumor growth rate often surpasses the rate of regular vascularization, 
which remains quiescent during health51. Since blood vessels function as a path to deliver oxygen and 
nutrients as well as take away metabolic waste, the lack of blood vessels relative to tumor mass size 
ultimately results in a hypoxic (<1% O2) and acidic (pH ~6.6-6.8) microenvironment, which in turn 
triggers angiogenesis by stimulating pro-angiogenic signaling 53-59. In particular, hypoxia activates the 
transcription factor hypoxia inducible factor 1 (HIF-1), which is positively linked to up- regulation of pro-
angiogenic factors such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor 
(bFGF), Interleukin 8 (IL-8). In addition, biochemical and mechanical cues derived from ECM also 
modulate tumor angiogenesis through direct and indirect pathways, some of which include modulation of 
pro-angiogenic signaling, as described next. 
Excessive matrix remodeling via desmoplasia generates stiff and denser stroma, which also 
ultimately stimulates angiogenesis. ECM-derived biomechanical cues stimulate proliferation, migration 
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and blood vessel branching of ECs as well as pro-angiogenic signaling of neighboring stromal cells. In 
addition, a dense matrix reduces the rate of diffusion of small molecules along the dysregulated transport 
during tumorigenesis, which ultimately creates uneven distribution of angiogenic molecules, thereby 
forming irregular blood vessels. Moreover, matrix degradation via matrix metalloproteinases (MMPs) is 
required to facilitate EC branching and blood vessel morphogenesis. For example, MT1-MMP is known 
to regulate precise matrix degradation to facilitate vessel sprouting from endothelial tip cells60. Likewise, 
seemingly-typical biochemical and mechanical cues derived from cancer cells, ECs, surrounding stromal 
cells, soluble factors, and ECM collectively promote tumor angiogenesis, yet these cues lead to blood 
vessels that are structurally and functionally different from normal ones, which in turn, hinder effective 
cancer therapy. Therefore, investigating how tumor angiogenesis is regulated in conjunction with tumor 
desmoplasia is necessary for improving therapeutic delivery.  
 
Cancer-associated fibroblasts, myofibroblasts  
As briefly described, tumor stiffening is mediated by CAF. CAF shares similar features with 
myofibroblasts, and thus the two terms have been used interchangeably. As a primary cellular mediator of 
wound healing, myofibroblasts are primarily involved in ECM deposition and facilitating new blood 
vessels formation for tissue repair. Thus, myofibroblasts deposit abundant matrices comprising thicker 
and linearized collagen type I and unfolded fibronectin, and secreted multiple pro-angiogenic morphogens 
such as VEGF, bFGF and IL-861. Their pro-fibrotic and pro-angiogenic potentials also have been 
associated with disease progression such as fibrotic disease and cancer.  
Myofibroblasts are recognized by their distinct morphology and α-SMA stress fibers, which 
trigger contractility32. The origin of myofibroblasts is controversial although various cell types including 
fibroblasts, both native or recruited bone-marrow mesenchymal stem cells, and endothelial cells exhibit 
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myofibroblastic potential upon the fibrosis-triggering chemical (TGF-β, and IL-8) and physical stimuli 
(substrate stiffness and shear stress)32. However, it has yet to be determined what the main cellular source 
of myofibroblasts is in mammary tissue during breast tumorigenesis. 
 
1.4. Obesity and breast cancer 
Obesity is a pathological condition resulting from unbalanced calorie uptake and energy 
expenditure62. The incidence of obesity in both adults and children has been progressively increasing over 
the past two decades worldwide62,63. This public health concern comes from the higher morbidity of obese 
patients with multiple diseases such as cardiovascular diseases, type 2 diabetes mellitus and several types 
of cancer including breast cancer64. In addition, childhood obesity increases the predisposition to develop 
these aforementioned diseases during adulthood65, which may further expand the population affected by 
obesity-associated health problems.  
Specifically, obesity has been link to a higher incidence of breast cancer, particularly in 
postmenopausal women66. This connection has been thought primarily due to the obesity-mediated 
increase in aromatase activity and thus, enhanced estrogen production66. However, recent studies showed 
that obesity has a strong correlation with the incidence of basal-like breast cancer (triple-negative) in pre-
menopausal women, and triple-negative breast cancer typically exhibits higher histopathological grades 
while not responding to hormone-based therapies suggesting that the connection between obesity and 
breast cancer may result from more than dysregulated endocrine functions67,68. Thus, a better 
understanding of obesity-mediated features will aid in interrogating the mechanism underlying the link.  
Obesity induces pronounced adipose tissue expansion upon the extra energy uptake, and this 
adipose tissue expansion results from hypertrophy as well as hyperplasia of adipocytes62,69. The 
abnormally expanded adipocytes also lose their functional integrity, which consequently dysregulates 
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leptin signaling, fatty acid synthesis, as well as insulin resistance, which are also known to modulate 
cancer cell growth as well as metabolism64. In addition, the abnormal growth of adipocytes consequently 
stimulates the infiltration of inflammatory cells, leading to chronic inflammation64. The infiltrating 
macrophages together with dysregulated adipocytes produce pro- and anti-inflammatory cytokines such 
as IL-6, IL-8, tumor necrosis factor-α (TNF-α), and TGF-β, all of which also are known to promote tumor 
growth, invasion and metastasis.62,64,70 In addition, aforementioned inflammatory cytokines also induce 
interstitial fibrosis which might be similar to tumor desmoplasia71. Fibrosis results from a chronic wound 
healing process where myofibroblasts are recruited and deposit abundant ECM deposition, thereby 
stiffening tissue as seen during tumor desmoplasia71,72. Despite the similarity between obesity-associated 
fibrosis and tumor desmoplasia, whether obesity-associated fibrosis is functionally linked to tumor 
progression has yet to be determined. Therefore, simple extrapolation of fat mass to the predisposition of 
obesity-associated cancer might not be appropriate since not only adipose tissue expansion but also its 
resulting cascades such as metabolic dysfunction, inflammation, and fibrosis potentially regulate cancer 
development and progression. 
 
1.5. Adipose tissue and its cellular source  
Adipose tissue 
Breast tissue primarily consists of compliant adipose tissue containing adipocytes, and adipose 
stromal cells (ASCs) including progenitor cells, fibroblasts, endothelial cells, pericytes, and immune cells 
(macrophages and mast cells). Adipose tissue (AT), specifically white adipose tissue, has been mainly 
considered an energy storage depot of our body. However, AT is also a secretory depot to produce a 
broad spectrum of bioactive morphogens such as adipokines (leptin, and adiponectin), inflammatory 
cytokines (TNF-α, TGF-β, IL-6, and IL-8) and chemokines (monocyte chemotactic protein-1)73.  
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AT is broadly divided into two major depots, skin (subcutaneous) and abdominal-/organ-
associated fat (visceral). This classification is seemingly simple yet AT develops very unique 
characteristics depending on its origin. In addition, their distinct features ultimately influence the 
development of specific diseases during obesity as well as its associated diseases74. For example, visceral 
AT exhibits metabolically active features with a higher level of lipolysis as well as lipid synthesis than 
subcutaneous fat, so visceral AT is positively correlated with type 2 diabetes and cardiovascular diseases 
while subcutaneous fat is inversely related to these metabolic diseases75,76. However, since visceral AT is 
directly connected with the liver through the portal venous system, all metabolites and soluble factors 
such as free fatty acids, hormones, and cytokines from visceral fat tissue have systemic effects, which 
may eventually influences subcutaneous fat73. In addition, architecture and cellular and extracellular 
components of fat tissue can be also organ-specific77. For example, mammary or breast AT exhibits 
unique architecture, cellular composition and molecular signaling profiles although anatomically it seems 
close enough to subcutaneous fat. In addition, its architecture changes signaling throughout a women’s 
lifetime (i.e. pregnancy and menopausal status), which also might influence the incidence of breast 
cancer11,78,79. Therefore, precise classification of the features of AT from different locations is prerequisite 
when determining clinical relevance. 
  
Mammary AT and its ECM remodeling 
Mammary AT embraces the functional components of the breast, mammary gland epithelium79. 
In healthy individuals, mammary gland epithelium is highly organized by cellular bilayers and complex 
stroma. Mammary gland morphogenesis results from a well-programmed process directed by various 
stimuli including ECM-derived physicochemical cues, which provide an instructive guide to epithelial 
cells and their neighboring stromal cells78. During mammary gland morphogenesis, TGF-β mediated 
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ECM deposits at the tip of the gland endbuds and this ECM remodeling ultimately facilitates epithelial 
cells to grow and sprout for branching80,81. In addition, during involution, the mammary AT is completely 
restructured by stimulating epithelial cell apoptosis but protecting the stem cell niche for recovery79.  
Such deconstruction and restoration of mammary AT stroma are well coordinated with mammary 
gland functions. Therefore, perturbed mammary structure might facilitate tumorigenesis. For example, 
changes in mammary stroma structure and its molecular signaling during pregnancy have been also 
correlated with pregnancy-associated breast cancer82. Likewise, during obesity mammary fat may also go 
through fat expansion, inflammation as well as fibrosis, which modulate mammary microenvironment. 
However, it remains unclear whether obesity modulates the mammary microstructure. If this is the case, 
then the cellular mediators of this change are not well understood. Therefore, I will discuss possible 
cellular candidates that can contribute to ECM remodeling in (mammary) AT in the following section. 
 
Adipocytes and adipose-derived stem cells  
AT contains two major cellular groups, adipocytes and adipose stromal vascular cells (ASVCs), 
which includes progenitor cells, (myo-) epithelial cells, fibroblasts, endothelial cells and immune cells 
(macrophages and mast cells). Floating adipocytes and settling adipose-derived stem cells (ASCs) can be 
easily separated by simple centrifugation83. 
Adipocytes are mature fat-laden cells differentiated from pre-adipocytes or stem cells under the regulation 
of transcription factors such as CCAAT/enhancer-binding protein (C/EBP) gene family and peroxisome 
proliferator-activated receptor-γ (PPAR-γ)84. Adipocytes were believed to be terminally differentiated and 
rarely proliferative. However, recent studies indicate that not only can adipocytes change their functions, 
but also commit themselves to different lineages in response to microenvironmental cues85. This finding 
opens up the potential of adipocytes to contribute to the progenitor cell population as well as 
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myofibroblastic cell population which contribute to matrix remodeling and furthermore fibrosis in 
mammary AT during obesity or tumorigenesis.  
 
In addition, ASVCs contained ASCs, which are multi-potent adult stem cells isolated by various 
markers including integrin family members (i.e. CD9, ALCAM/CD16), CD44, CD90/Th1 and ICAM-
1/CD5483. In healthy condition, the number of ASCs is maintained constant and if necessary, ASCs are 
differentiated to replenish other types of cells to maintain tissue homeostasis83. However, an abnormally 
larger population of ASCs in response to the microenvironmental cues of a host tissue might perturb 
tissue homeostasis as recent clinical reports showed controversial outcomes for implanted adipose tissue 
or ASC-based therapies86. Similarly, during obesity ASVC population including ASCs is enlarged either 
by their enhanced proliferation or dedifferentiation of adipocytes to progenitor-like cells64. However, 
whether obesity-associated changes of the microenvironment modulate the composition of ASVC remains 
unclear. Therefore, understanding pathological potentials of ASCs in diseases will be beneficial to 
developing adequate cancer therapy as well as tissue engineering approaches.  
 
 
Fig. 1.2. Cellular components in adipose tissue 
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1.6. Mechanotransduction and extracellular matrix components 
 Mechanotransduction  
Tensional homeostasis plays a critical role in maintaining organ, tissue and cell integrity87. 
Mechanotransduction, or cascade of transmitting outside-in and inside-out cues is mediated by the 
reciprocal interactions of 1) external-to-internal force, and 2) force sensory-to-responsive machineries. 
External forces such as shear, tensile or compressive stresses modulate contractility via integrin-mediated 
adhesion, actomyosin polymerization (source of internal force), and biochemical signaling 88.   
In cells, mechano-sensing machineries have been suggested including integrin-mediated adhesion, 
cadherin-mediated junction and ion-channels89. In particular, integrin-mediated focal adhesion (FA) 
complex is the most established model. Integrin is a transmembrane modality to sense ECM-associated 
stimuli and send the signal inward89. Moreover, each ECM ligand recruits a specific combination of 18 α- 
and 8 β-integrin subunits, which consequently triggers distinct cascade signaling90. Then, the FA complex 
is formed with integrin clusters to interact with fibrillar ECM and actin filaments via adhesion complex 
proteins required for FA assembly such as talin and vinculin90. Mechanical forces activate FA complex 
assembly, and the fully activated FA complex then stimulates tyrosine kinase or phosphatase such as focal 
adhesion kinase (FAK), which activates small GTPase RhoA and subsequently its effector, Rho Kinase 
(ROCK)90. The activated Rho/ROCK signaling phosphorylates myosin light chain, which consequently 
induces stress fiber development and myosin-mediated contractility90. The pulling force is transmitted 
from actin, integrin, and to ECM, which initiates the whole process of cyclic mechanotransduction again90. 
Finally, the transduced signaling such as activation of Rho/ROCK signaling regulates cell proliferation, 
differentiation, and migration90. Also, the contractile force changes ECM structure and conformation 
which then can influence cellular behaviors including cell adhesion, proliferation, and the pro-angiogenic 
potential90,91.  
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 Collagen and its assembly 
Collagen is one of the most widely used materials for tissue engineering material due to its 
biocompatibility, bioactivity, and ability to be remodeled92. Specifically, in the interstitial space, fibrillar 
collagen type I and III are the most abundant types and even further up-regulated during diseases93. In 
addition, dramatic changes in microstructure and organization of collagen matrix have been  clinically 
associated with disease progression such as cancer and fibrotic diseases42,94. Therefore, many in vitro 
engineered systems utilize collagen to interrogate the role of collagen physicochemical properties in the 
regulation of cellular behaviors. 
Collagen gelation or polymerization in vitro occurs through an enthalpy-driven self-assembly 
process which has three phases: lag phase, growth phase, and the plateau phase93. During the lag phase, 
when reaching a critical aggregation concentration, collagen monomers spontaneously start to form 
aggregates.. Afterwards, collagen fibrils grow both laterally and axially in accordance with collagen 
concentration, optimal temperature, neutral pH, ionic strength, salts, surfactant, and other macromolecules 
(cells, other proteoglycans, and glycosaminoglycan) during lag and growth phases, and the fibrils are 
assembled until available collagen monomers are depleted93.  
The microstructural changes of collagen fibers ultimately alter the biophysical properties of 
collagen fibers as well as the matrix as a whole, so modulating aforementioned parameters (temperature 
and pH, etc.) has been used to control collagen microarchitecture as well as the mechanical properties of 
collagen-based tissue constructs93.   However, there is still a lack of understanding as to whether and how 
individual physical parameters of collagen matrix microarchitecture (i.e. collagen fiber diameter, length 
and alignment) modulate cellular behaviors. 
 
Fibronectin and its mechanosensitive structure  
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Fibronectin (Fn) is a functionally important ECM protein due to its mechanosensitive structure95. 
Fn is a large dimeric glycoprotein present in both soluble (plasma Fn in blood) and insoluble forms 
(matrix Fn in various tissue stroma). Two 250kDa monomers are linked through disulfide bonding at their 
C-terminus. Each monomer contains three types of repeating modules (I, II, and III) and each module has 
specific functional binding domains for cells, adjacent Fn, growth factors, and other ECM proteins such 
as collagen, and fibrin96.  
Among the three types of repeating modules, type III is responsible for Fn’s force-mediated 
conformational change and subsequent interaction with cells and other ECM proteins due to its 
mechanosensitive structure. The type III module consists of disulfide bridge-free β-sheets making itmore 
susceptible to tensile force such cell-mediated contraction, whereas β-sheets in type I and II modules are 
stabilized by two disulfide-bonds, respectively97. In addition, Type III modules contain cell binding sites 
such as RGD-loop site in III10, multiple cryptic sites buried in the equilibrium state to bind Fn modules 
and integrins and the PSHRN site in III9. The PSHRN site, also called ‘synergy site,’ is functionally 
coupled with the RGD-loop site due to its spatial proximity96.  
Upon mechanical strain such as tensile force from cell contraction, Fn is extended and then its 
tertiary structure becomes unfolded. The unfolding Fn subsequently exposes Fn-binding cryptic sites as 
well as separating the RGD and synergy sites. Specifically, the changes in distance and orientation of 
RGD and synergy site influence the interaction with α5β1; α5β1 has higher affinity to RGD when it remains 
close and faces the synergy site, while the separation of the two sites decreases Fn’s affinity to α5β1
96. On 
the other hand, Fn binding to αvβ3 is unaffected by conformational changes. These altered integrin 
affinities of Fn directly influences cellular behaviors such as proliferation, differentiation, and pro-
angiogenic activity. Moreover, the exposed cryptic sites enable Fn to Fn interactions for Fn fibrillogenesis, 
so contraction-mediated unfolding of Fn is required for Fn assembly91,95. Furthermore, the bioactivity of 
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Fn-bound biomolecules is modulated in a force-dependent manner95,98. For example, contraction-driven 
Fn unfolding releases latent TGF-β by exposing the buried binding site holding the TGF-β99. 
In tumors, Fn is as extensively up-regulated as collagen, but more importantly its “unfolded” 
conformation contributes to enhancing tumor growth, angiogenesis and invasion100,101. In addition, Fn aids 
collagen assembly and influences collagen fiber orientation (i.e., linearity), dysregulations of which are 
representative of tumor desmoplasia and fibrosis102,103. Therefore, evaluation of the conformational 
changes of Fn in diseases vs. healthy conditions will aid us in identifying and understanding the 
pathology of diseases such as cancer. 
 
1.7. Biological and engineering approaches  
Orthotopic xenograft of mammary tumor model 
Mouse models of human cancer provide physiological relevance of the findings from in vitro 
tissue culture models104. Thus, we utilized an orthotopic xenograft tumor model where human cancer cells 
are injected into the cleared mammary fat pad with and without human stromal cells, and grown until 
tumor formation over 6 - 8 weeks105. This method allows us to evaluate human breast tumor progression 
with or without interaction with human stromal cells in vivo. Mammary fat pads provide implanted cells 
with a mammary-specific microenvironment as compared to subcutaneous xenografts104. However, the 
compromised immune system of this mouse model may influence the cancer-associated inflammation. In 
addition, mouse mammary gland structural changes during mice life cycles are different from that of 
human mammary gland structural changes, so the responses of mammary tumors grown in mouse 
mammary fat pad may differ from those in a native human mammary microenvironment106, which might 
be a caveat for currently available mouse models.  
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Obese mouse models 
The most widely used genetic mouse models of obesity are either those with the leptin-gene 
mutation (ob/ob) or the leptin receptor mutation (db/db)107. Ob/ob mice gain weight rapidly due to the loss 
of the leptin gene, and eventually develop obesity and insulin resistance with hyperinsulinemia. Db/db 
mice are leptin receptor-deficient so their perturbed leptin signaling causes hyperleptinemia. In addition, 
they develop insulin resistance, hyperinsulinemia, as well as hyperglycemia so this mouse model has been 
used for type 2 diabetes research107. However, human obesity is not just a monogenic disease but is 
affected by other genetic and environmental factors62. Thus, other polygenic mouse models as well as 
diet-induced obesity (DIO) models of obesity can complement the aforementioned monogenic mouse 
models. Especially given the fact that diet and sedentary life style rather than genetic mutation greatly 
influence the occurrence of human obesity, DIO models are useful to study human obesity. For DIO 
models, mice were fed with high-fat or low-fat diets for 6 to 8 weeks and naturally developed obesity108. 
 
 Förster resonance energy transfer imaging technique  
The unfolding process of Fn increase the distance between the type III domains.. Thus, the 
proximity between the type III domains can provide us with relative Fn conformation, and this average 
conformation can be measured by the Förster Resonance Energy Transfer (FRET) imaging technique31,97. 
Briefly, four specific cysteines and eight random lysines on the type III module are dual-labeled with 
Alexa Fluor 546 acceptor fluorophores and Alexa Fluor 488 donor fluorophores, respectively. Fn 
conformation determines the proximity of acceptors and donors within one Fn molecule, and the 
proximity enables non-radiative energy transfer from excited donors to acceptors via their dipole-dipole 
interaction. The donors are excited by a low intensity of laser light to prevent photo-bleaching and the 
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emitted signals from both donors and acceptors are collected by confocal fluorescence imaging. The ratio 
of the acceptor and donor intensities (IA/ID) is calculated as an indicator of Fn fiber conformation
31. 
Fn FRET intensity =
𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝐴𝑐𝑐𝑒𝑝𝑡𝑜𝑟 
𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝐷𝑜𝑛𝑜𝑟
  
Fn conformation relative to its quantified FRET intensity is determined using pre-obtained 
calibration curves showing the FRET intensity of chemically denatured dual-labeled Fn as well as ii) its 
corresponding circular dichroism spectra as an indication of β-sheet content in chemically denatured dual-
labeled Fn95,97. Low FRET intensity indicates unfolded Fn conformation and high FRET intensity implies 
a near-to-compact form of Fn. Similarly, the strain of Fn fiber relative to the FRET intensity can be 
obtained by referencing a pre-obtained calibration curve showing the FRET intensity as a function of real 
fiber strain, which were macroscopically measured using a strain device95. 
 
Surface forces apparatus  
Surface Forces Apparatus (SFA) is a sensitive technique that allows to measure a wide range of 
surface-surface interactions by means of optical interferometry109,110. In particular, this technique is 
capable of measuring from very weak surface interactions (such as electrostatic and van der Waals forces) 
to indentation of bulk materials (extraction of ECMs elastic moduli). Semi-reflective surfaces (back 
silvered mica glued onto semi-cylindrical surfaces) are used to build an optical interferometer that traps 
white light, similar to two facing mirrors. The optical interferometer is used to obtain the absolute 
distance between the surfaces from the light that exits the optical interferometer, resulting in fringes of 
equal chromatic order (FECO). For measurements, two cylindrical discs containing the mica substrates 
are faced to each other and mounted in a crossed configuration (cylindrical axes positioned at 90°). One 
surface is mounted on a double cantilever spring of known spring constant. The other surfaces is mounted 
on a motorized micrometer. The FECO fringes are recorded while the surfaces are moved by a known 
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distance. If the surfaces start to displace in a nonlinear fashion, the spring is deflecting. It is this deflection 
what allows to calculate the force acting between the surfaces. The resulting force distance profile can be 
further analyzed to extract the compressive elastic moduli of a viscoelastic media using the Johnson 
contact mechanics model111. The compressive elastic moduli of cell-deposited matrices can therefore be 
measured by means of the SFA. 
 
Imaging analysis of collagen fibers 
1) Confocal Reflectance Microscopy (CRM) 
To accurately characterize the collagen matrix, multiple imaging approaches have been 
established. Confocal reflectance microscopy (CRM) imaging has been the most commonly utilized 
technique to visualize the structure of fibrillar collagen network (fibril diameter, mesh size, pore size as 
well as orientation)109. CRM utilizes reflection, back scattering of light to visualize collagen fibers. A 
laser at 488nm is split through a beam splitter and the split laser illuminates collagen fiber. Subsequently 
the reflected light from collagen matrices is collected to construct a 3D collagen matrix. No specific 
chemical is required for this imaging technique, so it has been clinically used to examine the 
morphological features of melanocytic skin tumors. Moreover, reflectance is not affected by fluorescence 
imaging so it is possible to perform a dual imaging of collagen fibrils with fluorescently-labeled cells, or 
other proteins simultaneously109. However, one drawback of this technique is that collagen fibrils at 
certain angles cannot be visualized by CRM110. Therefore, additional techniques are necessary to 
complement CRM for accurate analysis. 
 
2) Other collagen imaging techniques 
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Second harmonic generation (SHG) imaging technique also has been utilized to image collagen 
fibrils from in vitro, ex vivo, and in vivo systems. Second harmonic generation is an optical phenomenon 
where two photons from laser light illuminated to material like collagen are converted to a single photon 
of half the wavelength with a doubled energy. This is related to the structure of the material, so non-
centric materials like collagen can be imaged via SHG111. 
Lastly, polarized microscopy has long been used to visualize the different size and orientation of 
collagen fibrils. While the refracted light from isotropic material shows unidirectional patterns regardless 
of the orientation of the material, the refracted light from anisotropic material such as collagen is diverged 
to two different directions and the split light travels at a different velocity. The orientation and structural 
factors of collagen fibrils determine the direction and velocity of the refracted light, which can then be 
visualized with different colors after being filtered through a polarizer112.  
 
1.8. Research objectives 
Dynamic extracellular matrix (ECM) remodeling and angiogenesis – two well-known hallmarks 
of cancer – are functionally linked during tumorigenesis61. Excessive matrix remodeling and its resulting 
stiffening provide biochemical and mechanical cues at various (nano to micro) scales to promote tumor 
growth in part by regulating angiogenesis113. These processes are directly and indirectly regulated by 
stromal myofibroblasts during tumorigenesis61. Various sources of myofibroblastic cells have been 
reported, but it has yet to be determined whether host cells in mammary tissue also contribute to the 
myofibroblast population upon the regulation of tumor-derived biochemical and mechanical cues. 
Mammary tissue consists of adipose tissue, which contains adipose-derived stem cells (ASCs) and 
adipocytes114. The multi-potency of ASCs and the plasticity of adipocytes have been reported previously85. 
However, their potential to differentiate into myofibroblastic cells, thereby promoting tumor stiffening 
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and angiogenesis remains poorly understood. In addition, it is interesting to note also that the population 
of ASCs in adipose tissue increases during obesity, a key risk factor for breast cancer. Also, obesity 
shares similar features with cancer such as a low-grade chronic inflammation and fibrosis thus making it 
possible that the obesity-primed ASCs may play a pivotal role in bridging obesity with breast cancer in 
much the same way that cancer-associated ASCs do. 
Thus, I hypothesize that ASCs and adipocytes promote breast tumor progression upon the 
regulation of pathological biochemical and mechanical cues during tumorigenesis as well as obesity. In 
particular, ASCs and adipocytes are committed to myofibroblastic cells, thereby partaking in dynamic 
ECM remodeling, and angiogenesis, all of which consequently promote tumor progression.  
This hypothesis was addressed by investigating the following sub-hypotheses: 
1. Cancer-activated ASCs promote breast tumor progression 
2. Cancer-activated adipocytes increase the myofibroblastic cell population, thereby 
stimulating ECM remodeling and angiogenesis 
3. Obesity-associated interstitial ECM remodeling promotes tumor malignancy 
4. Collagen fiber microstructure regulates the pro-angiogenic potential of ASCs. 
Further details of the studies completed to confirm or deny these hypotheses are described in the 
subsections below. 
 
1. Cancer-activated ASCs promote breast tumor progression 
In chapter 2, the pro-tumorigenic role of ASCs in the promotion of breast tumor progression will 
be discussed. For this study, both mouse and human cells were assessed as a model of progenitor cell 
components of adipose tissue. Well-characterized mouse preadipocytes 3T3L1 (ATCC) and adipose-
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derived stem cells (Lonza) were utilized to examine the pro-tumorigenic potential of adipose tissue-
derived progenitor cells upon tumor-derived biochemical and mechanical cues. To mimic tumor-derived 
morphogens, tumor-conditioned media (TCM) were collected from malignant breast cancer lines MDA-
MB231 (ATCC). Additionally, the responses of the progenitor cells to soluble factors from a series of 
mammary epithelial cells (benign to malignant) as well as mouse mammary cancer cells (MCN1 and 
MCN2) were assessed. Tumor-associated mechanical cues were recapitulated by culturing cells on 2D 
and 3D scaffolds (alginate, collagen and polyacrylamide) with varying stiffness. Finally, orthotopic 
mammary tumor models were generated to confirm our in vitro studies and for the analysis of in vivo 
samples, various physical tools (e.g., imaging techniques and mechanical testing tools) were utilized. 
 
2. Cancer-activated adipocytes increase the myofibroblastic cell population, thereby 
stimulating ECM remodeling and angiogenesis 
In chapter 3, the impact of cancer-activated adipocytes on ECM remodeling and angiogenesis 
were addressed. To assess the matrix remodeling and angiogenic potential of adipocytes in the presence 
of tumor-derived soluble factors, adipocytes were cultured in both 2D and 3D in vitro systems with TCM. 
Adipocytes were obtained through adipogenic differentiation of ASCs and 3T3L1s and cultured by TCM 
in 2D culture plate and 3D collagen scaffolds. The phenotypic changes of cancer-activated adipocytes 
were determined by analyzing their adipogenic markers and myofibroblastic features. To address the 
clinical relevance of in vitro findings, the adipogenic features of adipocytes in mouse and patient-derived 
tumors were analyzed. Finally, the impacts of their enhanced pro-angiogenic signaling on endothelial cell 
sprouting – an indication of angiogenesis – were assessed. 
 
3. Obesity-associated interstitial ECM remodeling promotes tumor malignancy 
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In chapter 4, I propose that obesity-associated interstitial ECM remodeling may provide a 
functional link between obesity and breast cancer. To investigate the role of obesity-associated interstitial 
fibrosis in the promotion of mammary tumorigenesis, pro-fibrotic features in the mammary fat of both 
mouse and human samples were separately extracted from cancer-free lean and obese subjects and 
analyzed. In addition, fibrotic characteristics of adipose tissue from obese and lean mice were also 
assessed as a function of fat depot (subcutaneous vs. visceral fat) and menopausal status (ovary intact vs. 
ovariectomized mice). To specifically look for the cellular mediators of obesity-mediated interstitial 
fibrosis, ASCs were isolated from age-matched lean and obese mice and characterized utilizing various 
physical oncological approaches. To understand the functional significance of fibrosis mediated by 
obesity-associated ASCs, the impacts of biochemical and physical cues of ECM derived from ASCs on 
tumor malignancy were examined. Lastly, clinical relevance of our findings was established by assessing 
human tumor specimens collected from normal and obese patients. 
 
4. Collagen fiber microstructure regulates the pro-angiogenic potential of ASCs. 
In chapter 5, I will discuss whether the microstructural changes of collagen fibers that were 
detected in the presence of tumors and obesity provide a feedback mechanism that regulates the 
phenotype of ASCs. To investigate whether microstructural changes of collagen fibers regulate the pro-
angiogenic potential of ASCs, we generated 3D collagen scaffolds with different fiber microstructures. 
We assessed the phenotypic changes of ASCs as a result of changes in fiber thickness and in turn how 
they remodeled their surrounding matrices. In addition, we assessed the pro-angiogenic potential of the 
ASCs, which were altered by the fiber microstructure through the use of co-culture 3D models with 
human umbilical vein endothelial cells (HUVECs). Finally, we investigated whether changes in the 
microstructure of collagen fibers regulate cell behaviors in a mechanoregulation-dependent manner. 
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The findings of my doctoral work suggest that ASCs and adipocytes contribute to an increase of 
myofibroblastic cells, thereby promoting tumor stroma remodeling and progression. In addition, obesity-
primed ASCs show a pro-tumorigenic potential similar to that of cancer-associated ASCs. Thus, 
microenvironmental cues including the change of collagen fiber structure, even at the micro-scale, 
potentially stimulate the phenotypic alteration of host adipose stromal cells favoring breast tumorigenesis.  
These findings suggest great clinical implications in the field of cancer research and tissue 
engineering. Although adipose tissue has been greatly appreciated for regenerative applications such as 
breast reconstruction, our findings call for more careful consideration of the contextual cues, which could 
possibly activate the pathogenic potential of host or exogenous adipose tissue. In particular, the health 
conditions of tissue recipients as well as donors might play a pivotal role in the safety of implanted 
adipose tissue. Implanted or host adipose tissue in cancer patients might develop pathogenic potential due 
to the contextual cues, and obesity-associated ASCs might not exhibit the same characteristics as those 
from normal individuals and again highlight that caution must be exercised in such procedures. In 
addition, given the increase of obesity and its strong connection with both pre- and post-menopausal 
breast cancer, our findings will contribute to developing better diagnostic and therapeutic approaches. 
Finally, as our studies indicate that even micro-scale alterations to the tumor microenvironment can 
influence the behavioral changes of host cells, more careful consideration is required when designing 
tissue engineering approaches based on adipose tissue and biomaterials.  
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CHAPTER 2 
 
IMPLANTED ADIPOSE PROGENITOR CELLS AS PHYSICOCHEMICAL 
REGULATORS OF BREAST CANCER  
 
Published in Proceedings of the National Academy of Sciences (2012) 
 
2.1. Contributors  
Co-authors of this work made the following contributions: Emily M. Chandler (alumnus in the Fischbach 
lab) is a co-first author, and she made significant contributions to this project leading in vitro studies to 
investigate the roles of tumor-derived cues in regulating the differentiating potential of ASCs. Joseph P. 
Califano (alumnus in the Reinhart-King lab) performed traction force measurement via traction force 
microscopy (TFM). Roberto C. Andresen Eguiluz, a Ph.D. student in the Gourdon lab aided in measuring 
tumor stiffness via dynamic mechanical thermal analysis (DMTA), Jason S. Lee (alumnus in the 
Fischbach lab) assessed the pro-angiogenic signaling of ASCs in response to varying stiffness, Christine J. 
Yoon (alumnus in the Fischbach lab) performed phosphorylation of focal adhesion kinase (pFAK) 
analysis of ASCs in response to tumor-derived cues. David T. Tims (alumnus), master student and James 
X Wang (alumnus), undergraduate student at the moment in the Fischbach lab measured ASC-mediated 
collagen contractility and the resulting stiffness of collagen scaffolds. Le Cheng, a Ph.D student in the 
Nikitin lab at the moment aided in performing in vivo study. Sunish Mohanan performed 
histopathological assessment of tumor sections. Mark R. Buckley (alumnus), a Ph.D. graduate student in 
the Cohen lab and Prof. Itai Cohen aided in measuring the stiffness of ASC-embedded collagen gels with 
their custom-built tool. Prof. Alexander Yu Nikitin providing help us to design and pursue in vivo 
experiments. Dr. Rebecca M. Williams performed second harmonic generation imaging analysis of 
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collagen in tumor explants, Prof. Delphine Gourdon provided help to measure tumor stiffness via DMTA, 
analyze the data and prepare the manuscript, Prof. Cynthia A. Reinhart-King provided her technical and 
scientific advice on TFM analysis, and Prof. Claudia Fischbach primarily led this project providing 
guidance for the experimental design, data interpretation and preparation of the manuscript. 
 
2.2. Abstract 
Multipotent adipose-derived stem cells (ASCs) are increasingly used for regenerative purposes, such as 
soft tissue reconstruction following mastectomy.  However, the ability of tumors to commandeer ASC 
functions to advance tumor progression is not well understood.  Through the integration of physical 
sciences and oncology approaches we investigated the capability of tumor-derived chemical and 
mechanical cues to enhance ASC-mediated contributions to tumor stroma formation.  Our results indicate 
that soluble factors from breast cancer cells inhibit adipogenic differentiation while increasing 
proliferation, pro-angiogenic factor secretion, and myofibroblastic differentiation of ASCs.  This altered 
ASC phenotype led to varied extracellular matrix (ECM) deposition and contraction, thereby enhancing 
tissue stiffness, a characteristic feature of breast tumors.  Increased stiffness, in turn, facilitated changes in 
ASC behavior similar to those observed with tumor-derived chemical cues.  Orthotopic mouse studies 
further confirmed the pathological relevance of ASCs in tumor progression and stiffness in vivo.  In 
summary, altered ASC behavior can promote tumorigenesis, and thus their implementation for 
regenerative therapy should be carefully considered in patients previously treated for cancer. 
 
2.3. Introduction 
Adipose-derived stem or progenitor cells (ASCs) are widely used in tissue engineering due to 
their multipotency, ability to enhance vascularization, and relative ease of isolation from the stromal 
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vascular fraction of adipose tissue115,116. In particular, ASCs are increasingly considered for reconstructive 
procedures following surgery for breast cancer, which compose the majority of the 93,000 breast 
reconstructions performed in the U.S. per year 117. ASCs offer several advantages over commonly utilized 
silicone and saline implants including their ability to regenerate functional adipose tissue, which 
reconstitutes a large fraction of the breast118,119. However, malignantly transformed cells may be present 
in breast cancer survivors without manifest disease, and it remains unclear whether implanted ASCs may 
increase the risk of tumor development and relapse 120 by establishing a microenvironment conducive to 
nascent or recurrent tumorigenesis.  
Mammary tumors are stiffer than normal mammary gland tissue 121,122, due in part to tumor-cell 
secreted morphogens that vary extracellular matrix (ECM) assembly. Altered ECM deposition and 
contraction not only enhances tumor rigidity 29, but further modulates tumor progression by perturbing 
epithelial morphogenesis 123 and vascular development 124. Myofibroblasts regulate these outcomes by 
controlling the mechanical properties of the tumor-associated ECM and by functioning as a major source 
of host-derived pro-angiogenic factors (e.g., vascular endothelial growth factor [VEGF]) 29,125. Generally, 
local fibroblasts are considered the primary origin of myofibroblasts and regulator of this desmoplastic 
reaction, but bone marrow- and tissue-derived mesenchymal stem cells may also contribute to this cell 
population. Specifically, ~20% of tumor-associated α-smooth muscle actin (α-SMA) positive 
myofibroblasts originate from bone marrow, whereas non-bone marrow tissues including adipose tissue 
contribute to the remainder126,127. However, the integrated effects of tumor-associated physicochemical 
cues on ASC-dependent tumorigenesis are not well understood. 
Here, we applied a physical sciences-based approach to correlate tumor-mediated changes in 
ASC phenotype with tissue stiffness, vascularization, and growth. Our findings support that ASCs can 
develop into myofibroblasts in response to physicochemical factors provided by cancerous cells. This 
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phenotypic change not only enhanced angiogenesis, but also ECM rigidity, which further increased the 
tumor-promoting capacity of ASCs in a positive feedback loop. These findings support the role of ASCs 
as key regulators of mammary tumor progression and recurrence, which warrant review of current tissue 
engineering therapies following mastectomy and may be explored towards more efficacious therapies for 
breast cancer patients. 
 
2.4. Materials and methods 
Cell culture 
3T3-L1, MDA-MB231, MCF-7 (all from ATCC), and MCN1 and MCN2 mammary tumor cells 
isolated from the mammary epithelium of MMTV-Cre, p53L/L and MMTV-Cre, p53L/L RbL/L, respectively 
128, were routinely cultured in MEM (α-modification [αMEM], Sigma) containing 10% FBS (Tissue 
Culture Biologicals) and 1% antibiotic (penicillin/streptomycin, Gibco). MCF-10A (ATCC), MCF10AT1, 
and MCF10ACA1a (both from Barbara Ann Karmanos Cancer Institute 129) were maintained in 
DMEM/F12 supplemented with horse serum, epidermal growth factor (EGF), hydrocortisone, cholera 
toxin, insulin, and penicillin/streptomycin (all from Invitrogen) as previously described 130. ASCs and 
HUVECs (both from Lonza) were cultured in their corresponding growth media (ADSC-GM and EGM-2, 
respectively; Lonza). Lonza isolates ASCs from lipoaspirates based on expression of stem cell-associated 
surface markers 131, cryopreserves cells at passage 1, and does not pool cells from multiple sources. Here, 
ASCs from two separate, female donors were utilized at passages less than 7. ASC function in response to 
TCM and matrix mechanical properties was assessed as described in SI Materials & Methods.  
Additionally, the effect of 3T3-L1 derived matrices on MDA-MB231 cell growth was measured as 
documented in SI Materials & Methods. 
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In vivo studies 
Media, ASCs and/or MDA-MB231 cells (1 x 106 in 20 µL of DMEM/ Ham’s F-12, 10 % FBS, 
1 % antibiotic) were injected into the cleared mammary fat pad of at least six 3 week-old female 
SCID/NCr mice (Charles River Labs, 01S11) (2 tumors per mouse) per condition in accordance with 
Cornell University animal care guidelines. Explants were harvested 6 weeks after implantation, imaged, 
weighed, and divided for subsequent formalin-fixation/paraffin-embedding and lysis in T-PER buffer 
(Pierce). H&E-stained sections were broadly evaluated for pathological features of malignancy. Cross-
sections were characterized further via immunohistochemical staining for CD31, α-SMA, type I 
procollagen, collagen, and desmin. Staining procedures and image analysis methods are described in SI 
Materials & Methods. VEGF and IL-8 content in lysates was measured via mouse VEGF and human IL-8 
DuoSets (R&D) and normalized to protein content as determined via BCA protein assay (Thermo 
Scientific). Tumor stiffness was determined using a Dynamic Mechanical Thermal Analyzer (DMTA) as 
further outlined in SI Materials & Methods. 
 
Analysis of ASC proliferation, adipogenesis, pro-angiogenic capability, and migration 
Conditioned media was collected from the different tumor and epithelial cell lines in αMEM (1% 
FBS, 1% antibiotic) over 24-hours, normalized to cell number, concentrated 10-fold in an Amicon 
centrifugal filter unit (Millipore, MWCO = 3kDa), and subsequently reconstituted with media containing 
1% FBS, 1% antibiotic specific to the treatment cell type (SI Table 1).  Control medium was incubated for 
24-hours without exposure to cells and then processed similarly. Conditioned media was globally tested 
for cytokines using Human Cytokine Antibody Arrays (Affymetrix) and specifically for IL-8 using 
ELISA DuoSets (R&D). Following 3 days of treatment in control media or TCM, cell counting was 
performed using a Z2 Beckman Coulter counter. To assess proliferation, 10 µM BrdU (Sigma) was added 
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to cells 20 hours prior to fixation in 4% paraformaldehyde.  Then samples were incubated in ice-cold 1N 
HCl, secondly 37oC 2N HCl, and then 0.1 M borate buffer prior to adding biotinylated mouse anti-BrdU. 
Subsequently, BrdU and nuclei were visualized by incubating streptavidin conjugated Alexa Fluor 555 
(both from Invitrogen) and DAPI (4',6-diamidino-2-phenylindole).  The percentage of BrdU positive 
nuclei was determined from 5 images per samples with 4 samples per condition. Adipogenesis of 3T3-
L1s and ASCs was induced as previously described 132 and by using ADSC-GM SingleQuots® (Lonza), 
respectively. Differentiation into adipocytes was assessed by Oil Red O staining, immunofluorescence 
analysis of PPARγ, and by measuring glycerol-3-phosphate dehydrogenase (GPDH) activity. To this end, 
supernatants collected after lysing cells on ice in a buffer containing 50mM Tris, 1mM EDTA, and 1mM 
β mercaptoethanol (all from J.T. Baker) were mixed with dihydroxyacetone phosphate and oxidized 
nicotinamide adenine dinucleotide (NADH).  The decrease in NADH absorbance at 340 nm was 
quantified on a spectrophotometer over a 7 min period. Enzyme activity was normalized to total protein 
content as measured by protein assay (Bio-Rad). To visually assess differentiation into lipid-rich 
adipocytes, cells were fixed in formalin prior to staining with Oil Red O (Sigma) for 2 hours.  Samples 
were imaged with a bright field microscope. For analysis of pro-angiogenic activities, 3T3-L1s or ASCs 
were preconditioned in control or TCM for 3 days, then fresh media containing 1% FBS and 1% 
antibiotic specific to the treatment cell type (SI Table 1) was added, collected after 24 hours, and 
processed as described above. VEGF secretion of preconditioned ASCs or 3T3-L1s was analyzed via 
human or mouse Quantikine ELISA (R&D Systems), respectively. To assess the effect of altered VEGF 
secretion on HUVEC migration, ASCs and 3T3-L1 cells were preconditioned in 24-well plates for 3 days.  
Collagen-coated transwell inserts seeded with HUVECs were placed atop tumor-preconditioned 3T3-L1 
or ASCs cells in 300 µL fresh αMEM (1% FBS, 1% antibiotic).  After 24 hours, inserts were formalin 
fixed following a swabbing of the top of the membrane to remove non-migrated HUVECs.  Cells on the 
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lower side of the membrane were stained with DAPI and nuclei were counted.  The number of migrated 
HUVECs was then normalized to the number of progenitor cells within each well. 
To determine the effect of tumor-derived soluble factors on adipose progenitor recruitment, 3T3-L1 cells 
were seeded on top of collagen I (PureCol, Inamed)-coated Nunc 10 mm Tissue Culture inserts (8.0 µm 
pore) with either 300 µL of TCM or control medium beneath the membrane. After 18 hours, 3T3-L1s 
were formalin fixed following a swabbing of the top of the membrane to remove non-migrated cells.  
Cells on the lower side of the membrane were stained with DAPI and the average number of nuclei was 
counted in 8-10 images per sample. 
 
Analysis of myofibroblast differentiation and matrix stiffening 
Differentiation into myofibroblasts was assessed by immunofluorescence analysis of α-SMA, 
procollagen I, and collagen I. TGF-β signaling was modulated by supplementing control or TCM with 2 
ng/mL recombinant human TGF-β1 or 0.5 µg/mL anti-human LAP (neutralizing TGF-β1 antibody) (both 
from R&D Systems), respectively. IL-8 signaling was evaluated by supplementing growth media with 3-
30 ng/mL recombinant human IL-8 (R&D). For contraction assays, ASCs were suspended in 15 mg/ml 
collagen (1 x 106 cells/ml) isolated from rat tails 133, cast into circular molds 0.5 mm thick and 4 mm in 
diameter 134, and cultured in TCM or control medium under free-floating conditions on an orbital shaker 
for 2 weeks, with media changes every other day. To inhibit proliferation, TCM or control medium 
containing 4 µg/mL mitomycin (Fisher Scientific) was added to gels when at the initially as an initial 
exposure has been shown to inhibit proliferation over long cultures 135.  Actin polymerization and pROCK 
signaling were inhibited by supplementing culture media with 1 µM cytochalasin D or 20 µg/ml Y-27632 
(both from Tocris), respectively. Gel contraction was determined by measuring the surface area of each 
gel using the magnetic lasso tool in Photoshop (Adobe) to trace the apical surface circumference.  For the 
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analysis of cell matrix stiffening, these same collagen gels were stained with 
dichlorotriazinylaminofluorescein (5-DTAF), sandwiched between two glass plates, and imaged with a 
Zeiss LSM 510 confocal microscope as previously described 136. A shear stress was applied to the gel 
while a photobleached line in the sample was imaged.  As described previously, a MATLAB algorithm 
was then used to calculate the gel modulus based on the displacement of the photobleached line 136. 
 
Western Blot analysis 
Cells were lysed in RIPA buffer (Thermo Scientific) containing protease inhibitor (Sigma), 
phosphatase inhibitor cocktail (Sigma), and 1mM phenylmethylsulfonyl fluoride (PMSF) in isopropyl 
alcohol. Equivalent quantities of protein were loaded as measured by BCA protein assay (Thermo 
Scientific). Proteins were separated by SDS-PAGE and transferred to a PDVF membrane (Bio-Rad).  
Primary antibody to α-SMA (Abcam) was incubated with the membrane overnight at 4°C, followed by a 
1 hour incubation with HRP-conjugated anti-rabbit secondary antibody (Novus Bio) at room temperature. 
Chemiluminescence detection was performed to visualize probed protein using ECL kit (GE healthcare) 
based on manufacturer’s protocol. 
 
Analysis of ASC response to matrix mechanical properties 
For TFM analysis, polyacrylamide gels 1, 5, and 10 kPa in stiffness were prepared with 
embedded fluorescent beads, and cellular traction stresses were measured using TFM as previously 
described 137-140.  Briefly, images of the gels in a stressed and relaxed state were taken pre- and post-
removal of the cells with trypsin, respectively.  The substrate strains were converted to traction stresses 
using the LIBTRC analysis library developed by Professor Micah Dembo of Boston University, who also 
invented the basic theory that underlies TFM. Polyacrylamide gels of the same stiffness were used for 
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immunofluorescence analysis of pFAK[Y397] as described in staining procedures section.  For studies of 
the combined effects of stiffness and TCM, cells were seeded on 0.2-30 kPa stiff polyacrylamide gels and 
cultured in either control media or TCM for 10 days followed by staining and analysis as further outlined 
in the staining procedures section.  
For studies using RGD-modified alginate substrates, alginate (Protanal LF 20/40, FMC) was 
modified with GGGGRGDSP (Peptides International) as previously described (1).  3%, 1.5%, and 0.75% 
(w/v) solutions of alginate in αMEM were cast between glass plates with 1 mm spacers and crosslinked in 
a solution of 0.1 M CaCl2, 0.01 M HEPES (J.T. Baker) prior to punching out topographically flat disks 1 
cm in diameter.  The aggregate moduli of these gels were measured on a mechanical tester (ELF 3100, 
Bose) under radial confinement and uniaxial compression at 15 % strain.  Cells were seeded on top of the 
gels and cultured in well plates.  For analysis of cell proliferation and adipogenic differentiation, cells 
were harvested by dissolving these constructs in 50mM EDTA (J.T. Baker) in PBS and analyzed as 
described above. To analyze VEGF secretion, cell-seeded gels were transferred to a new culture dish 
(containing fresh media with 1% FBS, 1% antibiotic). After 24 hours, media and cells were collected and 
analyzed as described above. 
 
Staining procedures  
For immunocytochemistry, formalin-fixed cells were rinsed with 0.05% Triton-X in PBS (PBS-
X) followed by incubation with 2% BSA in PBS-X (PBS-X/BSA) for blocking. Afterwards, the cells 
were incubated with the desired primary antibody diluted in PBS-X/BSA overnight at 4°C. Following two 
washes in PBS-X, samples were incubated with secondary antibodies diluted in PBS-X/BSA for 1 h at 
room temperature. The following primary antibodies were used: rabbit anti-mouse PPARγ (Cell 
Signaling), rabbit anti-FAK [pY397] (Invitrogen), mouse anti α-SMA (Abcam), rabbit anti-procollagen I 
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(SP1.D8, Developmental Studies Hybridoma Bank, Univ. of Iowa), and rabbit anti-collagen I (Millipore). 
DAPI was used as a nuclear counterstain, Alexa Fluor 488 or 568 served as the secondary antibody, and 
Alexa Fluor 568 phalloidin enabled detection of the F-actin cytoskeleton (all from Invitrogen).  Imaging 
was performed on a Zeiss Observer Z.1 microscope and AxioCam MRm camera unless otherwise noted.  
Cells cultured within collagen gels and stained with α-SMA primary and AlexaFluor 488 conjugated 
secondary antibody, phalloidin, and DAPI as described above were imaged on a Zeiss 710 Confocal 
Microscope. 
Paraffin sections of in vivo samples were subjected to antigen retrieval treatments (proteinase K 
[Dako] for CD 31 staining, antigen retrieval system [Dako] for α-SMA, and 0.1M citrate buffer for 
alternate stains) prior to standard immunostaining procedures.  Subsequently, samples were rinsed and 
blocked in 0.05% Tween-20 PBS (TBST) with SuperBlock (Thermo Fisher). An additional blocking 
treatment was required for α-SMA and procollagen I staining using M.O.M kit (Vector laboratories) and 
Vectastatin ABC kit (Vector laboratories), respectively. In addition to those previously listed, rat anti-
CD31 (Pharmingen), mouse anti-α-SMA (Invitrogen), and rabbit anti-desmin (Abcam) were used. For CD 
31 staining, the TSA biotin system (PerkinElmer) was used for signal amplification. 
For DAB-based immunohistochemistry, sections were deparaffinized, rehydrated, and peroxidase 
activity was blocked using 3% hydrogen peroxide.  An HRP-conjugated secondary antibody (Novus) and 
3,3´-diaminobenzidine (DAB) substrate kit (Thermo Fisher) were used for color development. Samples 
were counter-stained with Gill’s hematoxylin (EMD chemicals). IgG isotopes and primary antibody-
lacking sections served as negative controls. 
For picrosirius red staining, 4 µm thick sections of paraffin–embedded tissue were stained with 0.1% 
Sirius red F3B (Sigma) in saturated picric acid for two hours at room temperature followed by washes in 
1% acetic acid and distilled water. Stained sections were imaged with a Nikon Eclipse TE2000-S 
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microscope equipped with a rotating filter for polarized light under 10x magnification. Microscope setting 
(light intensity, exposure time, condenser opening, gain, and gamma parameter) was identically applied to 
all samples. 
 
Image analysis 
For image analysis, raw data images of in vitro samples and histological cross-sections were 
utilized. Background staining was excluded from images of various samples prior to isolating positive 
pixels of interest using Adobe Photoshop.  Isolated positive pixels were then quantified in ImageJ (NIH). 
Positive pixel density was averaged for 8-10 representative images per sample for 4 samples per in 
vitrcondition and for 15-20 representative images per explant. Staining intensity was normalized to cell 
number as determined by semi-automated counting of DAPI-stained nuclei utilizing ImageJ. Alpha-SMA 
positive cells in in vitro samples were manually quantified. Cell alignment was determined by using 
ImageJ to measure the angle of lines drawn through the long axis of up to 20 randomly selected cells per 
image.  The average cell angle was then calculated for each image, and the individual cell deviation from 
the average was computed and plotted. For all conditions, a total of 8-10 images were examined per 
sample with 4 samples per condition. 
Collagen fiber maturity in picrosirus stained sections was analyzed by their birefringence color 
appearing as red/orange, green, or blue/white according to fiber thickness. The birefringence color pixels 
(red, green, and blue) of collagen fibers were segmented using RGD stacks in ImageJ and the separated 
pixels were quantified. Threshold was manually adjusted based on grayscale images, and kept constant 
throughout all samples. Five to six images were analyzed per tumor for a total of three tumors per 
condition. 
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Multiphoton Second Harmonic Generation (SHG) microscopic imaging and analysis 
Multiphoton microscopy was accomplished on a previously described 141, custom-built 
multiphoton microscope. Tumor specimens were (placed in the tumor-size within biopsy foam pad), 
immersed in PBS and imaged with 780 nm illumination using an Olympus 20x/0.95W XLUMPlanFl 
objective.  For each specimen, six Z-series (2 µm steps, from 60 μm to 100 µm deep) were acquired. 
Emissions were separated into SHG (360-405 nm, pseudocolored blue) and autofluorescence (420-550 
nm, pseudocolored yellow) channels.  Only the SHG channel was used for image quantification of 
collagen matrix properties. In order to analyze the mean structural characteristics of the collagen matrix, a 
2D spatial autocorrelation was computed from the SHG channel image.  An isocontour was fit to 1/e of 
the maximum value of each image autocorrelation. The mean radius of this isocontour (the mean 
correlation distance in the image) indicates the size scale of the collagen framework in any image. For the 
collagen fibril linearity (FL) assessment, individual fibrils were traced throughout each Z-stack.  
Specifically, both the full-length and the shortest distance between fibril ends were measured using Fiji (a 
packaged version of Image J). The ratio of the linear distance over the full fibril length was calculated to 
be the collagen FL. 30-50 fibrils per z-stack were measured, and the collagen FL of each condition was 
obtained by averaging the FL of 4 z-stacks in each tumor.  A total 3 tumors per each condition were 
analyzed. 
 
Dynamic Mechanical Thermal Analysis (DMTA) of tumor sections 
  Tumors were cut with a vibratome into sections ranging from 0.7 to 2.7 ± 0.1 mm in thickness as 
determined optically.  These sections were punched into cylindrical thick sections of 2.6 ± 0.1 mm in 
diameter, fixed between the DMTA (Dynamic Mechanical Thermal Analyzer) parallel plates, and 
fully immersed in PBS in a standard submersion-compression clamp configuration at room temperature 
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(25oC). A controlled force was applied by the upper plate while the lower plate held the sample in a fixed 
position. Two series of compressive tests were then run on each tumor sample following an initial 
application of 9% pre-strain to ensure full sample engagement and homogeneous compression before 
measurement. In the first series, the maximum force applied was set at 0.01 N to exclusively probe the 
low-strain (9-14%) elastic regime, while it was set at 0.4 N in a second series to investigate the full elastic 
regime and the onset of material to plastic deformation (up to 30% strain). The rate of force application 
was kept constant at 0.025 N/min in all tests. The force F (force sensitivity of 0.001 N) and thickness L 
(distance resolution of 0.05 µm) were measured simultaneously and converted into engineering stress-
strain plots as follows: strain, =(Lo-L)/Lo (where Lo is the initial zero-strain sample thickness and L the 
thickness during compression) and stress, =F/Ao (where F is the force during compression, and Ao the 
initial zero-strain sample cross-sectional area). The mean Young’s modulus, E, was obtained for each 
sample from the slope of the stress-strain curve,  = E  in the low-strain (9-14%) elastic regime.   
 
Analysis of the effect of altered progenitor cell ECM 
3T3-L1-derived matrices were prepared as previously described 142.  More specifically, 3T3-L1s 
were seeded in 12-well plates and cultured for 8 days in either TCM or control media supplemented with 
50 µg/mL ascorbic acid (Sigma) with media changes every other day.  On day 8,the matrix was incubated 
at 37oC for 15 minutes in extraction buffer (20 mM NH4OH and 0.5% Triton-X in PBS). After washing in 
DI H20 and PBS followed by blocking with 1% BSA, Vybrant DiO (Invitrogen) labeled MDA-MB231 
cells were seeded atop the matrix.  pROCK signaling was inhibited by supplementing culture media with 
20 µg/mL Y-27632 (Tocris).  The number of MDA-MB231 cells was assessed by counting 10 images per 
sample for 6 samples per condition. 
 
  
 
 
38 
  
2.5. Results and Discussion 
Tumor-secreted soluble factors regulate the adipogenic and pro-angiogenic capability of ASCs 
To evaluate the effects of tumor cell-secreted soluble factors on ASC behavior, human ASCs 
were cultured in conditioned media (TCM) from commonly used highly (MDA-MB231) or less (MCF-7) 
aggressive human breast cancer cell lines. Additionally, mouse 3T3-L1 preadipocytes – a well-
characterized cell model for studies of adipogenesis 143 – were used to verify the broad implications from 
primary ASC studies. Analysis of cell numbers and BrdU incorporation suggested that tumor-secreted 
factors promoted ASC and 3T3-L1 proliferation (Figs. 2.1A and 2.2A). In contrast, these factors inhibited 
adipose differentiation of both cell types, as indicated by attenuated activity of the lipogenic enzyme 
glycerol-3-phosphate dehydrogenase (GPDH) (Fig. 2.1B), reduced activation of the key adipogenic 
transcription factor peroxisome proliferator-activated receptor gamma (PPAR) (Fig. 2.1C), and 
inhibition of lipid droplet accumulation (Fig. 2.2B). An experiment in which ASCs and 3T3-L1s were 
first exposed to TCM and then evaluated for VEGF secretion further suggested that exposure to tumor-
derived soluble factors enhances pro-angiogenic factor release by these cells (Fig. 2.1D). This increased 
pro-angiogenic potential is relevant to tumor angiogenesis as tumor-preconditioned ASCs and 3T3-L1s 
significantly enhanced VEGF-dependent migration of human umbilical vein endothelial cells (HUVECs) 
as compared to control cells (Fig. 2.1E).  Notably, the magnitude of these changes directly correlated with 
tumor aggressiveness since MDA-MB231-TCM induced greater phenotypic changes than media collected 
from MCF-7 cultures (Figs. 2.1 and 2.2). Comparison of effects mediated by isogenically matched normal 
MCF10A, premalignant MCF10AT, and fully malignant MCF10ACA1a confirmed these results. 
Specifically, premalignant cells had no significant effect on ASC adipogenic differentiation and VEGF 
secretion, but promoted ASC proliferation, whereas MCF10ACA1 mediated similar outcomes as MDA-
MB231 (Figs. 2.2). The described observations were broadly relevant as TCM collected from two murine  
  
 
 
39 
  
 
Fig. 2.1. Tumor-secreted soluble factors regulate ASC function. (A) TCM from MCF-7 and MDA-MB231 
increases 3T3-L1 and ASC cell numbers relative to control (n = 4). (B) TCM treatment significantly decreases 
the adipogenic capability of 3T3-L1 and ASCs relative to control as determined by spectrophotometric analysis 
of GPDH activity (n = 4). (C) Immunofluorescence analysis of the transcription factor PPARγ in 3T3-L1s 
confirmed that TCM inhibits adipogenic differentiation (Scale bar = 20 µm). (D) ELISA suggested that ASCs 
and 3T3-L1s increase VEGF secretion when pre-conditioned with TCM from either MCF-7 or MDA-MB231 (n 
= 4). *P < 0.05 from control; ♦P < 0.05 from MCF-7 condition. (E) 3T3-L1s and ASCs that were previously pre-
conditioned with TCM from MDA-MB231 enhanced HUVEC migration in a transwell assay as compared to 
3T3-L1s and ASCs pre-conditioned with control media; addition of a VEGF neutralizing antibody decreased 
migration to control levels (n = 4). *P < 0.05 from all other conditions of the same cell type. 
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Fig. 2.2. Tumor-secreted soluble factors alter ASC functions. (A) TCM from MCF-7 and MDA-MB231 
enhanced ASC proliferation as assessed by quantification of BrdU positive cells (Scale bar = 50 µm). (B) 
Differentiation of ASCs in control medium resulted in large lipid droplet formation, whereas ASCs cultured in 
TCM from MCF-7 or MDA-MB231 exhibited decreased lipogenesis, evidenced by diminished Oil Red O-
staining (Scale bar = 50 µm). (C) Quantification of BrdU positive ASCs after culture in conditioned media of 
isogenically matched MCF10A (normal), MCF10AT1 (premalignant), and MCF10ACA1a (malignant) cells 
confirms that increased ASC proliferation represents a function of tumor malignancy (Scale bar = 50 µm). (D) 
Adipogenic differentiation of ASCs in conditioned medium from normal and premalignant cells resulted in lipid 
droplet formation, whereas ASCs cultured in TCM from MCF10ACA1a cells exhibited decreased lipogenesis, 
evidenced by diminished Oil Red O-staining (Scale bar = 100 µm). (E) MCF10ACA1a TCM also significantly 
increased VEGF secretion by ASCs as measured by ELISA (n = 4). *P < 0.05 from control condition; ♦P < 0.05 
from MCF10A condition. 
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mammary tumor cell lines 128 also enhanced the proliferative and pro-angiogenic phenotype of adipose 
progenitor cells, and inhibited adipose differentiation (Figs. 2.3A-C).  
 
 
 
Fig. 2.3. Effect of tumor-derived soluble signals on 3T3-L1 cells. (A) Cell counting indicated enhanced 3T3-
L1 cell numbers with TCM supplementation from two mouse breast cancer cell lines (MCN1, MCN2) as 
compared to control medium (n = 4). (B) Adipogenic differentiation significantly decreased with murine TCM 
treatment relative to control conditions as assessed by spectrophotometric analysis of GPDH activity and Oil 
Red O staining (n = 4) (Scale bar = 20 µm). (C) Murine TCM also significantly increased VEGF secretion by 
3T3-L1s as measured by ELISA (n = 4). (D) Using a transwell assay, 3T3-L1 migration was enhanced towards 
TCM from MDA-MB231 and MCF-7 as compared to control medium (n = 3). *P < 0.05 from control; ♦P < 0.05 
from MCN2 condition. 
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To assess whether tumor cells actively recruit ASCs, we performed a transwell migration assay 
with TCM, which revealed that tumor cells attract adipose progenitor cells towards their respective 
location by enhancing their directed migration (Fig. 2.3D). Collectively, these data suggest that tumor 
cell-secreted soluble factors enhance the pro-angiogenic cell population in the tumor stroma by guiding 
ASC behavior. As TCM similarly modulated ASCs and 3T3-L1 behaviors, and because data generated 
with primary cells are typically more robust and generalizable the studies described in the following 
experiments were primarily performed with ASCs.  
 
Tumor-secreted soluble factors enhance ASC differentiation into ECM-stiffening myofibroblasts 
Myofibroblasts represent an abundant and pro-angiogenic cellular component of the tumor stroma 
whose differentiation is enhanced in the presence of reduced signaling by the adipogenic transcription 
factor PPAR144,145. Accordingly, ASCs exposed to TCM exhibited increased expression of α-SMA 
relative to control conditions (Fig. 2.4A), whereby MDA-MB231 exerted a more pronounced effect than 
MCF-7 (Fig. 2.5A). Next, we evaluated whether tumor cell-derived transforming growth factor-beta 
(TGF-) 146, which is pivotal to myofibroblast differentiation and secreted at higher levels by more 
malignant tumor cells 147 may be involved in inducing phenotypic changes of ASCs. Control media was 
supplemented with TGF- at levels found in MDA-MB231-TCM, and this treatment induced ASC 
differentiation into myofibroblasts as suggested by immunofluorescence and Western Blot analysis (Figs. 
2.4A, 2.5A, and 2.5B). Furthermore, addition of a TGF- epitope-blocking antibody to TCM abrogated 
myofibroblast differentiation. While these data verify that tumor-secreted TGF- functions as an 
upstream mediator of ASC differentiation into myofibroblasts (Fig. 2.4A) other molecules may also play 
a role. Comparison of control media as well as TCM from MCF-7 and MDA-MB231 via a cytokine 
antibody array revealed that interleukin-8 (IL-8), VEGF, tumor necrosis factor receptor 1 (TNFR1), and 
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Fig. 2.4. Tumor-secreted soluble factors enhance ASC differentiation into myofibroblasts. (A) Treatment of 
ASCs with TCM from MDA-MB231 significantly increased the number of α-SMA (green) positive cells as 
quantified by immunofluorescence image analysis. Addition of TGF- to control media (control + TGF-) 
mimicked this effect, while blockade of TGF- in TCM using a neutralizing antibody (MDA-MB231 - TGF-) 
inhibited it (n = 4) (Scale bar = 100 µm) *P < 0.05 from control and MDA-MB231-TGF-β conditions. (B) 
Collagen gels seeded with ASCs contracted significantly more when cultured in TCM as compared to control 
medium (n = 6), which occurred even in the presence of the proliferation inhibitor mitomycin C (Scale bar = 500 
µm). (C) Confocal imaging revealed that ASCs within these gels developed stress fibers necessary to generate 
contractile tension, but only differentiated into α-SMA positive cells in the presence of TCM (Scale bar = 100 
µm). (D) Pharmacological inhibition of cytoskeletal tension using cytochalasin D and Y-27632 contributed to 
the release of the contracted gels as determined via an increase in surface area (n = 3). (E) ASC-seeded collagen 
gels cultured in the presence of TCM were significantly stiffer relative to gels maintained in control media as 
determined by confocal-based stiffness measurements (n = 5) *P < 0.05. 
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matrix metalloproteinase 3 (MMP3) were enhanced in the different TCM (Fig. 2.5C). As IL-8 has been 
related to myofibroblast differentiation in prostate cancer 148 and was enhanced in MDA-MB231 vs. 
MCF-7 TCM (Fig. 2.5D), we assessed its effect on ASC myofibroblast differentiation. Results from these 
studies elucidated that IL-8 regulates ASC differentiation into myofibroblasts in a dose-dependent manner 
(Fig. 2.5E). These findings are of particular interest as myofibroblasts themselves can up-regulate IL-8 149, 
which may further promote ASC differentiation into myofibroblasts. Myofibroblasts mediate tissue 
stiffening by altering ECM composition and enhancing contraction. In particular, increased collagen I 
deposition has been associated with increased tumor stiffness and malignancy33.  
Our results support that ASC exposure to tumor-derived paracrine signals may contribute to this 
because ASCs produced significantly more procollagen I (6.0 ± 1.1-fold) and collagen I (4.2 ± 1.1-fold) 
when treated with TCM rather than control media (Fig. 2.6). Furthermore, ASCs seeded into 
microfabricated, free-floating 3-D collagen disks differentiated into myofibroblasts, developed stress 
fibers, and contracted significantly more when cultured in the presence of TCM as compared to control 
media (Figs. 2.4B and C). These variations in gel contraction were mediated by differences in TCM-
mediated changes in myosin-mediated cell contractility rather than proliferation. Specifically, 
pharmacological inhibitors cytochalasin D (i.e., an agent preventing actin polymerization) or Y-27632 
(i.e., an inhibitor of pROCK and thus RhoA signaling) added at levels not affecting cell viability restored 
the diameter of previously contracted gels (Fig. 2.4D), whereas disks cultured in TCM in the presence of 
mitomycin C contracted markedly more than similarly treated control disks (Fig. 2.4B). To more fully 
elucidate whether the integrated effects of varied ECM deposition and contraction indeed contribute to 
enhanced tissue rigidity, the mechanical properties of ASC-seeded disks were analyzed following culture 
in control or TCM. The shear modulus of these constructs was determined by applying a shear force to 
one side of a sandwiched gel while measuring the displacement of a photobleached line within the gel136.  
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Fig. 2.5. Effect of tumor-derived soluble factors on ASC myofibroblast differentiation. (A) 
Immunofluorescence analysis indicates that ASCs up-regulate α-SMA more significantly with TCM from MDA-
MB231 as compared to TCM from MCF-7 or control cells (n = 4) (Scale bar = 50 µm). (B) Western blot 
analysis of equally loaded samples shows elevated levels of α-SMA in ASCs treated with MDA-MB231 TCM, 
which were further enhanced by addition of TGF-β. (C) Cytokine array analysis indicates increased levels of 
noted cytokines within TCM as compared to control media. (D) ELISA of IL-8 detects greatest levels within 
MDA-MB231 TCM (n = 3). (E) Exposure of ASCs to relevant concentrations of IL-8 increased α-SMA and 
stress fiber formation (insets) in a dose-dependent manner (Scale bar = 200 µm). *P < 0.05 from all other 
conditions. 
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 Our results indicate that TCM-treated collagen cultures were 1.5-fold stiffer than the control 
constructs (Fig. 2.4E), confirming the effect of tumor-derived soluble factors on ASC-mediated changes 
in tissue stiffness. These changes may be explained by varied matrix contraction and irreversible changes 
in ECM deposition mediated, for example, by increased collagen crosslinking due to enhanced 
lysyloxidase (LOX) expression by myofibroblasts 150 and/or deposition of additional fibrillar ECM 
components such as fibronectin31.  
 
ASCs respond to ECM mechanical properties in a tumor-dependent manner 
Both normal and tumorigenic cells respond to increased matrix stiffness by adjusting integrin-
dependent adhesion, traction forces, and subsequent downstream signaling 123,151 with effects on cell 
proliferation and differentiation 46. To test the ability of ASCs to react to tumor-derived and/or self-
imposed changes in matrix stiffness we evaluated their adhesion characteristics and corresponding 
activation of mechano-regulated signaling pathways using hydrogels of pathologically-relevant stiffness 
122. Specifically, use of collagen-coated polyacrylamide gels allowed control over mechanical properties 
of the culture substrates without affecting adhesion ligand density, which can independently affect cell 
behavior 152. ASCs spread significantly more on substrates  mimicking breast tumor rigidity (~10kPa 122) 
 
Fig 2.6. Effect of tumor-secreted soluble factors on ASC collagen deposition. (A) ASCs cultured in MDA-
MB231 TCM exhibited increased collagen type I matrix assembly relative to ASCs maintained in control 
medium as indicated by positive staining for type I procollagen and (B) collagen. (Scale bar = 20 µm).  
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Fig. 2.7. ASC response to matrix mechanical properties. (A) Traction Force Microscopy indicated that ASCs 
cultured on hydrogels of increased stiffness spread significantly more and exert greater traction forces relative to 
cells cultured on soft matrices; representative ASC phase images with corresponding traction maps are shown (n 
= 13-32, error bars represent standard errors) (Scale bar = 50 µm) *P < 0.05 from 1 kPa condition. (B) 
Immunofluorescence indicates increased recruitment of pFAK to ASC focal adhesions on stiffer matrices (white 
arrows) (Scale bar = 20 µm). (C) Cell counting suggested that increased matrix stiffness enhances ASC numbers 
and that pharmacological inhibition of cytoskeletal tension with Y-27632 or cytochalasin D inhibits this effect (n 
= 4). (D) ASC numbers on stiff matrices were further enhanced with culture in TCM whereby TCM from MDA-
MB231 exerted a more pronounced effect than TCM from MCF-7 (n = 3) *P < 0.05 between all conditions; +P 
< 0.05 between MDA-MB231 and control conditions. (E) Image analysis of the deviation from the average angle 
of phalloidin-stained cells revealed that ASC alignment represented an integrated effect of both substrate 
stiffness and tumor malignancy; 10 kPa represented a critical threshold of alignment in the presence of MDA-
MB231 TCM, while 30 kPa were necessary with MCF-7 TCM (Scale bar = 50 µm) *P < 0.05.  
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relative to substrates approximating premalignant (~5kPa) and adipose tissue (~1kPa 122) stiffness (Fig. 
2.7A). Traction force microscopy (TFM) confirmed that these morphological changes were accompanied 
by greater traction forces of ASCs on stiffer relative to more compliant matrices (Fig. 2.7A). These 
observations directly correlated with the recruitment of phosphorylated focal adhesion kinase (FAK) to 
focal adhesions (Fig. 3B, pFAK[Y397]), a result of activated Rho-ROCK signaling due to force-induced 
changes in adhesion dynamics 153. Accordingly, ASC number was greater on stiffer matrices, and 
administration of cytochalasin D and Y-27632 inhibited this effect (Fig. 2.7C) confirming that Rho-
ROCK mediated changes in cytoskeletal tension enable ASCs to respond to ECM stiffness.  
To broadly assess stiffness-dependent cellular responses to a more relevant, biocompatible 
material that can be used for adipose tissue engineering and breast reconstruction applications154,155, we 
cultured adipose progenitors on RGD-modified alginate disks similarly mimicking normal, premalignant, 
and cancerous breast tissue stiffness. Interestingly, increased stiffness recapitulated the effects of TCM 
and promoted the proliferative capacity and VEGF-secretion of these cells, while inhibiting their 
adipogenic differentiation (Fig. 2.8). These results are consistent with previous studies, which indicate 
elevated adipocyte conversion on more compliant matrices46,156 and with less spread, rounder cell 
morphology157.  
To investigate whether tumor-secreted soluble factors enhance ASC response to ECM rigidity, 
ASCs were cultured on polyacrylamide substrates of a broad range of stiffnesses (0.2-30 kPa)), in the 
presence or absence of TCM from MCF-7 or MDA-MB231. Cell growth was commensurate with 
increasing stiffness whereby the level of tumor malignancy affected ASC stiffness response. More 
specifically, TCM from the more malignant MDA-MB231 cells increased cell growth on gels of lower 
stiffness relative to TCM of the less malignant MCF-7 (Fig. 2.7D). Furthermore, the combined effects of 
ECM stiffness and tumor-derived soluble factors promoted cellular alignment on stiffer, but not soft, 
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matrices, and this effect was more pronounced with TCM from MDA-MB231 than MCF-7 (Fig. 2.7E). 
Collectively, these results suggest that tumor-secreted factors dramatically enhance adipose-derived cell 
responses to stiffness leading to (i) an increased contractile cell population, and (ii) directed force 
generation158, which may ultimately exacerbate tumor rigidity and hence malignancy.  
 
ASCs modulate tumor progression in vivo 
To determine the relevance of our in vitro findings to tumor growth in vivo, ASCs and MDA-
MB231 cells were injected individually or in combination into the cleared mammary fat pad of 
immunocompromised mice. Co-injection of MDA-MB231 with ASCs yielded larger tumors than delivery 
 
 
Fig. 2.8. Effect of matrix stiffness on adipose progenitors. Culture of 3T3-L1s on RGD-modified alginate 
hydrogels mimicking stiffness of normal (compliant, ~1.8 kPa), moderately diseased (~5.2 kPa) and malignant 
breast tissue (stiff, ~12 kPa) demonstrate that matrix mechanical properties mediate similar effects on adipose 
progenitors as tumor-derived soluble factors. (A) Enhanced matrix stiffness increased cell numbers (n = 8), (B) 
decreased adipogenesis as determined by GPDH analysis and Oil Red O-staining, (n = 3), and (C) enhanced 
VEGF secretion as measured by ELISA (n = 4). *P < 0.05 from compliant condition. ♦P < 0.05 from moderate 
condition. (Scale bar = 50 µm.) 
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of tumor cells alone in accordance with previous results 159,160 (Fig. 2.9A). In contrast, injected ASCs 
largely formed adipose tissue (Fig. 2.9C and 2.13A, B) that was similar in size to explants from sham-
injected media suggesting that the different size of the tumors was caused by varied tumor malignancy 
rather than the additional volume assumed by the co-injected ASCs. Furthermore, tumors resulting from 
the mixture of ASCs and MDA-MB231 cells appeared more locally invasive upon explantation relative to 
MDA-MB231-borne tumors, which were easily demarcated for dissection. Pathological evaluation of 
H&E-stained cross-sections confirmed this assessment and revealed an enhanced degree of local invasion 
 
 
Fig. 2.9. ASCs modulate tumor progression in vivo. (A) Tumors resulting from the co-injection of ASCs and 
MDA-MB231 cells (Both) (n = 12) were significantly larger than tumors formed by MDA-MB231 cells alone (n 
= 12). Soft tissue explants generated from injected ASCs (n = 12) or Media (n = 2) are shown for a comparison 
(Scale bar = 5 mm). (B) Immunofluorescence analysis indicates that -SMA levels were greatest in the explants 
resulting from co-implantation of ASCs and MDA-MB231 cells as compared to those from MDA-MB231 and 
ASCs alone (Scale bar = 50 µm). (C) Similarly, the density of CD31+ blood vessels was enhanced in explants 
from the co-implanted group (Scale bar = 20 µm). For -SMA and CD31+ image analysis, ASC (n = 6), Both (n 
= 6), and MDA-MB231 (n = 12) explants were analyzed. (D) Mechanical analysis of tumor sections via DMTA. 
The mean stress-strain profile was measured in PBS at room temperature through the low-strain (9-14%) elastic 
regime. The engineering stress  versus strain  curve represents the average of 2 compressions per tumor 
section performed on 4 tumor sections from MDA-MB231 alone, and 9 tumor sections from the co-implantation 
group (see SI Materials and Methods). The mean Young’s modulus, E, was extracted from the slope of the 
stress-strain curve,  = E . (E) Compared to tumors from MDA-MB231, co-injected tumors contain more 
mature and linearized collagen fibers as revealed by second harmonic generation (SHG) imaging and picrosirius 
red staining of cross-sections, which is further quantified in Fig. S9. For (A-C) *P < 0.05 from ASCs condition; 
♦P < 0.05 from MDA-MB231 condition. 
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Fig. 2.10. ASCs modulate tumor progression in vivo. Representative H&E sections of tumors resulting from 
co-injection of ASCs and MDA-MB231 cells (Both) (n = 7) or MDA-MB231 cells alone (n = 8) scored for 
pathological features of malignancy are shown (Scale bar = 40 µm). (A) Co-implanted tumors exhibited 
enhanced local invasion relative to MDA-MB231 tumors as evidenced by indistinct tumor boarders. Tumor cells 
infiltrated and separated skeletal myofibers (*) and often surrounded atrophic skeletal myofibers (). (B) 
Enhanced desmoplasia in the co-implanted group was evident as variably sized, pale to brightly eosinophilic, 
loose bands of connective tissue () scattered within the tumor. Additionally, rossettes (*) which indicate an 
anaplastic phenotype in tumors, were evident in the co-implanted tumors. (C) Multinucleated tumor cells (), 
indicating the breakdown of cell division machinery, are also more evident in the co-implanted tumors as 
compared to MDA-MB231 tumors alone. 
 
 
 
Fig. 2.11. ASCs increase pro-angiogenic factor levels in tumors. (A) VEGF and (B) IL-8 content was 
enhanced within tumors containing ASCs as compared to those from only MDA-MB231 cells as revealed by 
ELISA of lysates. *P < 0.05 from ASC condition; ♦P < 0.05 from MDA-MB231 condition. ASC (n = 6), 
ASC/MDA mixture (n = 6), and MDA (n = 12) implants were analyzed.   
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and desmoplasia for the co-implanted tumors versus the control tumors (Figs. 2.10A, B). Additionally, 
cytological features of malignancy (multinucleated cells and rosettes) were augmented in the co-
implanted group as compared to the MDA-MB231 group (Fig. 2.10). To correlate variations in tumor 
growth with differences in myofibroblast differentiation, immunohistochemical analysis was performed, 
which confirmed that the density of α-SMA myofibroblastic cells (Fig. 2.9B) was increased in tumors 
originating from co-injection of both cell types rather than tumor cells alone. Circulating ASCs can be 
recruited to and associate with blood vessels in the form of α-SMA pericytes 161. In our co-implantation 
studies, however, immunohistochemical analysis of desmin, a pericytes marker 162, verified that the 
majority of α-SMA positive cells were myofibroblasts rather than pericytes as desmin staining showed no 
significant difference (p=0.33) between co-implanted and control tumors. Nevertheless, blood vessel 
density was greater in the co-implantation group (Fig. 2.9C), and ELISA of tumor lysates suggested that 
ASC/myofibroblast secretion of pro-angiogenic VEGF and IL-8 125,149 may have contributed to these 
differences (Fig. 2.11A, B).  
To evaluate if varied myofibroblast content correlated with increased stiffness, we determined the 
mechanical properties of the different tumors via Dynamic Mechanical Thermal Analysis (DMTA) 
compression tests on 1 mm-thick tumor sections, in the elastic regime of deformations. The mean 
Young’s modulus (E) was more than 50% higher in tumors generated by co-implantation of ASCs than in 
those generated in the absence of ASCs (3.1 ± 1.2 kPa vs. 2.0 ± 0.8 kPa) (Figs. 2.9D and 2.12). Data from 
the full elastic and plastic regime of deformations (Fig. 2.12) additionally indicated that tumors from the 
co-implanted group exhibit both higher stiffness and a smaller range of elastic (reversible) deformations 
than tumors grown without ASCs (Fig. 2.12B). Consistent with these results, tumors resulting from co-
injection contained more procollagen I and collagen (Figs. 2.13A, B), were characterized by enhanced 
collagen fibril maturity and linearity (Figs. 2.13C, D), and likely also comprised increased fibronectin 31. 
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Such changes are indicative of enhanced desmoplasia and aggressiveness 33 and may further contribute to 
ASC-mediated changes in tumor growth; decellularized matrices of TCM-preconditioned adipose 
progenitors increased tumor cell growth relative to matrices from control cells in a manner dependent on 
generation of cytoskeletal tension (Fig. 2.13E). Nevertheless, additional conditions including paracrine 
signaling between ASC-derived cells and tumor cells may also contribute to the observed changes in 
tumor growth in our studies159.  
 
 
 
Figure 2.12. ASCs increase tumor stiffness. Tumors formed in vivo by MDA-MB231 alone (MDA-MB231) or 
MDA-MB231 in the presence of ASCs (Both) were analyzed for stiffness via DMTA of cross-sections in PBS at 
room temperature (n = 8-18). (A) The lines within the boxes indicate the mean Young’s modulus for each 
condition, while the colored boxes span the 25th to 75th percentile. The whiskers correspond to the maximum and 
minimum measured Young’s modulus values. The mean Young’s modulus of the tumor sections from the co-
implanted group (Both = 3.1 ± 1.2 kPa) is approximately 50% higher than that of the sections from the tumors 
grown without ASCs (MDA = 2.0 ± 0.8 kPa). (B) DMTA mean stress-strain profiles of tumor sections over the 
full regime of elastic and plastic deformation (n = 4-9). The boxed-in area corresponds to the low-strain (9-14%) 
regime from which the Young’s moduli (shown in A) were extracted. Tumors from the co-implanted group 
(Both) exhibit not only higher moduli but also a smaller range of elastic deformations, i.e., earlier onset to plastic 
deformation than tumors grown without ASCs (17% versus 23%), and more pronounced stiffening prior to 
rupture, as indicated by the steeper stress-strain slope at high strains in the co-implanted group. *P < 0.05 from 
MDA-MB231. 
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Fig. 2.13. ASCs modulate collagen deposition and structural changes in tumors, which, in turn, alters 
tumor cell behavior. (A) Immunohistochemical analysis of tissues subjected to co-injection of ASCs and 
MDA-MB231 cells (Both) or either cell type alone indicated increased collagen synthesis with co-injection, as 
indicated by greater levels of the precursor type I procollagen (brown). (B) Masson’s Trichrome staining 
confirmed greater collagen deposition (blue) in tumors formed by both ASCs and MDA-MB231 cells as 
compared to tumors formed by MDA-MB231 only. *P < 0.05 from ASC condition; ♦P < 0.05 from ASC 
condition from MDA-MB231 condition. For type I procollagen and collagen image analysis, ASC (n = 6), 
ASC/MDA mixture (n = 6), and MDA (n = 12) implants were analyzed. (Scale bar = 20 µm.) (C) Images 
captured from picrosirius red-stained cross-sections via polarized light microscopy (as shown in Figure 4e) were 
analyzed for non-collagen (white), immature/thin collagen (green), and mature/thick collagen content. Co-
implanted tumors (Both) contain more mature collagen fibrils than control tumors. (D) A 2D spatial 
autocorrelation analysis based on SHG images shows that the average collagen framework size (autocorrelation 
mean radius) in the ASC-containing tumor explants (Both) is significantly greater than their counterparts (MDA-
MB231). Additionally, analysis of fibril linearity (a ratio of the shortest distance to the full-length between fibril 
ends) indicate that collagen fibrils in tumors from the co-implantation group (Both) are straighter than those 
from control tumors. *P < 0.05 from MDA-MB231. For picrosirius red and SHG image analysis, MDA-
MB231/ASC (n = 3) and MDA-MB231 (n = 3) explants were analyzed. (E) MDA-MB231 grow more on 
decellularized matrices from MDA-MB231-conditioned 3T3-L1 than matrices from 3T3-L1 preconditioned with 
control media. These differences are related to varied cytoskeletal tension as treatment with the pROCK 
inhibitor Y-27632 inhibits this effect (n = 6). *P < 0.05 from control. 
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2.6. Conclusions 
Breast cancer cell signaling may undermine normal ASC function to form a physicochemical 
microenvironment that promotes tumorigenesis. Epidemiologically, controversy still exists as to whether 
fat grafting procedures contribute to recurrence of breast cancer163. Our findings suggest this possibility 
and long-term follow up studies will be needed in which not only the use of ‘simple’ fat, but implants 
concentrated with ASCs are evaluated. Additionally, the results presented herein provide a possible 
explanation for why obesity - associated with an increased pool of ASCs - represents a risk factor for 
breast cancer164,165 and highlight novel design parameters for ASC-based breast reconstruction. 
Specifically, ASCs are frequently applied using relatively rigid biomaterial scaffolds or hydrogels166,167, 
but vehicles mimicking the mechanical properties of adipose tissue and potentially co-delivery of 
morphogens are needed to ensure adipose tissue functionality. In particular, PPAR agonists may 
represent attractive candidate molecules due to their ability to promote adipogenesis, while inhibiting 
myofibroblast differentiation145. Definition of whether tumor-related changes of ASC functions are due to 
selective mechanisms or cell fate instruction will also be needed to help increase the safety of such 
applications. Although the goal of the present study was to better define the physicochemical 
contributions of ASCs to breast cancer, a variety of other cancers may also depend on such phenomena. 
Because ASCs can be activated and released into the circulation to participate in tumor progression at 
spatially distinct sites they may, for example, impair the prognosis of prostate 168 and colorectal cancer 
patients 169. Collectively, therapeutic application of ASCs independent of site should be carefully 
considered in patients previously treated for cancer, and the use of cell delivery vehicles accurately 
mimicking non-tumorigenic microenvironmental conditions should be a prerequisite.  
 
 
  
 
 
56 
  
CHAPTER 3 
 
CANCER-ACTIVATED ADIPOCYTES AND THEIR ROLE IN EXTRACELLULAR 
MATRIX REMODELING AND ANGIOGENESIS 
 
3.1. Contributors 
Co-authors of this chapter made the following contributions: Jacqueline Gonzalez, undergraduate student 
in the Fischbach lab performed 2D experiments to analyze the phenotypic changes of adipocytes in 
response to tumor-derived factors. Seth Moore, undergraduate student in the Fischbach lab analyzed the 
contractile behaviors of adipocytes in response to tumor-derived factors. Manuel Gregoritza, visiting 
scholar in the Fischbach lab assessed the adipogenic activity of adipocytes cultured in a 3D system. Dr. 
L.T. Vahdat provided breast tumor specimens. Dr. Clifford A. Hudis provided human mammary tissue 
from cancer-free individuals. Prof. Claudia Fischbach guided the direction of project, assisted with 
experimental design and provided insight for data analysis. 
  
3.2. Abstract 
Due to the increasing socioeconomic impact of obesity and its associated diseases, both 
adipocytes and the metabolic and endocrinal roles of adipose tissue have recently been highlighted in the 
development and progression of obesity-associated diseases. Recent studies indicated the loss of 
adipogenic features in adipocytes adjacent to cancer cells as well as a high ratio of fibroblasts to 
adipocytes in tumor stroma, implying a possible contribution of adipocytes to the formation of cancer-
activated fibroblasts, called myofibroblasts. Thus, we hypothesize that tumor-derived soluble factors 
induce conversion of adipocytes into myofibroblastic cells, and that the converted adipocytes stimulate 
ECM remodeling and pro-angiogenic signaling. First, we assessed the morphological changes of 
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adipocytes in tumor stroma, and then examined whether the changes were mediated by tumor-derived 
soluble factors through culturing adipocytes with tumor-derived soluble factors. Our findings indicate that 
adipocytes, both in 2D and 3D cultures, lost their adipogenic phenotype in response to tumor-derived 
soluble factors while gaining myofibroblastic features. TCM-treated adipocytes contained more α-SMA 
positive cells that exhibited increased contractility. Also, they produced more matrix protein such as 
fibronectin and collagen. Moreover, TCM-treated adipocytes stimulated pro-angiogenic signaling of 
vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8), which ultimately promoted sprouting 
of human umbilical vascular endothelial cells (HUVECs) in our 3D co-culture system.  Taken together, 
our study suggests the possible contribution of adipocytes to increasing myofibroblastic cell population 
and consequently tumor stroma remodeling. This study will aid in understanding the pro-tumorigenic 
potential of adipocytes and ultimately a link between obesity and cancer.  
 
3.3. Introduction 
Obesity and its associated diseases, such as type 2 diabetes, hypertension and cancer, have 
emerged as a public health concern, the metabolic functions of adipose tissue have received more 
attention170. Adipocytes serve as an energy depot as well as endocrine organ171. In health, adipocytes 
properly regulate lipid metabolism in concert with various adipokines and hormones such as leptin, 
adiponectin and insulin172. In addition, adipocytes also secrete inflammatory cytokines such as interleukin 
6 (IL-6) and TNF-α173. However, during disease progression their well-controlled functions go awry 
through direct or indirect interactions with local inflammatory or cancer cells.  Therefore, adipocytes 
potentially play a role promoting the development and progression of obesity-associated diseases170,173. 
In particular, an increasing number of studies highlight the metabolic and endocrinal dysfunction 
of adipocytes in exacerbating various types of cancer such as breast, prostate and ovarian cancer; all of 
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these cancer types have adipocytes in close proximity. For example, previous reports showed that 
crosstalk between adipocytes and ovarian cancer cells can upregulate the lipolysis of the adipocytes and 
consequently provide abundant fatty acid to fuel primary and metastatic ovarian tumor growth174,175. In 
addition, adipocytes at the invasive region of the tumor facilitated breast cancer cell invasion via 
stimulation of epithelial to mesenchymal transition of the cancer cells in an IL-6-dependent manner176. 
Interestingly, it was also noted that the cancer-activated adipocytes lost adipogenic features but acquired 
fibroblastic morphology in tumor stroma implying that adipocytes can be a source for cancer-activated 
fibroblasts (CAF)173. 
Our previous studies suggested that α-smooth muscle actin (α-SMA)-positive CAF can be derived 
from adipose-derived stem cells (ASCs) upon the regulation of tumor-derived factors such as 
transforming growth factor-β (TGF-β) and IL-8177,178. The myofibroblastic ASCs, in turn, construct a pro-
tumorigenic microenvironment by participating in dynamic extracellular matrix (ECM) remodeling and 
stimulating pro-angiogenic signaling177. However, whether adipocytes can contribute to the 
myofibroblastic cell population upon the presence of tumor-derived stimuli remains unclear. Interestingly, 
recent studies highlighted plasticity of adipocytes into progenitor-like cells showing that dedifferentiated 
adipocytes exhibit similar characteristics of ASCs such as proliferative and multi-lineage potential85. Thus, 
the cancer-activated adipocytes may also similarly contribute to tumor stroma remodeling via changing 
their phenotype to myofibroblastic cells. 
Therefore, we propose that tumor-derived factors induce the conversion of mature adipocytes into 
myofibroblastic cells and that the converted adipocytes contribute to both ECM remodeling and pro-
angiogenic activity. In this study, we assessed the phenotypic changes of mouse and human progenitor 
cell-derived adipocytes in response to malignant cancer cell-derived factors leveraging both 2D and 3D 
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culture systems. This study suggests a role for adipocytes in remodeling tumor stroma and ultimately will 
aid in understanding an adipocyte-mediated link between obesity and cancer.  
 
3.4. Materials and methods  
Analysis of adipocyte size in mouse mammary tissue and tumors  
Orthotopic mammary tumors were obtained as previously described48. Briefly, MDA-MB231 
cells (1 x 106) were prepared in 20 µL of DMEM/ Ham’s F-12 (Gibco) containing 10 % FBS (Tissue 
Culture Biologicals) and 1 % antibiotics (penicillin/streptomycin, Gibco). Immediately the cell 
suspension was injected into the cleared mammary fat pad of 3 week-old female SCID/NCr mice (Charles 
River Labs, 01S11). Tumors were harvested 6 weeks after implantation, and their control mammary fat 
was harvested from the age-matched cancer free- female mice (SCID/NCr). The explants were then 
formalin-fixed, paraffin-embedded, and cross-sectioned for haemotoxylin and eosin (H & E) staining. The 
stained sections were imaged on a Zeiss Observer Z.1 microscope and AxioCam MRm camera and 
subsequently the surface area of individual adipocyte was measured using Image J (NIH). 20 to 30 
adipocytes from 10 representative images per tissue and tumors or tissues were analyzed, and averaged. 
The procedures required for in vivo models were performed in accordance with Cornell University animal 
care guidelines. 
 
Analysis of patient-derived breast tumor specimens  
H & E stained human breast tissue and breast tumor specimen were obtained from 16 breast 
cancer patients with BMI (an index of weight to height) less than 25.  The sections were imaged and 
analyzed for the surface area of adipocytes as described above. Human specimens were obtained in 
collaboration with Dr. Linda T Vahdat under the approval of IRB Study 0408007390 in Cornell Weill 
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Medical College, and human mammary tissues were obtained in collaboration with Dr. Clifford A. Hudis 
under approval of the Institutional Review Boards of Memorial Sloan-Kettering Cancer Center (MSKCC) 
and Weill Cornell Medical College. The samples were collected as previously described179. 
 
In vitro adipocyte preparation and cell culture 
Mouse preadipocytes cell line, 3T3L1 cells (ATCC) and human adipose derived stem cells 
(ASCs) (Lonza) were used to produce in vitro adipocytes. The adipogenic potential of 3T3L1 cells 
(3T3L1s) and pluripotency of ASCs were previously confirmed180,181. 3T3L1s or ASCs were cultured on 
2D culture plate in MEM (α-modification [αMEM], Sigma) with 10% FBS and 1% antibiotic or ADSC-
GM (Lonza), respectively until they were 90% confluent. Then adipogenic differentiation of 3T3L1s was 
initiated by a treatment of insulin (Sigma), dexamethasone (Sigma), indomethacine (Fischer Scientific), 
corticosterone (Fischer Scientific), and 3-isobutyl-1-methylxanthine (IBMX) and then completed by 
supplement of insulin every other day up-to 8 days. ASCs were differentiated into adipocytes by 
supplement of commercialized hormonal cocktails PGM-2 (Lonza) for 2 weeks. 
 
Tumor Conditioned Media (TCM) preparation 
Tumor conditioned media (TCM) was collected as previously described48. Briefly, breast cancer 
cell line, MDA-MB231 cells (MDA-MB231) were incubated in αMEM (1% FBS, 1% antibiotic) for 24 
hours and the media containing tumor-derived factors was collected. For control medium, cell-free 
αMEM (1% FBS, 1% antibiotic) was collected in the same manner. Then the media was normalized to 
cell number, concentrated through Amicon centrifugal filter unit (Millipore, MWCO = 3kDa), and 
reconstituted with media containing 1% FBS, 1% antibiotic to make 2-fold concentration of tumor-
derived factors as final concentration.  
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Analysis of adipogenic features  
Lipid accumulation of (trans-) differentiated 3T3L1s and ASCs was visually assessed and 
quantified by Oil Red O staining and extraction assay as previously described 132. Cells were formalin-
fixed and stained with Oil Red O (0.33% w/v in isopropanol, Sigma) for 2 hours. After the excess Oil Red 
O from samples was washed with PBS, the samples were imaged with a bright field microscope (Zeiss 
Observer Z.1 microscope). For the quantification of lipid accumulation, Oil Red O incorporated into lipid 
was extracted in 100% isopropanol (J.T. Baker) and the absorbance of the extracted Oil Red O was 
measured at 510 nm. Also, DNA concentration was measured to normalize the obtained Oil Red O optical 
density. For DNA quantification, cell lysates were collected in DNA lysis buffer and then measured for 
DNA content by QuantiFluor® dsDNA System (Promega) following the manufacturer’s protocols. In 
addition, adipogenic activity was assessed via measuring glycerol-3-phosphate dehydrogenase (GPDH) 
activity. The supernatants were collected from the cell lysates in a buffer containing 50mM Tris, 1mM 
EDTA, and 1mM β mercaptoethanol (all from J.T. Baker). Subsequently the supernatants kept in ice were 
quickly mixed with dihydroxyacetone phosphate and oxidized nicotinamide adenine dinucleotide 
(NADH).  The decrease in NADH absorbance at 340 nm was measured on a spectrophotometer over a 7 
min period. The GPDH activity was normalized to total protein content as measured by BCA kit as 
manufacturer’s protocol suggested (Thermo Scientific).  
 
Immunofluorescence imaging analysis 
For immunofluorescence, TCM or control media-treated adipocytes were formalin-fixed, blocked 
in 1% BSA (Fischer Scientific) in Phosphate buffered saline (PBS), and then incubated with primary 
antibodies of Fn (Invitrogen) and collagen (Millipore) in PBS containing 0.05% triton-x (EMD) and 1% 
BSA overnight at 4°C. Next day, the samples were washed in PBS and labeled by AlexaFluor 488 
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conjugated secondary antibody for Fn and collagen, and 4',6-diamidino-2-phenylindole (DAPI) for nuclei 
(All from Invitrogen). Subsequently the stained samples were mounted with Prolong® Gold reagent 
(Invitrogen) and then imaged with fluorescent microscope (Zeiss). 
 
Western Blot analysis  
Cell lysates were prepared in RIPA buffer containing protease and phosphatase inhibitor cocktail 
(all from Thermo Scientific), and 1mM phenylmethylsulfonyl fluoride (Fischer Scientific) in isopropyl 
alcohol (VWR). The protein concentration was quantified by BCA kit and the equal amount of the 
proteins was loaded to SDS-PAGE. The loaded proteins were separated and subsequently transferred to a 
PDVF membrane (Bio-Rad). The membrane was blocked in 5% milk powder in PBST and then incubated 
with primary antibodies targeting the proteins of interest including Fn, and collagen as well as house 
keeping proteins such as HSP90 (Santa Cruz) in 5% milk powder in PBST overnight at 4°C. Next day the 
membranes were incubated with HRP-conjugated secondary antibody (Novus Bio) at room temperature 
for an hour. Chemiluminescence detection was performed to visualize the probed protein using ECL kit 
(Thermo Scientific) based on manufacturer’s protocol. To quantify the resulting blots, densitometry was 
performed via Image J and Adobe Photoshop CS4.  
 
Isolation of adipocytes 
ASC-derived adipocytes in 2D culture plate were trypsinized and their extracellular matrix was 
digested by 1.5mg/ml collagenase Type 1 (Worthington Biochemical Corp.). Then the cells were filtered 
through a 250µm cell strainer (Pierce) and centrifuged in Histopaque-1077 solution (Sigma) to separate 
ASCs from floating adipocytes. Isolated ASCs were cultured in DMEM/F12 (Gibco) supplemented 10% 
FBS (Tissue Culture Biologicals), 1% antibiotic (penicillin/streptomycin). 
  
 
 
63 
  
3D Adipocyte dedifferentiation in vitro model fabrication  
For analyzing dedifferentiation of adipocytes in 3D context, we micro-fabricated adipocyte-
embedded 3D collagen gels. This 3D collagen scaffold fabrication procedure was adopted from our 
previously published protocol182. First, collagen was collected from rat-tail tendon (Pel-Freez Biologicals), 
solubilized in 0.1% [v/v] acetic acid, lyophilized and then reconstituted back in acetic acid at a 
concentration of 15mg/ml. Then, 4-mm-diameter and 250-µm-thick round shape of polydimethylsiloxane 
(PDMS) micro-wells were fabricated using Sylgard® 184 silicone elastomer kit (Dowcorning) and their 
surface was treated by 1% [v/v] poly-ethylenimine (Aldrich) and then 0.1% [v/v] glutaraldehyde (Fischer 
scientific) to crosslink collagen gels with PDMS mold. The reconstituted collagen in acetic acid was 
neutralized to pH 7.2 and then mixed with 1x106 of adipocytes to produce a final concentration of 0.6% 
collagen suspension. Subsequently, adipocyte-embedded collagen scaffolds were polymerized in the 
PDMS micro-well at 37°C. The completely polymerized collagen scaffolds were cultured in either TCM 
or control media for 7 days. 
 
Contraction assay  
The contractility of the transdifferentiated adipocytes was measured using free-floating collagen 
gels. Collagen gel fabrication procedure was similar to the one for a 3D collagen scaffold in a micro-well 
as described above. 500 µm thick and 4 mm in diameter of circular collagen disks were fabricated using a 
Plexiglas® template. 15 mg/ml of collagen in 0.1% acetic acid was neutralized to pH 7.2 with 1N NaOH, 
10x and 1x media (DMEM/F12), then slowly mixed with isolated adipocytes (1x 106 cells/ml), and finally 
casted in the Plexiglas® mold134. Subsequently gels were cross-linked at 37°C for 30mins, then 
transferred into 24 well plate (VWR), and treated with hormonal cocktails for adipogenic differentiation 
as previously described. After the 2 week-long-treatment of the hormonal cocktails, the adipocytes in the 
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gels were then cultured in TCM or control medium on an orbital shaker up-to 2 weeks, with media 
changes every other day. Lastly, gel contraction was determined by calculating the amount of the 
reduction in the surface area of each gel between Day 0 and final time point by image J.   
 
Pro-angiogenic Factor Measurement 
After treating adipocytes with TCM or control media for 7 days, DMEM/F12 with 1% FBS and 
1% antibiotics were added to the adipocytes and incubated for 24 hours. Then the media was collected 
and analyzed for the levels of VEGF and IL-8 via VEGF and IL-8 ELISA duo set (R&D), respectively. 
Also, the DNA content of each sample was collected and measured as previously described for 
normalization.  
 
Endothelial cell invasion assay in 3D collagen scaffolds 
To evaluate functional impacts of the dedifferentiated adipocyte-mediated pro-angiogenic 
signaling, HUVEC invasion assay was performed after treating adipocytes in 3D scaffolds with and 
without TCM for 7 days. After the treatment of TCM or control media, a monolayer of HUVECs 
(475x103 cells/mL) was seeded atop the adipocyte-encapsulated collagen scaffolds. After one hour, 
HUVEC invasion media containing HUVEC-GM, 1% [v/v] L-ascorbic acid (50 µg/mL; Acros Organics, 
Morris Plains, NJ), and 0.16% [v/v] tetradecanoyl phorbol acetate (50 ng/mL; Cell Signaling Technology, 
Inc., Danvers, MA) was added, and cultured for 4 days. For VEGF, IL-8 and their cognate receptor 
inhibition study, 500ng/ml of VEGF and IL-8 neutralizing antibodies or 500ng/ml of VEGFR2 and 
CXCR1 antibodies (all from R&D) were supplemented in the invasion media and cultured for the same 
period of time. The HUVEC was immunofluorescently stained for their surface marker, CD31 (Sigma-
Aldrich), and the resulting HUVEC sprouting was assessed by confocal microscopy analysis. 5 to 6 top-
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to-bottom images per sample were obtained by Zeiss 710 confocal microscope with a 25×/0.8 water 
immersion objective at 5µm intervals. Sprouting HUVEC was determined by their length, which is equal 
or longer than 15µm, and the number of HUVEC sprouts was manually counted throughout the Z-stack 
images. The presented number of sprouts per condition was obtained averaging the counts of three 
samples in each experiment (n=3). 
 
Statistical analysis 
Statistical differences between two conditions or among multiple conditions were calculated by 
Student’s t-tests or ANOVA, respectively. For ANOVA, post-hoc pairwise comparisons were performed 
by Tukey’s test. When a P-value was less than 0.05 based on two-sided testing, the difference between or 
among conditions was considered statistically significant. All tests were performed on Microsoft Exel and 
GraphPad Prism 5©. Unless otherwise noted, values are reported as the mean with error bars to indicate 
standard deviations.  
 
3.5. Results  
Adipocyte size is reduced in mouse and human mammary tumors 
To see if there were any morphological differences between adipocytes in mammary tumors vs. 
mammary fat, first we microscopically assessed the morphological changes of adipocytes in mammary 
tumors and mammary fat sections. Adipocyte size has been linked to their functional changes and has 
been used as an important indicator of adipocyte dynamics183. Fewer adipocytes were found in both 
mouse and human mammary tumors as compared to respective control mammary fat. In addition, the size 
of cancer-associated adipocytes was significantly reduced as compared to that of normal adipocytes (Figs. 
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3.1A and B). This finding substantiates previous findings showing a significant reduction of adipocyte 
size at the invasive edge of tumor stroma176.  
 
Tumor-derived soluble factors induce the loss of adipogenic features  
To evaluate if loss of adipocyte features was mediated by tumor-derived soluble factors, we 
cultured adipocytes with tumor-derived soluble factors in vitro. First, adipocytes were obtained from 
mouse preadipocytes, 3T3L1 cells (3T3L1s) and human adipose-derived stem cells (ASCs). Then, 
adipocytes were cultured in 2D culture plate with or without tumor-conditioned media (TCM) containing 
soluble factors derived from the MDA-MB231 breast cancer cell line for 4 weeks (Fig. 3.2A). 
Subsequently, adipogenic features were assessed via Oil Red O staining for lipid staining and glycerol-3-
 
 
Fig. 3.1. Reduced size of adipocytes in mouse and human mammary tumors. (A) Microscopic assessment of 
H&E stained normal mouse mammary tissue and mammary tumor stroma showing that adipocytes in tumors 
were significantly smaller compared to those in tumor-free mammary fat. (B) Adipocytes in human mammary 
tumors became significantly smaller as compared to those in cancer-free mammary fat.  (Scale bars = 100 μm). 
♦p < 0.05. 
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Fig. 3.2. Tumor-derived soluble factors induce loss of adipogenic features. (A) 3T3L1 and ASC-derived 
adipocytes were cultured in the presence and absence of TCM collected from MDA-MB231 breast cancer cells 
for 4 weeks. (B) After 4 weeks, the changes in the quantity of lipid, size of individual lipid droplets, and GPDH 
activity were recorded from 3T3Ll-derived adipocytes cultured in TCM relative to those cultured in control 
media. (C) ASC-derived adipocytes also lost adipogenic features as indicated by decreased lipid content and 
GPDH activity in response to TCM. (Scale bars = 200 μm). ♦p < 0.05. 
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phosphate-dehydrogenase (GPDH) activity, which has been used as an indicator of fat synthesis184.  
Microscopically, the quantity of Oil Red O stained lipid droplets in 3T3L1-derived adipocytes 
was robustly maintained up to 4 weeks in absence of TCM while the amount of lipid droplets 
dramatically decreased when they were cultured with TCM.  Also, the size of individual lipid droplet 
within 3T3L1-derived adipocytes significantly decreased when the adipocytes were cultured in TCM as 
compared to those cultured in control media (Fig. 3.2B). In addition, to confirm whether the 3T3L1-
derived adipocytes lost adipogenic activity, GPDH activity of 3T3L1-derived adipocytes were assessed. 
After one week, significant reduction of GPDH activity was observed in 3T3L1-derived adipocytes when 
the adipocytes were cultured in TCM, which mirrored the results from the Oil Red O image analysis. Also, 
the decreasing trend of GPDH activity was assessed up to 4 week (Fig. 3.2C).  
Similarly, ASC-derived adipocytes cultured in control media maintained their lipid droplets for 2 
weeks whereas most of the ASC-derived adipocytes were delipidated in the presence of TCM. In 
accordance with the microscopic assessment, GPDH activity of ASC-derived adipocytes significantly 
decreased in response to TCM after one week. In addition, GPDH activity of TCM-treated adipocytes 
continuously decreased as compared to adipocytes cultured in control media up to 2 weeks (Fig. 3.2C). 
Although TCM induced dramatic loss of adipogenic features from both adipocyte cell lines, ASC-derived 
adipocytes also spontaneously lost adipogenic characteristics on 2D culture in absence of TCM85. The 
adipogenic phenotypes of ASC-derived adipocytes were maintained up to 2 weeks, but after 4 weeks 
ASC-derived adipocytes cultured in control media also significantly delipidated (data not shown). This 
data suggests that the inherent capacities to develop and maintain adipogenic features might be different 
between 3T3L1- and ASC-derived adipocytes.  
 
Tumor-derived soluble factors stimulate the conversion of adipocytes into myofibroblastic cells 
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Next, we assessed if the delipidated adipocytes developed different characteristics in response to 
TCM. First, the proliferative capacity of TCM-treated adipocytes was assessed.  This was done as it has 
been noted that dedifferentiated adipocytes gain progenitor cell-like characteristics, including 
proliferative and multi-lineage potential, while terminally differentiated adipocytes rarely proliferate185. 
Our BrdU analysis indicated that ASC-derived adipocytes became actively proliferative after a 7-day 
culture with TCM and there was a much larger BrdU positive cell population among TCM-treated 
adipocytes (40.8 ± 0.2 %) as compared to adipocytes cultured in control media (20.9 ± 1.2 %) (Fig. 3.3A). 
However, approximately 20% of cells among the ASC-derived adipocytes were BrdU positive and this 
proliferating cell population might come from non-differentiated ASCs or spontaneously dedifferentiated 
adipocytes in response to a plastic culture plate85.  
Given the previous observation showing that dedifferentiated adipocytes share similar surface 
marker profiles as ASCs and that ASCs have the potential to develop myofibroblastic features in response 
to tumor-derived cues, we examined if ASC-derived adipocytes can develop a myofibroblastic phenotype 
in response to TCM85,177. First, we quantified extracellular matrix (ECM) components, including 
fibronectin (Fn) and type I collagen, since the primary role of myofibroblastic cells is excessive ECM 
deposition186. Our IF and western blot analysis indicated that TCM-treated adipocytes deposited abundant 
Fn matrices and only a few fat laden cells were observed after one week. However, adipocytes cultured in 
control media still contained relatively large lipid droplets while less fibronectin matrices were deposited 
over the time. Along with the enhanced Fn matrices, our western blot analysis indicated that a larger 
quantity of collagen was produced by TCM-treated adipocytes similar to myofibroblastic ASCs177 
(Fig.3.3B).  
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Fig. 3.3. Tumor-derived soluble factors stimulate the trans-differentiation of adipocytes. (A) BrdU analysis 
indicated that TCM-treated adipocytes were more proliferative than those cultured in control media. (B-C) IF 
and western blot data indicated that TCM-treated adipocytes deposited a denser ECM containing more Fn and 
collagen as compared to the matrices deposited by the control media-treated counterparts. (D-E) Western blot 
analysis indicated that α-SMA level was higher in TCM-treated adipocytes, and IF analysis also showed that the 
α-SMA positive cell population increased among the dedifferentiated (non-fat) cells. (Scale bars = 200 μm). ♦p < 
0.05. 
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 Next, to confirm if the enhanced production of ECM protein was due to the enlarged 
myofibroblastic cell make-up among cancer-activated adipocytes, we assessed the myofibroblastic cell 
marker, α-SMA, positive cell population among ASC-derived adipocytes cultured in either control media 
or TCM.  First, we measured α-SMA protein expression from the total cell population via western blot. 
Our analysis indicated that the a-SMA level was significantly higher in TCM-treated adipocytes as 
compared to those from adipocytes cultured in control media (Fig. 3.3C). Then, we specifically assessed 
the a-SMA positive cell population among only non-fat-laden cells. For this, non-fat cells were isolated 
from the total population of cancer-activated adipocytes by centrifugation and removing floating fat cells, 
and then analyzed for the population of α-SMA positive cells via IF. As shown in Fig. 3.3D, the isolated 
non-fat cells from TCM-treated adipocytes exhibited a well-spread morphology with enhanced α-SMA 
stress fibers while those from the control group were poorly spread with only faint α-SMA positive 
immunoreactivity. In addition, the quantification of α-SMA positive cell population confirmed that non-
fat cells among TCM-treated adipocytes contained a larger α-SMA positive cell population as compared 
to those cultured in the control media (41.5 ± 3.5 % and 19.4 ± 3.7 %, respectively).  
 
TCM-treated adipocytes in 3D culture change their phenotype similarly as in 2D culture 
Cell morphology is tightly linked to cell fate, and it has been widely accepted that dimensional 
difference (2D vs. 3D) induces morphological changes of cells and possibly phenotypical changes187. In 
addition, conventional 2D ceiling culture of mature adipocytes leads to spontaneous dedifferentiation of 
adipocytes over time188. Therefore, to confirm our findings in the 2D culture with a 3D culture model, we 
utilized 3D collagen scaffolds as fibrillar collagen is the most abundant ECM component in the interstitial 
area and provides biochemical and physical support to cells93.  
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 Similar to our 2D studies, adipocytes were obtained through adipogenic differentiation of ASCs. 
Then, through centrifugation, only the floating adipocytes were collected and incorporated into collagen 
scaffolds, excluding undifferentiated ASCs during adipogenesis. After 7-days of treatment with TCM or 
control media, confocal imaging was performed on the scaffolds immunofluorescently stained for α-SMA 
or Fn with Oil Red O. Microscopically, significant delipidation but increased α-SMA immunoreactivity 
 
Fig. 3.4. TCM-treated adipocytes in 3D culture change their phenotype similarly as in 2D culture. (A) The 
adipogenic and myofibroblastic features of ASC-derived adipocytes were assessed via IF and confocal image 
analysis after culture in 3D collagen scaffolds with and without TCM for one week. Image analysis of the 3D 
construct indicated significant reduction in Oil Red O stained lipid droplets and an increase in α-SMA and Fn 
immunoreactivities in TCM-treated adipocytes relative to their control counterparts. (Scale bars = 50 μm). (B) 
An Oil Red O extraction assay confirmed the reduced fat content of TCM-treated adipocytes as compared to that 
of adipocytes cultured in control media. (C) A collagen gel contraction assay confirmed that the mean surface 
area of collagen gels containing TCM-treated adipocytes significantly decreased over time, implying the 
enhanced contractility of TCM-treated adipocytes. (Scale bars = 1000 μm). ♦p < 0.05. 
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were observed in ASC-derived adipocytes cultured in TCM as compared to the adipocytes cultured in 
control media (Fig. 3.4A). In addition, TCM-treated adipocytes deposited Fn matrices throughout the 3D 
construct while adipocytes cultured in control media deposited only a thin layer of Fn matrix on the very 
top of the scaffold. Also, the changes in fat content of dedifferentiated adipocytes were confirmed by 
quantification of Oil Red O uptake (Fig. 3.4B). In addition to the increased α-SMA stress fiber formation 
and ECM deposition, increased contractility is a key functional outcome of myofibroblastic cells189. The 
change in surface area of cell-embedded collagen scaffolds has been used as an indirect indicator of cell-
mediated contractility177. Our data showed that TCM-treated adipocytes led to significantly decreasing the 
surface area of the collagen scaffolds where the adipocytes were embedded whereas a relatively small 
change was observed from the surface area of adipocyte-embedded scaffolds treated with control media, 
implying that TCM-treated adipocytes exhibited increased contractility (Fig. 3.4C). This enhanced 
contractility reflected the increased α-SMA stress fiber levels184.  
 
TCM-treated adipocytes exhibit enhanced pro-angiogenic potential 
It has been widely accepted that myofibroblasts are highly pro-angiogenic, secreting multiple pro-
angiogenic factors such as VEGF and IL-861. Therefore, we tested if pro-angiogenic behaviors of 
adipocytes were modulated by tumor-derived cues, and if the pro-angiogenic potential was similarly 
regulated in 2D and 3D. Our ELISA analysis of VEGF and IL-8 from 2D culture suggested that ASC-
derived adipocytes cultured with TCM secreted higher levels of VEGF and IL-8 as compared to 
adipocytes without any treatment and those cultured with control media (Fig. 3.5A). A similar trend was 
observed in 3D models. Interestingly, the differences of pro-angiogenic factor secretion between TCM-
treated adipocytes and their control counterparts were greater in 3D as compared to 2D (Fig. 3.5B).  
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Enhanced pro-angiogenic signaling of TCM-treated adipocytes promotes HUVEC sprouting 
To assess the functional impacts of the altered pro-angiogenic signaling from dedifferentiated 
adipocytes on the sprouting of Human umbilical vein endothelial cells (HUVECs), we cultured a 
monolayer of HUVECs atop TCM- or control media-treated adipocytes in the collagen scaffolds and 
quantified HUVEC sprouting via confocal immunofluorescence imaging (Fig. 3.6A). In accordance with 
 
Fig. 3.5. TCM-treated adipocytes exhibit enhanced pro-angiogenic potential. (A) ELISA assessment 
indicated that TCM treated-adipocytes in 2D culture secreted a higher concentration of VEGF and IL-8 as 
compared to both adipocytes on Day 0 and those cultured in control media. (B) A similar but more pronounced 
trend was observed in 3D culture. ♦p < 0.05 and p < 0.05 from control and D-0, respectively. 
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the enhanced pro-angiogenic signaling of TCM-treated adipocytes, the number of HUVEC sprouts co-
cultured with TCM-treated adipocytes was significantly larger than that with adipocytes cultured in 
control media (Fig. 3.6B). To confirm these changes are primarily mediated by altered VEGF and IL-8 
signaling, HUVEC sprouting was assessed in the presence and absence of VEGF and IL-8 neutralizing 
antibodies as well as their cognate receptor antibodies, VEGFR2 and CXCR1, respectively. The enhanced 
HUVEC sprouting with TCM-treated adipocytes was significantly reduced with the blockade of VEGF 
and IL-8 molecules as well as inhibitors of VEGFR2 and CXCR1 whereas no significant change was 
observed in adipocytes cultured in control media (Fig. 3.6C)  
 
3.6. Discussion 
Fibrotic tumor stroma often appears devoid of adipocytes or contains smaller adipocytes with a 
higher ratio of fibroblasts to adipocytes, suggesting the possibility of adipocyte-to-fibroblast trans-
differentiation176,190,191. However, it remains unclear whether adipocytes developed myofibroblastic 
features in response to tumor-derived factors and therein participate in ECM remodeling and pro-
angiogenic activities. In this study, our findings indicated that adipocytes decreased their adipogenic 
features in response to tumor-derived soluble factors both in 2D and 3D culture. On the other hand, TCM-
treated adipocytes contained more a-SMA positive myofibroblastic cells, which deposited matrices 
enriched in Fn and collagen. In addition, TCM-treated adipocytes up-regulated VEGF and IL-8 signaling 
and consequently stimulated angiogenic-activities of HUVECs.  
3T3L1s have been widely utilized as a model system of human pre-adipocytes, yet species-
dependent discrepancies have been addressed indicating that there might be a difference in metabolic 
sensitivity of adipocytes between mice and humans192. In addition, 3T3L1s are committed pre-adipocytes, 
and might exhibit different gene and protein expression profiles, consequently leading to distinct 
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behaviors as compared to those of multi-potent ASCs193. In accordance with previous reports, we also 
recognized inherent differences of mouse and human adipocytes. For example, adipogenesis of 3T3L1s 
and their maintenance of adipogenic features were much robust than those of ASCs.  In addition, a 
morphological difference was observed between mouse and human adipocytes both in vitro and in vivo, 
suggesting that there might be species-dependent adipogenic features. However, despite of the inherent 
differences between 3T3L1- and ASC-derived adipocytes, their responses to tumor-derived factors were 
still comparable. We observed decreased size of adipocyte in mammary tumor stroma from both mice and 
humans as compared to those in normal mouse and human mammary adipose tissue, respectively (Fig. 
3.1A and B). In addition, our in vitro study confirmed that both mice and human adipocytes similarly 
decreased their adipogenic features in response to tumor-derived cues (Fig. 3.2).  
 Adipocyte differentiation is primarily governed by adipogenic transcription factors such as 
peroxisome proliferating-activated receptor-gamma (PPAR-γ) and CCAAT/enhancer binding protein-α 
(C/EBP-α) 194. It has been shown that this process is modulated by multiple factors such as tumor-necrosis 
factor-alpha (TNF-α), TGF-β, and bone morphogenic proteins (BMPs)114,194. TNF-α has been known to 
regulate adipogenesis as well as lipolysis, implying TNF-α might participate in the process of adipocyte 
delipidation195. In addition, TGF-β is known as a molecular mediator of myofibroblastic differentiation 
and also inhibits adipocyte differentiation via repressing transcriptional activity of C/EBPs and 
subsequently PPAR-γ196,197. As previous studies, including ours, indicated, MDA-MB231 TCM contained 
higher levels of TNF-α and TGFβ, which might play a role in stimulating loss of adipogenic features and 
gain of myofibroblastic features, respectively. However, further studies are necessary to define a specific 
molecular mechanism underlying the conversion of adipocytes into myofibroblasts177,198.  
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Fig. 3.6. Enhanced pro-angiogenic signaling of TCM-treated adipocytes promotes HUVEC sprouting. (A) 
As this schematic showed, a HUVEC invasion assay was performed to investigate the functional significance of 
the pro-angiogenic signaling mediated by dedifferentiated adipocytes. Adipocytes in 3D collagen scaffolds were 
treated with either TCM or control media for seven days, and then a monolayer of HUVECs was cultured atop 
the scaffolds to assess HUVEC sprouting through the collagen bulk. (B) HUVEC sprouting was enhanced in 
response to the increased VEGF and IL-8 secreted from TCM-treated adipocytes as compared to that with 
adipocytes cultured in control media. (C) Blockade of VEGF and IL-8 abrogated HUVEC sprouting associated 
with TCM-treatment whereas no pronounced effect on HUVEC invasion was observed in control media. 
Similarly, inhibition with VEGF and IL-8 receptors reduced HUVEC sprouting in the presence of TCM-treated 
adipocytes, implying that the changes in HUVEC sprouting were mediated by VEGF and IL-8 pro-angiogenic 
signaling. (Scale bars = 50 μm). p < 0.05 from all other conditions. 
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In addition, 2D ceiling culture has been known to induce spontaneous dedifferentiation of 
adipocytes showing fibroblastic morphology, and the dedifferentiated adipocytes share similar features 
with ASCs such as surface markers and gene expression85. However, it was noted that the cell population 
from the dedifferentiated adipocytes was more homogenous in comparison to ASCs85. In particular, α-
SMA positive cells were rare among dedifferentiated adipocytes versus ASCs, which contain about 15% 
of α-SMA positive cells at their first passage199. Thus, significantly enhanced α-SMA positive cell 
population among TCM-treated adipocytes from our study was a TCM-derived effect rather than a 
spontaneous conversion.  
Moreover, our analysis indicated that TCM-treated adipocytes in 2D culture contained a larger 
population of myofibroblastic cells which exhibited enhanced proliferative, contractile and ECM 
depositing potential as compared to those cultured in control media (Fig. 3.3). As hormone-induced 
adipogenic differentiation of progenitor cells often was not 100% efficient200, it is possible that a subset of 
un-differentiated progenitor cells within the culture contributed to enlarging a myofibroblastic cell 
population in response to TCM. Thus, our findings obtained through 2D culture were confirmed by 
performing similar studies in 3D culture exclusively incorporating adipocytes. Despite the concern that 
possible contamination of multiple cell types in 2D culture might result in different outcomes from those 
in 3D culture, our findings suggested that TCM-treated adipocytes in 3D culture reduced their adipogenic 
features and acquired myofibroblastic features, which mirrored TCM-treated adipocytes in 2D (Fig. 3.4). 
Adipocytes primarily produced laminin, collagen IV, V and VI201. However, mammary tumor 
stroma consists of abundant fibrillar ECM components such as collagen I and Fn, which are deposited by 
non-fat stromal vascular cells61,201. However, previous reports indicated that dedifferentiated adipocytes 
were able to produce osteoid ECM in an implanted tissue construct upon osteogenic stimulation85. Our 
findings also suggested that adipocytes in tumor stroma could possibly contribute to deposition of an 
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ECM rich in collagen and Fn through cancer cell-derived paracrine signaling. The enhanced fibrillar 
ECM deposition and their remodeling have been positively correlated with tumor stiffening and tumor 
malignancy202. In addition, it is also possible that the changes in ECM composition, architecture and its 
resulting mechanical cues also give feedback to adipocyte fate. Fn has been known to inhibit adipogenic 
differentiation and various matrix metalloproteinases (MMPs); in particular, MMP 14 and MMP 11 are 
known to regulate adipocyte fate203 191. Moreover, previous studies indicated that stiff substrates and 
cyclic tensile force (stretching cells) repressed adipogenesis through modulating cell shape and actin 
cytoskeleton reorganization204. However, more studies are required to understand whether there were 
ECM-mediated effects on TCM-derived adipocyte conversion, and whether these aforementioned cues 
and their resulting mechanism for adipogenesis simply regulate the conversion of adipocyte to non-fat 
cells in a reversed signaling cascade or via completely different pathways.  
Finally, we showed that TCM-treated adipocytes secreted higher levels of VEGF and IL-8, which 
consequently stimulated HUVEC sprouting. It has been known that adipocytes exhibit inherent pro-
angiogenic potential, and this potential is enhanced under stresses such as hypoxia205. Our findings also 
suggested that the pro-angiogenic potential of TCM-treated adipocytes may surpass that of adipocytes 
since TCM-treated adipocytes secreted much higher concentrations of VEGF and IL-8 as compared to 
those of adipocytes and control-media treated adipocytes (Fig. 3.5A). Consequently, HUVEC sprouting 
was stimulated through VEGF and IL-8 signaling. In addition, adipocytes adjacent to cancer cells produce 
higher levels of MMPs, which may participate in regulating HUVEC sprouting176. Thus, to verify the pro-
angiogenic factor-derived effects on HUVEC sprouting, we either neutralized VEGF and IL-8 or 
specifically blocked VEGFR2 and CXCR1. CXCR1 is highly specific for IL-838, and VEGFR2, one of 
the VEGF tyrosine kinase receptors, is known to stimulate angiogenesis39. In addition, VEGFR2 is known 
to be trans-activated by IL-8 interacting with its receptors206,207. Our inhibition study confirmed that 
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enhanced HUVEC sprouting in the presence of TCM-treated adipocytes was primarily modulated by 
VEGF and IL-8 signaling. This finding implies that adipocytes adjacent cancer cells might facilitate 
cancer cell growth and invasion via stimulating angiogenesis. 
In conclusion, through this study we proposed several possible roles of adipocytes in modulating 
ECM deposition and pro-angiogenic activities upon exposure to tumor-derived soluble factors. The tumor 
and obesity-associated microenvironment share similar features such as hypoxia, chronic inflammation, 
and fibrosis, all of which may play a critical role in stimulating the pathogenic potential of adipocytes208. 
Therefore, this study suggests broad clinical implications, not only for cancer therapy but also obesity-
associated diseases such as type 2 diabetes and atherosclerosis. However, certainly more studies are 
required to understand whether there is an organ- or depot-specific potential for adipocyte trans-
differentiation since cancer (i.e. breast vs. prostate) interacts with organ-specific adipose tissue, and a 
majority of obesity-associate metabolic diseases are specifically associated with visceral fat depot over 
subcutaneous fat171. So far, many studies, including this study, utilized either a mouse cell line- or human 
ASC-derived adipocytes, which certainly cannot address potential regional differences in adipose tissue 
functions.  Therefore, future studies testing primary adipocytes isolated from different anatomical 
locations are necessary. 
In addition, as an increasing number of studies suggested, dedifferentiated adipocytes are 
certainly an attractive option for cell-based regenerative medicine for human as well as small animals due 
to difficulty to acquire adequate number of pure stem cell popluation199. However, our findings reiterate 
the importance of microenvironmental cues on regulating cell behaviors and pathological potential, 
suggesting a careful consideration of clinical use of adipocytes. Lastly, understanding the precise 
mechanism underlying adipocyte conversion will aid in developing better tissue engineering and 
therapeutic approaches. 
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CHAPTER 4 
 
OBESITY-DEPENDENT CHANGES OF INTERSTITIAL ECM MECHANICS AND 
THEIR ROLE IN BREAST TUMORIGENESIS 
 
4.1. Contributors  
Co-authors of this chapter made the following contributions: Jacqueline Gonzalez, undergraduate student 
in the Fischbach lab analyzed pro-fibrotic features of mouse adipose tissue and human tumor specimens. 
Priya Bhardwaj, research assistant in the Dannenberg lab prepared mammary tissue from the mouse 
models of obesity. Roberto C. Andresen Eguiluz in the Gourdon lab performed ECM stiffness 
measurements via SFA and helped in writing the manuscript. Karin C. Wang in the Gourdon lab prepared 
FRET labeled Fn and aided in FRET analysis. Haibo Sha in the Ling Qi lab prepared adipose tissue from 
the mouse models of obesity. Sunish Mohanan performed histopathological analysis of tumor specimens. 
Rebecca M. Williams aided in SHG imaging and collagen image analysis. Prof. Ofer Reizes provided 
NANOG promoter (GFP+) MDA-MB231 and helped with their characterization. Dr. L.T. Vahdat 
provided breast tumor sections from obese and lean patients. Dr. A. J. Dannenberg provided human and 
mouse mammary tissue from obese and lean individuals as well as constructive advice on the direction of 
this project. Prof. Delphine Gourdon also provided scientific and technical advice on the data analysis and 
aided in writing the manuscript. Prof. Claudia Fischbach guided the direction of project, assisted with 
experimental design, provided insight for data analysis and wrote this manuscript. 
 
4.2. Abstract  
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Obesity and extracellular matrix (ECM) stiffness are considered independent risk and prognostic factors 
for breast cancer. Whether they are functionally linked is uncertain. Here, we investigated the hypothesis 
that obesity enhances local myofibroblast content in mammary adipose tissue and that these stromal 
changes increase malignant potential via enhancing interstitial ECM stiffness. Indeed, mammary fat of 
both diet- and genetically-induced mouse models of obesity were enriched for myofibroblasts and 
stiffness-promoting ECM components. These differences were related to varied adipose stromal vascular 
cell (ASVC) characteristics as ASVCs isolated from obese mice contained more myofibroblasts and 
deposited denser and stiffer ECMs relative to ASVCs from lean control mice. Accordingly, decellularized 
matrices from obese ASVCs stimulated mechanosignaling and thereby the malignant potential of breast 
cancer cells. Finally, the clinical relevance and translational potential of our findings were supported by 
analysis of patient specimens and the observation that caloric restriction in a mouse model reduces 
myofibroblast content in mammary fat. Collectively, these findings suggest that obesity-induced 
interstitial fibrosis promotes breast tumorigenesis via altering mammary ECM mechanics with important 
implications for anti-cancer therapies and adipose tissue-based reconstructive approaches following 
mastectomy.  
 
4.3. Introduction 
Obesity, with increasing worldwide prevalence, is a key risk factor for the development and 
prognosis of breast cancer209. This correlation is commonly attributed to obesity-mediated differences in 
adipose endocrine functions210. However, given the critical role of contextual cues in tumorigenesis, 
obesity-mediated alterations to the local microenvironment may also be important. In particular, obesity 
induces fibrotic remodeling of adipose tissue211,212 and these changes have been associated with malignant 
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potential213. Nevertheless, the exact mechanisms through which interstitial fibrosis in obese adipose tissue 
may impact the risk of and prognosis for breast cancer remain largely elusive.  
Similar to obesity, tumors also feature fibrosis in the surrounding stroma, which is commonly 
referred to as desmoplasia. The concomitant changes in ECM density and rigidity not only enable 
detection by mammography and palpation, respectively, but also represent important risk factors for 
tumor development, progression, and response to therapy27,47,214. More specifically, enhanced stiffness 
changes cellular mechanosignaling42, which, in turn, stimulates cancer aggressiveness through various 
mechanisms including perturbed epithelial morphogenesis123, growth factor and cytokine signaling124 and 
stem cell differentiation46,48. However, whether obesity-associated fibrotic remodeling alters local ECM 
mechanical properties and if these differences activate protumorigenic mechanotransduction remains to 
be elucidated. 
Myofibroblasts are major cellular regulators of fibrotic and desmoplastic remodeling and thus, 
tissue mechanical properties215. Myofibroblasts are highly contractile and assemble a fibronectin (Fn) and 
collagen type I-rich ECM that is characterized by enhanced density, fibrillar architecture, crosslinking and 
partial unfolding: all parameters causally linked to increased ECM stiffness32. Various proinflammatory 
cytokines enhanced during obesity (e.g. transforming growth factor 1 [TGF1]216) can initiate 
myofibroblast differentiation in mesenchymal cell types including adipose-derived stem cells (ASCs)48,215. 
Nevertheless, the impact of obesity on myofibroblast content of mammary adipose tissue remains elusive 
as most previous studies were performed with subcutaneous (s.c.) and visceral fat. Yet extrapolation of 
such results to mammary fat should be avoided because both global functions217 and fibrotic remodeling71 
of adipose tissue can vary significantly between anatomic depots.  
Here, our goal was to characterize the role of obesity in myofibroblast-mediated interstitial 
fibrosis in mammary fat, determine the impact of these variations on ECM mechanical properties, and 
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assess if these changes enhance the malignant potential of mammary tumor cells due to altered 
mechanotransduction. We have applied a multidisciplinary approach that integrates biological and 
physical sciences-based techniques ultimately extending our quantitative understanding of the functional 
relationship between obesity-induced alterations in ECM mechanics as it pertains to increased breast 
cancer pathogenesis. 
 
4.4. Materials and methods 
Animal models and tissue isolation 
To characterize obesity-associated interstitial fibrosis mammary, subcutaneous (s.c.) or visceral 
fat was isolated from both dietary and genetic mouse models of obesity (n=10/group). For diet-induced 
obesity (DIO) model, female 5 week-old C57BL/6J mice (Jackson Laboratories) were randomized and 
fed low fat (LF) or high fat (HF) diets (Research Diets: D12492i, 10 kcal% fat and 12450Bi, 60 kcal% fat, 
respectively) ad libitum for 10 weeks as previously described (Fig. 1A)218. For the genetic model, 8 week-
old B6.Cg-Lepob/J (ob/ob) and their age-matched C57BL/6J wild type controls (Jackson Laboratories) 
were fed PicoLab Rodent Diet 20, #5053 (W.F. Fisher & Son) ad libitum for 3 weeks until sacrifice (Fig. 
1A). To mimic menopause, either ovariectomy or sham surgery was performed on C57BL/6J mice at 4 
weeks of age. One week post-surgery, ovariectomized (OVX) and ovary intact mice were randomized for 
dietary intervention (LF or HF) (Fig. S1A). To study the effect of caloric restriction, OVX mice received 
10 weeks of HF feeding and were subsequently subjected to 30% caloric restriction (CR) for 7 weeks 
using previously established protocols (Fig. 6E)219. Age-matched control mice were fed LF or HF diets 
for a total of 17 weeks (n=6/group). Isolated tissues were formalin fixed for immunohistochemical 
evaluation, or frozen and stored at -80°C for subsequent biochemical analysis. Animal protocols were 
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approved by the Institutional Animal Care and Use Committees at Weill Cornell Medical College and 
Cornell University.  
 
Cell isolation and culture 
ASVCs were isolated from the stromal vascular fraction of either s.c. or visceral white fat of both 
genetic (11 week-old) and dietary (14 week-old) mouse models (Jackson Laboratories) via collagenase 
digestion and density centrifugation (Fig. 2A)220. Briefly, isolated tissue was minced in Krebs-Ringer-
HEPES (KRBH) buffer prepared as previously described221 and digested with 1.5mg/mL collagenase type 
1 buffer (Worthington Biochemical Corp.). Digested tissue was filtered through a 250µm cell strainer 
(Pierce) and centrifuged in Histopaque-1077 solution (Sigma) to separate ASVCs from adipocytes. 
Isolated ASVCs were cultured in media containing 1:1 Dulbecco's Modified Eagle Medium 
(DMEM)/F12 (Gibco) supplemented with 10% FBS (Tissue Culture Biologicals), 1% antibiotic 
(penicillin/streptomycin) (Gibco) up to passage 4. Human MDA-MB231 breast cancer cells (ATCC) were 
cultured in MEM (α-modification [αMEM], Sigma) containing 10% FBS and 1% antibiotic. MDA-
MB231 cells transduced with a NANOG promoter GFP reporter construct were prepared as previously 
described222 and cultured in MEM (Gibco) supplemented with 10% FBS and 1% antibiotic. 
 
Mammary tissue immunostaining and image analysis 
Cross-sections were prepared from paraffin-embedded mammary fat and immunofluorescently 
stained for Fn and α-SMA. Antigen retrieval was performed with 0.1 M citrate buffer, pH 6.0 (α-SMA) 
and additional proteinase K treatment (Fn) (Dako). Subsequently, tissue sections were permeabilized and 
blocked with SuperBlock (Thermo Fisher) in 0.05% Tween-20 PBS (PBST). For α-SMA staining, 
M.O.M kit blocking reagent (Vector laboratories) was used for an additional blocking. After overnight 
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incubation (4°C) with primary antibodies directed against Fn (Sigma-Aldrich) or α-SMA (Invitrogen), the 
sections were incubated with AlexaFluor 488-conjugated secondary antibody, counterstained with 4',6-
diamidino-2-phenylindole (DAPI), and then mounted with Prolong® Gold reagent (all from Invitrogen). 
For each sample, 10 to 20 randomly selected areas were imaged with a Zeiss Observer Z.1 microscope 
and an AxioCam MRm camera, and average fluorescence intensity was calculated. To correct for 
background, all images were thresholded by subtracting fluorescence intensity of negative controls using 
Adobe Photoshop (n=10 samples/group). The isolated positive pixels of each image were quantified in 
ImageJ (NIH) and then normalized to the number of adipocytes.  
 
Characterization of collagen fibers by SHG imaging analysis  
 Multiphoton SHG imaging was used to characterize collagen structure in fresh murine mammary 
tissue of genetic model and cross-sections of DIO mouse mammary tissue, human mammary tissue and 
tumors.  Imaging was performed with a custom-built multiphoton microscope using 780 nm illumination 
and an Olympus 20x/0.95W XLUMPlanFl objective141. Emissions were separated into SHG (360-405 nm, 
pseudocolored purple) and autofluorescence (420-550 nm, pseudocolored green) channels. For murine 
samples, mammary tissue from 11 week-old ob/ob and lean mice (n=3 per condition) was isolated and 
immersed in PBS. Z-stacks (50-120 µm in depth) of areas adjacent to the mammary epithelium, as 
identified in transmitted light mode, were acquired at 2m-intervals; 5 to 6 spots per tissue were imaged. 
For human specimens, 4m cross-sections were deparaffinized, rehydrated, and immersed in PBS. 
Micrographs of 10 regions per sample were collected and a total of 10 specimens per condition were 
analyzed. SHG channel images were extracted and analyzed through Fiji (NIH) and a custom-built 
autocorrelation analysis algorithm as previously described141. To assess fibril linearity (FL) in murine 
samples, individual fibrils were tracked through the entire Z-stack and both ends identified via Fiji. The 
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distance between both ends (D) and full-length of the fibrils (L) was recorded and their ratio (D/L) 
represented as FL; 30 to 50 fibrils per Z-stack were analyzed. To analyze collagen structure in human 
tumor specimens, a 2D spatial autocorrelation was computed from the SHG channel image. An 
autocorrelation ellipse was generated by fitting to 1/e of the maximum value of each image 
autocorrelation; the mean radius of the ellipse (in pixels) indicates the length scale of the collagen 
framework. The minimum and maximum radius of the ellipse were obtained and presented as the 
correlation width and correlation length of the fibers, respectively. 
 
Characterization of isolated ASVCs 
ASVCs isolated from s.c. fat of both genetic and dietary mouse models were plated on glass 
coverslips, cultured for 3 to 5 days, fixed with 4% paraformaldehyde (PFA), and then 
immunofluorescently analyzed for α-SMA, proliferative capacity, and ECM deposition. To determine 
proliferation, ASVCs were incubated with 10µM bromodeoxyuridine (BrdU) (Sigma-Aldrich) for 20 
hours. After fixation, cells were pretreated with ice-cold 1N HCl, 37oC 2N HCl, and 0.1 M borate buffer, 
incubated with biotinylated mouse anti-BrdU (Invitrogen), and finally fluorescently labeled with 
streptavidin-conjugated Alexa Fluor 555. For IF of α-SMA, Fn, and collagen, fixed cells were 
permeabilized with 0.05% Triton X-100 (VWR) in PBS (PBS-X), blocked in 1% BSA (Fischer 
Scientific) in PBS, and then incubated with primary antibodies directed against α-SMA, Fn, and collagen 
(Millipore) overnight at 4°C. Subsequently, samples were labeled with species-specific AlexaFluor 488-
conjugated secondary antibodies. The percentage of BrdU and α-SMA positive cells was determined by 
manually counting 5 representative images for each sample for a total of 3 samples. Matrix thickness was 
determined by confocal analysis of Z-stack images (1 m interval) captured with a Zeiss 710 confocal 
microscope. Differences in ASC secretion of SDF-1 were evaluated via SDF-1 ELISA duo set (R&D) 
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following 24 hours of incubation in serum-starved media and normalized to DNA content as measured 
from cell lysates by QuantiFluor® dsDNA System (Promega) (n=3/group). Also ASVCs isolated from 
visceral fat of ob/ob and wild type mice were similarly assessed as s.c. ASCs to evaluate the fat depot-
dependent profibrotic characteristics. 
 
Western Blot analysis 
Tissue and cell lysates were prepared in RIPA buffer containing protease and phosphatase 
inhibitor cocktail (all from Thermo Scientific) as well as 1mM phenylmethylsulfonyl fluoride 
(Calbiochem). Protein concentrations were measured using a BCA kit (Thermo Scientific) and equal 
amounts of protein samples were loaded on gels (Bio-Rad), separated by reducing SDS-PAGE, and 
transferred to PVDF membranes (Bio-Rad). After blocking with 5% milk powder, membranes were 
incubated overnight (4C) with primary antibodies raised against α-SMA, Fn, and p-FAK [397] 
(Invitrogen) as well as the house keeping proteins HSP90 (Santa Cruz), -actin (Millipore), and GAPDH 
(Ambion). Following incubation with species-specific HRP-conjugated secondary antibodies (Novus Bio) 
chemiluminescence detection was performed using an ECL kit (Thermo Scientific). Finally, densitometric 
analysis was performed with Image J and Adobe Photoshop CS4. 
 
Analysis of Fn conformation via FRET 
Differences in Fn conformation were determined as previously described31,223. Briefly, 2x104 
ASVCs from ob/ob and wild type mice were seeded in Lab-TekTM chamber slides (Thermo Scientific) 
pre-coated with 30 g/mL unlabeled Fn (Invitrogen) in PBS (n=3 per condition). Subsequently, human 
plasma Fn (only 8% FRET-labeled Fn with an excess of 92% unlabeled-Fn to prevent intermolecular 
energy transfer between adjacent proteins in fibers223) was added to yield a final Fn concentration of 50 
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mg/mL necessary for FRET analysis. 24 hours post-incubation, cells were fixed with 4% PFA, washed 
with PBS and then imaged using a Zeiss 710 confocal microscope with a 40x water immersion objective 
under conditions that prevented photobleaching. Z-stack images (1m interval) were captured at 6 
randomly chosen areas following excitation with a 10% laser intensity through the 488 nm channel, and 
then the signals from both the donor (514-526 nm) and acceptor (566-578nm) channels were collected. 
Image processing of the acceptor and donor images was performed as previously described224. Briefly, 
MATLAB (MathWorks, Inc.) was used to compute the FRET intensity (ratio of acceptor and donor 
channels) images, to calculate the mean and standard deviation of the FRET intensities, and to compile 
FRET intensity data at each representative location for histogram plotting (n=3/group). The quantified 
FRET intensity was used to determine relative Fn conformation referencing pre-obtained calibration 
curves for the FRET intensity of chemically denatured dual-labeled Fn and its corresponding circular 
dichroism spectra95,97. 
 
Analysis of ECM stiffness via SFA 
To measure the compressive elastic moduli of cell-free matrices deposited by ob/ob or wild type 
ASVCs, the SFA (SurForce LLC, CA) was utilized225,226. For measurements, mica surfaces holding the 
matrix were mounted on a double cantilever of known spring constant (k=980N/m) and compressed with 
a bare mica surface from the top. The force acting between the surfaces was then measured as a function 
of surface separation (Fig. 3C).  
Briefly, two semi-cylindrical surfaces, which have previously been back-covered with silvered 
mica, build an optical interferometer. The surfaces were prepared in a laminar flow cabinet, keeping 
samples as clean as possible. Optical grade muscovite mica (S&J Trading, Australia) was hand-cleaved 
into thin and uniform sections, and further metallized with 55nm of silver on their back side, to obtain 
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semi reflective surfaces (used to build the optical interferometer). Equally thick mica sections, silver side 
down, were glued onto a pair of fused silica discs (diameter=10mm, radius of curvature=20mm) (ESCO 
Products, NJ) with UV curing glue for 45-50 minutes (61 Norlan, NJ). For each pair, the bare (upper) 
surface used for indentation was kept in a dessiccator until needed. The other (lower) surface was first 
coated with 30 µg/ml of Fn (Invitrogen) in PBS to facilitate cell adhesion then placed in a custom-made 
PDMS well containing culture media and cells (obesity-associated or control ASCs) during the 24 hour 
matrix deposition process. 2x104 cells were seeded on the Fn-coated surfaces with 50 µg/mL of Fn 
supplemented (mimicking the FRET experiment) culture media for 24 hours. Next, matrices were 
decellularized using an extraction buffer (20mM NHOH4 in 0.5% PBS-X) and subsequent multiple 
washing steps with PBS and distilled water227. Shortly after decellularization, the compressive Young 
modulus of the matrix was quantified via SFA without any chemical crosslinking. 
Paired discs were mounted in a crossed cylinder axis configuration, to obtain a well-defined flat 
circular junction equivalent to a sphere-on-flat like contact. The SFA chamber was filled with PBS at 
37°C, keeping both discs fully immersed during the SFA measurements. Before starting an experiment, 
the system was allowed to equilibrate to 37°C for 1 hour. Then, individual samples were probed at 4 
different positions approximately 0.5mm apart. Each position was compressed at least 3 consecutive 
times with increasing normal force. 
Compressive measurements were performed in the quasi-static regime, at the lowest speed 
achievable with our normal motor (V = 8-9nm/s) to prevent any viscous contribution. The system was 
allowed to equilibrate for 20 minutes between each compressive cycle.  Measured force-distance profiles 
were further analyzed to extract the compressive elastic moduli using the Johnson contact mechanics 
model228, in which the indentation under compression (d) between a sphere and a flat was related to 
normal force (F)  by the following equation: 
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𝐹
𝑅
= 𝐸𝜋
𝛿2
𝐷0
      (1) 
where R is the equivalent radius of curvature of the cylindrical discs, D0 is the undistorted (prior to 
compression) thickness of the matrix and E the compressive Young’s modulus of the ECM (Fig. 3C). 
 
Analysis of tumor cell migration in response to obesity-dependent differences in SDF-1 levels 
To investigate the effect of SDF-1 from ob/ob ASVCs on tumor cell recruitment, a transwell 
migration assay was used. MDA-MB231 cells were seeded on collagen-coated transwell inserts (Corning 
Inc.), which were subsequently placed in wells that contained ASVCs cultured in low serum media with 
or without SDF-1 antibody (50g/mL) (R&D). After 18 hours, transwell membranes were fixed with 
formalin, stained with DAPI, and imaged from the bottom to the top with a Zeiss 710 confocal 
microscope. Subsequently, the number of migrated MDA-MB231 cells was quantified via manual 
counting of DAPI-stained nuclei at the bottom of the membrane. To further confirm the importance of the 
SDF-1/CXCR4 signaling axis to varied MDA-MB231 migration, SDF-1 signaling was inhibited by 
blocking its corresponding receptor with a CXCR-4 antibody (25g/mL) (R&D) (n=3/group). 
 
Analysis of tumor cell responses to obesity-mediated ECM changes 
Variations in tumor cell behavior as a function of obesity-mediated differences in ECM assembly 
were assessed with decellularized matrices (Fig. 4B). Briefly, 3x104 cells were seeded on Fn-coated 
Thermanox™ coverslips (Thermo Scientific) and cultured for 8 days after which cells were removed 
through detergent-based extraction as previously described48,227. Subsequently, MDA-MB231 cells were 
seeded on the decellularized matrices and cultured for 8 to 10 days (n=3 /condition). To assess tumor cell 
growth, MDA-MB231 were trypsinized and counted using a hemocytometer. Matrix-dependent 
differences in FAK phosphorylation were determined by IF and Western Blot analysis of pFAK[397] as 
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described above. The role of stiffness-dependent differences in tumor cell contractility and their effect on 
growth was tested by culturing tumor cells on the different decellularized matrices in the presence and 
absence of the ROCK inhibitor Y-27632 (10 µg/mL) (Tocris).  
To determine the importance of obesity-mediated differences to NANOG expression, NANOG 
promoter GFP reporter MDA-MB231 cells222 were cultured on the different matrices and the number of 
GFP positive cells was determined by image analysis with ImageJ (NIH). Correlation of GFP expression 
with ECM-dependent differences in integrin signaling was assessed by staining for pFAK[397] as per 
above and quantifying the number of MDA-MB231 doubly positive for GFP and pFAK[397]. To more 
directly test the effect of stiffness on NANOG transcription, PA gels of various Young’s moduli were 
fabricated as described previously229. Briefly, the stiffness of PA gels was tuned by altering the ratio of 
40% acrylamide and 2% bis-acrylamide (both from BioRad), and the surface of the polymerized gels was 
functionalized by a photo-initiated reaction with N6 (n-hydroxysuccinimidyl acrylamidohexanoic acid) 
(kindly provided by Valerie Weaver’s lab, UCSF) and crosslinking with 30g/mL of Fn. Cells were 
seeded on the different gels, cultured for 5 days, fixed with 4% PFA, and counterstained with DAPI. 
GFP-positive cells were evaluated as a percentage of the total number of cells using images captured with 
a Zeiss 710 confocal microscope. Five gels per stiffness were fabricated, 8-10 representative images per 
gel were analyzed (n=4/group). 
ECM-dependent differences in cancer stem cell-like properties were evaluated by determining the 
capability of MDA-MB231 cells to form tumor spheres. To this end, NANOG promoter GFP reporter 
MDA-MB231 cells cultured on the decellularized matrices from control and obesity-associated ASVCs 
were trypsinized and suspended in serum-free DMEM/F12 containing basic FGF, EGF (20ng/ml each, 
both from Invitrogen), 1x B27, and 1x antibiotic/anti-mycotic (both from Gibco)230. Subsequently, a 
limiting dilution analysis was performed by serial dilution culture of MDA-MB231 cells in 96-well plates 
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under serum-free conditions for 7 days (n=12/group). The number and size of spheres were 
microscopically assessed. Stem cell frequency was assessed using the extreme limiting dilution 
algorithm231.  
The level of matrix-bound SDF-1 and its role in mechanoregulation of cancer stem cell-like 
properties of MDA-MB231 were analyzed. For the analysis of the matrix-bound SDF-1, decellularized 
matrices deposited by either ob/ob or wild type ASVCs were prepared as described above and then lysed 
in RIPA buffer. The level of SDF-1 from the lysate was measured by ELISA. In addition, to examine if 
there is any SDF-1/CXCR4 signaling-mediated effect on modulating FAK phosphorylation and cancer 
stem cell-like properties of MDA-MB231, SDF-1-CXCR4 signaling was inhibited by blocking CXCR4 of 
MDA-MB231. Prior to being seeded on decellularized matrices, MDA-MB231 were incubated with 
CXCR4 antibody (25ug/mL) in αMEM containing 1% FBS and 1% antibiotic for 2 hours, and cultured on 
the matrix with the CXCR4-contained media, which was replenished every other days. After 10days, 
pFAK[397] and Nanog positive cell populations were assessed similarly as described above. 
 
Patient-derived tumor specimens and histopathological analysis 
Paraffin-embedded breast tumor specimens were obtained from existing archived samples of 17 
lean and 18 obese breast cancer patients under the approval of IRB Study 0408007390 at Weill Cornell 
Medical College. Tumor specimens were categorized by the patient’s BMI whereby a BMI of <25 and 
>30 was considered lean and obese, respectively. The two cohorts were evenly matched for age (average 
age: 44.7  9.7 [lean] vs. 44.8  8.8 [obese]), menopausal status (premenopausal: 59% [lean] vs. 56% 
[obese]; postmenopausal: 41% [lean] vs. 44% [obese]), stage and subtype of breast cancer at the time of 
diagnosis.  In both groups, the majority of patients (83%) had stage 3 breast cancer at diagnosis and the 
remainder (17%) had de novo stage 4 breast cancer as their initial diagnosis. Also the tumors from two 
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patient groups were found to be unbiased to any specific subtype of breast cancer as being impartially 
distributed among 8 types including Lumina A, B, A/B, HER2, and HER2 status not specified, HER2/neu 
enriched, triple negative, basal-like breast cancer. To assess the degree of desmoplasia, hematoxylin and 
eosin (H&E)-stained sections were scored by a pathologist in a blinded manner. Additionally, specimens 
were subjected to SHG imaging analysis of collagen as well as IF staining of -SMA and Fn as described 
above. For the latter, images of 10 randomly selected areas were captured per sample and subjected to 
image analysis. Lastly, the level of NANOG protein on the specimens was assessed by 
immunohistochemical staining. The paraffin-embedded tumor sections were deparaffinized, rehydrated 
and treated by EDTA (pH 8) antigen retrieval solution. Subsequently endogenous peroxidase and then 
non-specific binding of antibodies were blocked by a 10 minute-treatment with 3% hydrogen peroxide 
and 1 hour-incubation with blocking solution from ImmPRESS Kit (Vector Lab), respectively. The 
blocked sections were incubated by NANOG antibody (Cell signaling) overnight at 4°C and then labeled 
by HRP-conjugated secondary antibody (Novus Bio). Finally HRP-tagged NANOG positive cells were 
visualized by the reaction with 3,3´-diaminobenzidine (DAB) and DAB substrate kit (Thermo scientific), 
counterstained by hematoxylin and mounted. The NANOG stained sections were imaged and graded by a 
histopathologist. 
 
Statistical analysis 
Microsoft Excel and GraphPad Prism 5© were utilized to perform statistical analysis. Student’s t-
tests and ANOVA were used to compare parametric data between two conditions and among multiple 
conditions, respectively. For ANOVA, post-hoc pairwise comparisons were determined by Tukey’s test. 
Difference in stem cell frequency was evaluated by Chi-squared test and the log-dose slope obtained from 
the stem cell frequency was validated by goodness of fit tests. The statistical correlation between the non-
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parametric variables of human breast tissue was assessed by Spearman’s rank correlation and its 
coefficient was denoted as rho (ρ). The association between patients’ body condition (obesity vs. lean) 
and other categories (age, breast cancer subtype, menopausal status) was tested by Fisher’s exact test. In 
addition, non-parametric data from histopathological evaluation of human tumor specimens were 
analyzed via Mann-Whitney U test. Two-sided testing was performed for each analysis and a P-value less 
than 0.05 was considered statistically significant. Unless otherwise noted, values are reported as the mean 
with error bars to indicate standard deviations. In vitro results are shown for one representative study after 
similar results were replicated in three separate experiments. 
 
4.5. Results  
Obesity increases interstitial fibrosis in mouse mammary fat pads 
To quantify fibrotic remodeling, myofibroblast content and related ECM changes were assessed 
in mammary adipose tissue harvested from two well-established mouse models of obesity. Diet-induced 
obesity was achieved by feeding high fat diet to female C57Bl/6 mice for 10 weeks starting at 5 weeks of 
age. Obesity was reflected by increased weight of these mice relative to lean control animals fed with low 
fat diet (29.74 ± 4.15 g vs. 21.07 ± 0.63 g) (Fig. 4.1A). Additionally, age-matched female ob/ob mice 
were used, which are morbidly obese compared to wild type mice (54.39 ± 2.93 g vs. 19.8 ± 1.46 g) due 
to a loss-of-function mutation in the gene encoding the satiety hormone leptin232. Immunofluorescence 
(IF) analysis suggested that both diet and genetically induced obesity enhances interstitial -smooth 
muscle actin (-SMA; i.e., a myofibroblast marker) levels relative to the respective control conditions 
(Fig. 4.1B). This was further confirmed by Western Blot analysis of mammary adipose tissue from diet-
induced mouse models. Levels of Fn, an ECM component primarily deposited by myofibroblasts32,233, 
were also enhanced in obese animals (Fig. 4.1C). Importantly, high fat diet equally increased -SMA and 
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Fn content in mammary adipose tissue of ovariectomized mice (Fig. S1) suggesting that the above-
described changes are relevant to postmenopausal breast cancer, the primary type of breast cancer whose 
risk increases with obesity234. Interestingly, ovariectomy did not further stimulate -SMA in response to 
high fat diet (P=0.9706) (Fig. 4.2) although this regime increased mouse weight compared to high fat diet 
alone (mouse weights: 23.52 ± 2.09 g [ovariectomy/low fat diet]; 39.69 ± 2.72 g [ovariectomy/high fat 
diet]; 29.74 ± 4.15 g [high fat diet]). As this increase in weight is accompanied by elevated mammary 
  
Fig. 4.1. Obesity increases interstitial fibrosis in mouse mammary fat pads. (A) Mammary fat harvested 
from both dietary and genetic models of obesity was compared to its lean counterpart harvested from age-
matched (15 weeks and 11 weeks, respectively) mice. (B) IF and Western Blot analysis indicated that obesity-
associated mammary fat (HFD, ob/ob) contains more α-SMA positive myofibroblasts than mammary fat from 
lean control animals (LFD, WT). (Scale bars = 200 μm) (C) Similarly, Fn levels were enhanced in mammary fat 
from ob/ob relative to wild type (WT) mice. (D) SHG imaging analysis suggested that collagen fibers in 
mammary fat from both HFD and ob/ob mice are more linearized as compared to those from, LFD and WT mice 
respectively. (Scale bar = 50 μm) p < 0.05, *p < 0.05, and ●p < 0.05 indicate the difference from LFD, WT, 
and all others, respectively. 
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gland inflammation218, our results imply that inflammation may not be the sole regulator of obesity-
induced fibrosis. 
In addition to these molecular and cellular characteristics of fibrosis, tissues were analyzed for the 
effect of obesity on ECM physical properties. More specifically, second harmonic generation (SHG) 
imaging analysis was utilized to quantify ECM structural changes and revealed that interstitial collagen 
was more linearized in mammary adipose tissue of ob/ob vs. wild type mice (Fig. 4.1D). Hence, obesity 
caused structural changes of collagen that were previously associated with enhanced stiffness, 
 
Fig. 4.2. Mammary fat of obese OVX-mice exhibits enhanced interstitial fibrosis. (A) Ovariectomized 
(OVX) mice subjected to high fat diet for 10 weeks were used as a postmenopausal obesity model; age-matched 
OVX mice fed with low fat diet served as controls. IF analysis of (B) -SMA and (C) Fn content in mammary 
fat from OVX mice support that obesity promotes interstitial fibrosis in breast adipose tissue following 
menopause. (Scale bar = 200 μm) p < 0.05 
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malignancy, and ASVC-mediated ECM remodeling33,48. Consequently, obesity initiates fibrotic 
remodeling of mammary adipose tissue by triggering molecular, cellular, and ECM structural changes.  
 
Obesity enhances the pro-fibrotic phenotype of ASVCs  
To confirm that the detected cellular and molecular differences were functionally linked, we next 
performed in vitro experiments where we compared both the myofibroblast content and the ECM 
remodeling capacity of ASVCs isolated from the stromal vascular fraction of lean and obese adipose 
tissue (Fig. 4.3A). Given the small quantity of ASVCs that can be isolated from mammary adipose tissue 
and that differences observed in mammary fat were comparable to those present in s.c. depots from ob/ob 
mice (Fig. 4.4), ASVCs were isolated from the stromal vascular fraction of s.c. adipose tissue from age-
matched lean (20.2 ± 1.4 g) and ob/ob (56.56 ± 3.33 g) mice. Indeed, IF and Western Blot analysis 
verified that ASVCs from obese mice were enriched for -SMA positive, myofibroblastic cells (Fig. 
4.3B). Furthermore, these cells also exhibited enhanced proliferative capacity as quantified by BrdU 
incorporation (Fig. 4.3C) and secreted greater levels of stromal vascular cell-derived factor 1 (SDF-1) 
(Fig. 4.3D), both additional markers of myofibroblasts235,236,237. Finally, compared to wild type ASVCs, 
ob/ob-derived ASVCs assembled thicker ECMs enriched with collagen and Fn as indicated by IF and 
additionally verified for Fn through Western Blotting (Figs. 4.3E and F), thus further confirming the 
profibrotic phenotype of these cells. Collectively, these results suggest that obesity promotes 
myofibroblast-mediated ECM remodeling via altering ASVC fate. In addition, similar changes were 
observed in ASVCs from diet-induced mouse model of obesity (Fig. 4.3G).  
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Fig. 4.3. Obesity enhances the profibrotic phenotype of ASVCs. (A) ASVCs were isolated from the stromal 
vascular fraction of subcutaneous fat from age-matched lean and obese (both genetically and diet-induced) mice, 
expanded, and their profibrotic characteristics analyzed. (B) IF and Western Blot analysis suggested that ASVCs 
from ob/ob mice contain more α-SMA positive myofibroblasts relative to ASVCs from lean mice. (Scale bars = 
200 μm). (C) ASVCs from ob/ob mice exhibited enhanced proliferative capacity due in part to increased 
proliferation of myofibroblasts as indicated by an elevated percentage of α-SMA and BrdU double positive 
ASVCs in ob/ob vs. WT conditions. (Scale bars = 200 μm). (D) ASVCs from ob/ob mice secreted higher levels 
of SDF-1 as determined by ELISA followed by normalization to DNA content. (E) Confocal analysis of IF-
stained samples indicated that ASVCs isolated from ob/ob mice deposit thicker ECMs, which are enriched in Fn 
and collagen type I. (Scale bars = 200 μm). (F) Western Blot analysis confirmed that ASVCs from ob/ob mice 
deposit more Fn relative to ASVCs from WT mice. (G) Similarly, ASVCs isolated from diet-induced obese mice 
(HFD contained more α-SMA positive cells relative to their lean counterparts (LFD) and were characterized by 
increased BrdU incorporation, SDF-1 secretion, and matrix deposition. (Scale bars = 200 μm).  p < 0.05. 
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Obesity-associated ASVCs deposit partially unfolded and stiffer ECMs 
Next, we tested whether obesity-mediated differences in ASVC fate translated to altered 
mechanical properties of the ECM. While increased rigidity of fibrotic and tumor tissue is typically 
believed to reflect alterations in collagen synthesis and crosslinking33, variations in the Fn matrix structure 
and mechanics may be equally important. In fact, cellular deposition and remodeling of Fn is critical to 
the formation and turnover of collagen I-based ECMs238-240, and both Fn conformational and mechanical 
changes may play an important role in this process102,241. Fluorescence Resonance Energy Transfer 
(FRET) analysis of Fn conformation suggests that ASVCs isolated from obese mice partially unfold Fn 
matrix fibers relative to ASVCs from lean control mice (Figs. 4.5A and B) thereby mimicking differences 
mediated by tumor-associated ASVCs31. Importantly, partial Fn unfolding may not only change cellular 
behavior via exposure of cryptic binding sites91,242 or disruption of strain-sensitive binding sites such as 
the a5b1 integrin binding site243, but also by directly elevating Fn fiber rigidity95. To confirm that obesity 
affects overall rigidity of ECM deposited by ASVCs at the cellular level, we performed measurements 
with the Surface Forces Apparatus (SFA) (Fig. 4.5C). The SFA is a force-sensing technique that uses 
 
Fig. 4.4. Subcutaneous depots of adipose tissue feature markers of interstitial fibrosis. Western Blot 
analysis confirmed that (A) α-SMA and (B) Fn levels are enhanced in subcutaneous adipose tissue from ob/ob 
vs. WT mice in a manner comparable to mammary fat. p < 0.05. 
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optical interferometry to determine the absolute surface separation between two reflecting atomically 
smooth mica surfaces. It allows studying normal (compressive and tensile) forces, and friction between 
surfaces and was initially established to measure mechanical properties of molecular-thin films under 
confinement and shear244,245. When applied to decellularized matrices, this technique confirmed that 
obesity elevates matrix rigidity to levels previously associated with enhanced malignancy (Fig. 4.5D)123. 
Consequently, obesity impacts the mechanical properties of the ECM deposited by ASVCs that may 
ultimately lead to interstitial stiffening.  
Interestingly, ASVCs isolated from visceral fat of ob/ob vs. wild type mice similarly exhibit 
enhanced profibrotic potential as detected by elevated -SMA and Fn content and partial unfolding of 
deposited Fn matrices. However, ASVCs from visceral fat deposited less ECM as compared to ASVCs 
from s.c. fat. These results suggest that our findings are broadly relevant and that obesity may alter the 
mechanical properties of adipose interstitial tissue at varying anatomical depots (Fig. 4.6).  
 
Obesity-associated ASVCs stimulate MDA-MB231 migration and mechanosensitive growth  
To evaluate whether the above-described changes affect the properties of tumor cells, the impact 
of obesity-mediated differences in ASVC paracrine signaling and matrix deposition on mammary tumor 
cell migration and growth were determined. Transwell migration assays showed that factors secreted by 
obese ASVCs stimulated MDA-MB231 migration compared to a similar number of lean ASVCs (Fig. 
4.7A). Notably, these differences occurred in an SDF-1-dependent manner as antibody-based inhibition of 
both ASVC-secreted SDF-1 and the tumor cells’ cognate CXCR4 receptor prevented the pro-migratory 
effect mediated by ob/ob ASVCs.  
The effect of differential ECM properties on tumor cells was tested using decellularized matrices 
assembled by ASVCs from age-matched wild type and ob/ob subcutaneous adipose tissue (Fig. 4.7B). 
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Fig. 4.5. Obesity-associated ASVCs deposit partially unfolded and stiffer ECMs. (A) Conformation of 
ASVC-assembled Fn matrices was determined by confocal analysis of FRET between donor [D] and acceptor 
[A] covalently coupled to Fn. Low FRET intensity due to separation of D and A indicates partial Fn unfolding, 
while enhanced FRET intensity suggests intact secondary/tertiary structure. Accordingly, Fn matrices deposited 
by obesity-associated ASVCs (ob/ob) contained more regions that were significantly unfolded (blue fibrils vs. 
green-yellow fibrils) relative to Fn matrices deposited by control ASVCs (WT). (Scale bars = 50 μm). (B) 
Analysis of FRET distribution confirmed that obesity-associated ASVCs induce elevated Fn fiber strain: 
Histogram of FRET intensities (i.e., acceptor intensity divided by the donor intensity [IA/ID]) derived from 
analysis of the fields of view shown in (A) and box and whiskers plots of the FRET intensity of 6-8 
representative fields of view per condition. (C) Compressive elastic moduli of ECMs deposited by ob/ob and WT 
ASVCs was determined by indentation of decellularized ECMs between two silvered mica surfaces mounted on 
a cantilever spring of constant k. Surface separation was determined by optical interferometry and 
mathematically related to normal force (F) whereby R is the equivalent radius of curvature of the cylindrical 
discs, D0 or D the undistorted or force-applied thickness of the matrix, respectively. (D) SFA analysis confirmed 
that ECMs deposited by obesity-associated ASVCs (ob/ob) on mica surfaces are stiffer than those deposited by 
their lean counterparts (WT); decellularization prior to analysis did not compromise the structural properties of 
Fn-rich matrices as indicated by IF. (Scale bars = 100 μm). p < 0.05. 
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Corresponding to our previous observation that stiffening of ASVC-derived   ECMs promotes breast 
cancer cell proliferation48, MDA-MB231 growth was enhanced on decellularized ECMs from ob/ob 
relative to wild type ASVCs (Fig. 4.7C). Increased stiffness stimulates cell growth by enhancing 
phosphorylation of focal adhesion kinase (pFAK), which, in turn, is caused by an elevation in RhoA/Rho-
associated protein kinase (ROCK)-mediated cell contractility90. Accordingly, both IF and Western Blot 
analysis indicated that MDA-MB231 cells contained more pFAK when seeded onto ECMs deposited by 
 
Fig. 4.6. Obesity-associated ASVCs promote fibrotic ECM remodeling in visceral fat. ASVCs isolated from 
visceral fat of ob/ob mice contained more myofibroblasts compared to their WT counterparts as identified by IF 
analysis of (A) α-SMA and (B) Fn. (C) Accordingly, confocal analysis of matrix thickness confirmed that 
matrices deposited by visceral ASVCs from ob/ob mice were thicker than those deposited by ASVCs from WT 
mice. Interestingly, ASVCs from visceral fat deposited less ECM as compared to ASVCs from s.c. fat. (Scale 
bar = 200 μm). (D) FRET analysis of Fn conformation suggested that ASVCs from visceral depots of ob/ob mice 
promote partial unfolding of Fn relative to the corresponding WT ASVCs resulting in decreased FRET intensity. 
Depicted here by more blue vs. green-yellow fibrils in ASVC-deposited, pseudocolored Fn matrices (left), 
histograms of the corresponding distribution of FRET intensity (middle), and box and whiskers plots of the 
FRET intensity of 6-8 representative fields of view per condition (right). p < 0.05 and ●p < 0.05 indicate 
differences from WT (V) and all others, respectively. 
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ob/ob vs. lean ASVCs (Fig. 4.7D). Moreover, inhibition of cell contractility using the ROCK inhibitor Y-
27632 blocked the growth-promoting effect of ECMs deposited by ob/ob ASVCs (Fig. 4.7E), which 
further confirmed that obesity-induced interstitial ECM stiffness promotes tumor cell growth by altering 
cell contractility-dependent signal transduction (Fig. 4.8A).  
 
Fig. 4.7. ASVCs from obese mice stimulate MDA-MB231 migration and mechanosensitive growth. (A) 
Transwell assays revealed that ASVCs from ob/ob mice promote MDA-MB231 migration relative to ASVCs 
from WT mice. These differences were dependent on functional SDF-1/CXCR4-signaling because obesity-
dependent promigratory effects were abrogated by inhibiting SDF-1 from ASVCs or blocking CXCR4 on MDA-
MB231. (B) To determine the effect of obesity-mediated differences in ECM physicochemical properties on 
mammary tumor cells, decellularized ECMs were prepared from ob/ob and WT ASCs and reseeded with MDA-
MB231. Subsequently, changes in tumor cell behavior were evaluated as a function of stiffness-dependent 
differences in cell contractility. (C) Cell counting suggested that MDA-MB231 (red for actin) grew more on 
decellularized ECMs (green for Fn) from ob/ob ASVCs than on ECMs from WT ASVCs. (Scale bar = 100 μm). 
(D) Image analysis of IF-stained cells and Western Blotting indicated that MDA-MB231 contained more 
pFAK[397] that was localized along the cell boundary when plated on decellularized matrices from obesity-
associated ASVCs. (Scale bar = 50 μm). Red arrows indicate localized pFAK. (E) Enhanced pFAK levels 
suggested that elevated MDA-MB231 growth was related to ECM stiffness-dependent changes in cell 
contractility. Indeed, blocking the catalytic sites of Rho associated kinase p160ROCK with Y27632 decreased 
MDA-MB231 growth on ob/ob-derived ECMs to control levels. p < 0.05 and ●p < 0.05 indicate the difference 
from WT and all others, respectively. 
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Obesity-associated ASVCs promote MDA-MB231 expression of NANOG 
As an additional measure of increased malignancy, we assessed whether obesity-mediated 
differences in ASVC matrix assembly enhance the expression of pro-carcinogenic molecules. We chose 
to test NANOG as a specific example given that this self-renewal transcription factor is a negative 
prognostic factor for breast cancer patients246 and a promoter of cancer stem cell characteristics247,248. To 
monitor changes in NANOG expressing cells and thus cancer stem cells, MDA-MB231 cells were 
transduced with a reporter in which the NANOG promoter drives GFP expression as previously 
described222. GFP+ cells selectively express the stem cell markers NANOG, SOX2, and OCT4 compared 
to GFP- cells and have high stem cell frequency based on tumor sphere analysis249. Interestingly, the 
number of GFP+ cells was significantly increased on decellularized matrices deposited by ob/ob ASVCs 
relative to wild type ASVCs, suggesting that tumor cells enhanced NANOG transcription by interactions 
with obesity-associated ECM (Fig. 4.9A). Importantly, these differences correlated with altered 
mechanotransduction as IF and Western Blot analysis revealed that NANOG promoter (GFP+) - active 
cells contained enhanced levels of pFAK when cultured on ob/ob ASVC-derived ECMs (Fig. 4.9B). To 
 
Fig. 4.8. Decellularized matrices from obesity-associated ASVCs promote pFAK and tumor sphere 
formation. (A) Analysis of IF images indicated that addition of the ROCK inhibitor Y-27632 reduced pFAK in 
MDA-MB231 cultured on decellularized matrices from ob/ob-ASVCs to levels comparable to culture on 
matrices deposited by WT ASVCs. Scale bar = 50 μm) ●p < 0.05 indicates the difference from all others. 
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more directly determine the contribution of stiffness to NANOG promoter activity, cells were seeded onto 
polyacrylamide gels of stiffnesses relevant to normal and obesity-associated ECM rigidity. Culture on 
gels of increased elastic modulus elevated the number of NANOG promoter (GFP+) – active cells relative 
to softer gels (Fig. 4.9C). 
Finally, to confirm a functional contribution of obesity-dependent ECM changes to NANOG-
mediated differences in malignancy, tumor sphere formation of MDA-MB231 cells was evaluated 
following culture on decellularized ECMs deposited by ob/ob and wild type ASVCs. Indeed, tumor 
sphere formation of cells preconditioned on ob/ob-associated ECMs was increased suggesting enhanced 
self-renewal and stemness relative to cells preconditioned on control ECMs (Figs. 4.9D and 4.10). 
Collectively, these results suggest a contribution of obesity-mediated variations of ECM remodeling to 
NANOG-mediated tumorigenicity.  
 
Obesity-associated ECM remodeling is clinically relevant 
To determine the clinical relevance of our findings, we analyzed histological characteristics of 
desmoplastic remodeling in breast cancer specimens collected from lean and obese women. Pathological 
scoring of hematoxylin & eosin stained cross-sections revealed that tumors from obese patients exhibited 
more severe desmoplasia relative to tumors from lean patients (Fig. 4.11A, Table 1). Accordingly, IF 
analysis confirmed increased levels of -SMA positive cells and Fn content in samples from obese vs. 
lean patients (Figs. 4.11B and C). Moreover, SHG analysis suggested that obesity leads to collagen-
dependent structural changes contributing to enhanced mechanical rigidity because samples from obese 
patients not only exhibited increased collagen fiber linearity, but also fibril thickness (Fig. 4.11D). 
Together, these data suggest clinical relevance of our findings and that therapeutic interference with this 
process may prove valuable to improve patient outcome. 
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Fig. 4.9. Obesity-associated ASVCs promote MDA-MB231 expression of NANOG. (A) IF and Western Blot 
analysis of a reporter cell line in which the NANOG promoter drives GFP expression suggested that MDA-
MB231 increased transcription of NANOG when cultured on decellularized matrices from ob/ob vs. WT-
ASVCs. (Scale bar = 50 μm). (B) Enhanced NANOG transcription correlated with elevated pFAK[397] levels in 
this cell line as detected by IF and Western Blot analysis. White arrows indicate pFAK. (Scale bar = 50 μm). (C) 
Increased ECM stiffness promoted NANOG transcriptional activity because culture on polyacrylamide gels of 
elevated stiffness increased the number of GFP+ cells. (Scale bar = 50 μm).  (D) Limited dilution assay indicated 
that the number of tumor spheres in a given population was increased when MDA-MB231 were cultured on 
decellularized matrices of ob/ob vs. WT-ASVCs. Left: number of tumor spheres formed from 80 cells per well; 
right: natural log fraction of negative responses as a function of seeding density. (Scale bar = 100 μm) p < 
0.05 indicates the difference of 140 Pa (C) and WT from all others. 
 
Fig. 4.10. Decellularized matrices from obesity-associated ASVCs enhance tumor sphere formation. MDA-
MB231 increased tumor sphere formation when cultured on matrices deposited by ob/ob-ASVCs as compared to 
those assembled by WT ASVCs. (Scale bar = 50 μm).  p < 0.05.  
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Nevertheless, controversy exists with regards to the therapeutic value of weight loss to the 
reversibility of adipose tissue interstitial fibrosis250,251. Therefore, we tested whether caloric restriction 
could reduce interstitial fibrosis in mammary fat. Ovariectomized mice were subjected to 10 weeks of 
high fat diet to mimic postmenopausal obesity followed by 7 weeks of caloric restriction to suppress 
further weight gain according to our previous reports (weights of mice: 22.10 ± 0. 58 g [low fat diet]; 
38.93 ± 2.17 g [high fat diet], 30.12 ± 0.82 g [high fat diet/caloric restriction]) (Fig. 4.11E)219. 
Subsequently, mammary fat pads were excised and changes in interstitial fibrosis were assessed by 
 
Fig. 4.11. Obesity-associated ECM remodeling is clinically relevant. (A) Histopathological scoring of clinical 
specimens indicated that breast cancers from obese patients exhibit a higher degree of desmoplasia. (Scale bar = 
200 μm). Correspondingly, image analysis of IF-stained specimens suggested that breast cancers from obese 
patients were characterized by (B) enhanced α-SMA and (C) Fn content. (Scale bar = 100 μm) (D) SHG imaging 
analysis detected thicker and more linearized collagen fibers in tumors from obese patients. (Scale bar = 100 μm) 
(E) To investigate if caloric restriction can reverse obesity-mediated fibrosis, mice fed with HFD for 10 weeks 
were subsequently subjected to 30% of caloric restriction for 7 weeks. Western Blot analysis showed that 
reduced caloric intake (G) significantly lowered α-SMA levels, while (F) moderately decreasing Fn content.  < 
0.05, and *p < 0.05 indicate differences from Lean (WT) and HFD/CR, respectively. 
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quantification of -SMA and Fn levels. Western Blot analysis suggested that caloric restriction reduced 
the content of myofibroblasts in mammary fat interstitial tissue (Fig. 4.11F). A similar trend, but no 
statistical significance was noted for Fn (Fig. 4.11G). These results suggest that caloric restriction 
decreases features of fibrotic remodeling in mammary adipose tissue, but longer term follow up will be 
required to determine whether these cellular changes translate to differences in ECM physicochemical 
properties.  
 
4.6. Discussion  
Our results suggest that obesity leads to the formation of mechanical niches in adipose tissue that 
exhibit characteristics similar to tumor-associated stroma and promote carcinogenesis via altering 
mechanotransduction. More specifically, obesity increases the number of myofibroblasts in the stromal 
vascular fraction of mammary adipose tissue. These myofibroblasts not only deposit a more fibrillar, 
partially unfolded, and stiffer ECM, but also help recruit tumorigenic cells via increased secretion of 
SDF-1. Tumor cells interacting with the stiffer ECMs, in turn, exhibit varied mechanosignaling ultimately 
promoting mammary tumor cell growth and expression of malignancy markers.  
The breast cancer-promoting capacity of obesity is widely recognized and mainly attributed to the 
altered paracrine and endocrine functions of adipose tissue64, including elevated estrogen levels252. 
However, obesity not only worsens the clinical outcome of estrogen receptor (ER) positive, but also ER- 
and triple-negative breast cancer253,254 suggesting that other, so far underappreciated, mechanisms play 
additional roles. According to the presented data, obesity-mediated differences of adipose interstitial 
mechanics may represent such a mechanism. Although our studies utilized ER-negative MDA-MB231 
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Tab. 1. Demographics and desmoplastic grade of lean and obese breast cancer samples  Statistical 
examination of clinical specimens from 17 lean and 18 obese breast cancer patients confirmed the parity of age, 
cancer subtype, and menopausal status between the two cohorts. Histopathological analysis of desmoplasia 
indicated that the majority of tumors from lean patients was characterized by mild (grade 1) or moderate (grade 
2) desmoplasia, while tumors from obese patients were characterized by moderate to severe (grade 3) 
desmoplasia. * indicates statistical difference between the two cohorts. 
.  
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breast cancer cells, increased ECM stiffness also promotes malignancy of other tumor subtypes255,256 
underscoring the broad relevance of our results.  
 While previous reports indicate that obesity stimulates fibrosis in subcutaneous and visceral 
adipose tissue71, our results imply that similar changes occur in mammary adipose tissue. This 
observation is highly significant given that (i) the global functions and fibrotic remodeling of adipose 
tissue vary between anatomic depots71,213,217 and (ii) the local microenvironment of the breast is 
indisputably relevant to mammary tumorigenesis257-259. Interestingly, obesity caused similar levels of 
fibrotic remodeling in mammary fat from ovariectomized and control mice further suggesting that 
obesity-associated stiffening of the ECM occurs independent of hormone status and thus, is pertinent to 
both pre- and postmenopausal breast cancer.  
The described obesity-associated changes in ECM physicochemical characteristics were related to 
elevated myofibroblast population in the adipose stromal vascular fraction similar to tumor desmoplasia48. 
ASVCs isolated from obese adipose tissue were enriched for myofibroblasts and deposited a fibrillar, 
collagen type I- and Fn-rich ECM that was characterized by increased thickness, linearization, and partial 
unfolding. Importantly, these changes in ECM composition and structure elevated global matrix stiffness 
consistent with previous reports that increased ECM quantity123, fibrosis-associated changes of collagen 
type I260, as well as partial unfolding of Fn95 all elevate ECM rigidity.  
By combining both decellularized matrices and hydrogel-based artificial ECMs, we showed that 
the detected differences in ECM mechanical properties directly regulate the malignant capability of tumor 
cells. Our results confirmed that decellularized ECMs from obesity-associated ASVCs increased MDA-
MB231 proliferation due in part to altered mechanosignaling. Importantly, elevated mechanosignaling is 
also correlated with the tumor cells’ ability to up-regulate NANOG, a marker characteristic of increased 
malignancy and stem-like properties of tumor cells. This observation is important as cancer stem cells are 
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believed to promote cancer relapse and metastasis due to their self-renewal, differentiating capacity, and 
high resistance to chemo- and radiation therapy261,262. Together, our results suggest that the poor clinical 
prognosis of obese breast cancer patients may be related to ECM-mediated differences in cancer stem cell 
maintenance that may ultimately contribute to recurrence. Clearly, this is an exciting possibility, but 
future studies are needed to further evaluate this concept and assess the in vivo relevance of these 
changes.  
Using specimens from lean and obese patients as well as testing the effect of caloric restriction on 
fibrotic remodeling of mammary fat, we provide experimental evidence supporting the clinical 
importance of our results. More specifically, we show that tumor desmoplasia and the related qualitative 
and quantitative ECM changes257 worsen with obesity. Weight loss and exercise are routinely 
recommended to obese cancer patients as this regime may improve the clinical outcome of cancer 
patients263. A number of possibilities including altered metabolism264 and reduction of local inflammation 
may contribute to this end108. Additionally, our data suggest that caloric restriction inhibits fibrotic 
remodeling because myofibroblast content in mammary fat of obese mice decreased with this condition; a 
similar trend was noted for ECM remodeling although the effect may be delayed relative to cellular 
change265,266. 
In addition to diet, a number of additional clinical scenarios could be impacted by our results. 
Mammography is a commonly-utilized modality for early detection of breast cancer and overall risk 
assessment because women with mammographically-dense breasts typically have a higher probability of 
developing breast cancer. However, radiographic breast density is inversely correlated with BMI. As fat is 
radiolucent, obese women appear to have non-dense breast tissue267 although our data suggest that local, 
microscale density changes occur that may impact cancer risk. Therefore, alternative high-resolution 
imaging will be necessary in order to better localize and monitor regions that may stimulate tumorigenesis 
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in the obese. Furthermore, adipose tissue or ASVCs are increasingly being considered for regenerative 
approaches of mastectomy patients. Thus far, little attention is given to the body habitus of the patient 
from whom the ASVCs are isolated. Yet our data imply that ASVCs from obese individuals might 
promote recurrence of breast cancer relative to ASVCs from lean patients via changing the 
physicochemical properties at the implantation site. Stratification of patients based on BMI may help to 
better assess the potential risk, if any, associated with adipose tissue-based plastic and reconstructive 
approaches268.  
 Based on our reported results a number of questions arise that provide ample opportunity for 
future studies. For example, what are the mechanisms contributing to obesity-associated differences in 
ECM mechanics and thus, mammary tumorigenesis? Is obesity-associated hypoxia an initiator of the 
detected changes due to its ability to upregulate the collagen-crosslinking, and thus, also increase the 
activity of the ECM stiffness-inducing enzyme lysyl oxidase33,213,269 Alternatively, which role does 
obesity-associated chronic inflammation play in this process? Macrophages are enhanced in obese 
mammary tissue, but whether these differences indeed contribute to the elevated myofibroblast content in 
obese mammary fat remains to be confirmed. Moreover, obesity-associated fibrosis has been correlated 
with elevated levels of collagen type VI and its cleavage product endotrophin213. Nevertheless, the 
functional contributions of these molecules has only been tested at the biochemical level; whether their 
tumor-promoting effects270 may also be related to altered ECM mechanics will need to be assessed. 
Finally, our study focused on the direct effect of obesity-mediated ECM differences on tumor cells. 
However, altered ECM mechanics can also promote tumorigenesis via indirect mechanisms; i.e., via 
influencing soluble factor (e.g. adipokines) signaling and by altering stromal cell responses89. Together, 
our results are of broad relevance to the field of obesity-induced cancer and inform a multitude of future 
studies in the arena of physical sciences oncology. 
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Fig. 4.12. Obesity-associated interstitial ECM remodeling promotes tumor growth.  
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CHAPTER 5 
 
MICROSTRUCTURE OF COLLAGEN FIBERS REGULATES 
 THE PRO-ANGIOGENIC POTENTIAL OF ADIPOSE-DERIVED STEM CELLS 
 
 
 
5.1. Contributors 
Co-authors of this chapter made the following contribution: Young Hye Song, Ph.D. graduate student in 
the Fischbach lab, aided in analyzing pro-angiogenic behaviors of adipose stromal cells and endothelial 
cells. Roberto C. Andresen Eguiluz, Ph.D. graduate student in the Gourdon lab and Jacqueline Gonzalez, 
undergraduate student in Fischbach lab at that time, measured the compressive moduli of collagen 
scaffolds and analyzed the results. Jiranuwat Sapudom, Ph.D. graduate student in the Pompe lab at 
Leipzig University, characterized interior architecture of collagen scaffolds. Siyoung Choi, a post-
doctoral fellow in the Fischbach lab, aided in spinning electron microscopy (SEM) imaging. Prof. Denise 
Hocking at University of Rochester provided Fn-null mouse embryonic fibroblasts for the study. Prof. 
Tilo Pompe at University of Leipzig provided a custom-built algorithm for SEM image analysis. Prof. 
Delphine Gourdon provided resources for FRET analysis and advice on characterizing mechanical 
properties of collagen scaffolds. This project was completed under the guidance of Prof. Claudia 
Fischbach, who provided me with scientific and technical advice to complete this work. 
 
5.2. Abstract 
Angiogenesis is critical to normal (e.g. wound healing) and pathological (e.g. cancer) tissue remodeling 
and influenced by surrounding stromal cells. However, the effect of extracellular matrix (ECM) 
microarchitecture on endothelial-stromal cell interactions remains unclear. In particular, collagen is one of 
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the most abundant ECM proteins in the body and is enhanced during tumorigenesis. Here, we investigated 
the impact of collagen fiber morphology on the pro-angiogenic potential of adipose-derived stem cells 
(ASCs) and the functional consequences on human umbilical vein endothelial cells (HUVECs) sprouting. 
To this end, ASC-embedded 3D collagen scaffolds with thick and thin fibers were fabricated by cold- and 
warm-casting, respectively, and overlaid with a confluent HUVEC monolayer. Pore size was greater in 
cold-cast collagen gels relative to warm-cast scaffolds, while the opposite was true for fiber diameter. 
Accordingly, cold-cast collagen gels induced ASC differentiation into contractile alpha-smooth muscle 
actin (α-SMA)-positive myofibroblasts, which deposited partially unfolded fibronectin compared to cells 
in warm-cast gels. Furthermore, ASCs embedded in cold-cast collagen gels increased vascular endothelial 
growth factor (VEGF) and interleukin-8 (IL-8) secretion in a Rho-dependent manner, stimulating 
increased sprouting of HUVECs. Our study indicates that microstructural changes of collagen fibrils can 
modulate the pro-angiogenic potential of ASCs with implications for regenerative medicine and cancer 
research.  
 
5.3. Introduction  
Because adequate perfusion is essential for all living tissues, new vessel growth via angiogenesis 
is a critical aspect of wound healing, tissue regeneration, and therapeutic approaches for various disorders 
such as ischemic heart diseases and cancer50,52. The multistep process of angiogenesis requires 
coordinated efforts of peripheral stromal cells under the regulation of biochemical and physical cues50,271. 
Upon receiving the stimulation, stromal cells secrete angiogenic factors and remodel surrounding 
extracellular matrix (ECM), both of which collectively direct ECs’ angiogenic behaviors51,52,271. Among 
the stromal cells, progenitor cells, such as bone-marrow mesenchymal stem cells (MSCs) have been 
highlighted by an increasing number of studies regarding their roles in the promotion of functional tissue 
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remodeling, showing that the presence of progenitor cells not only promotes EC sprouting but also blood 
vessel maturation272,273.  
Adipose-derived stem cells (ASCs) are considered a promising autologous cellular source for 
regenerative medicine due to their abundance and accessibility. More importantly, the pro-angiogenic 
potential of ASCs has been demonstrated by improved vascularization of ASC-implanted in vitro and in 
vivo models274-276. This may be due in part to the plasticity of ASCs, which can differentiate into various 
cell types involved in angiogenesis, including endothelial cells, smooth muscle cells, and myofibroblastic 
cells83,277. In particular, α-smooth muscle actin (α-SMA) positive myofibroblasts greatly contribute to 
tissue remodeling by secreting pro-angiogenic factors such as vascular endothelial growth factor (VEGF), 
basic fibroblast growth factor (bFGF), and interleukin-8 (IL-8), and by actively depositing thicker and 
aligned fibrillar ECM during wound healing, fibrosis, and tumor desmoplasia61,186. Thus, myofibroblastic 
differentiation of ASCs has been linked to tumor progression via enhanced angiogenesis and matrix 
remodeling177,178. Transforming growth factor-β (TGF-β) has been indicated as a primary molecular 
mediator of myofibroblast differentiation, but ECM-mediated physical cues are equally critical in 
determining cell fate196. 
 Matrix properties have been known to regulate cellular behaviors such as proliferation, 
differentiation, and migration by modulating cytoskeleton organization and contractility46,278,279. ECM-
derived biochemical and physical cues are modulated by changes in density, composition, conformation, 
and structure of ECM components at various spatial scales. Among interstitial ECM components, fibrillar 
collagen type I is the most abundant ECM protein and, together with fibronectin (Fn), plays a major role 
in regulating ECM integrity280. Changes in collagen microstructure, including collagen density, cross-
linking, and alignment have been clinically correlated with disease stages202,281-283. Moreover, it has been 
shown that fibronectin conformational changes modulate cellular behaviors including angiogenic 
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potential via altered integrin engagement284. Nevertheless, little is known regarding the role of collagen 
fiber microstructure in the regulation of cellular behaviors. This is in part due to the difficulty of 
decoupling individual effect of fibrillar microstructure from other physical parameters of collagen matrix, 
which often concomitantly occur during tissue remodeling in vivo.  
 Engineered collagen scaffolds with varying mechanical property, interior architectures or fibrillar 
structures have been widely utilized for in vitro biological assays133. In vitro, collagen polymerization 
conditions such as pH, temperature, and ion strength modulate interior architecture (pore size) and 
microstructure of fibers (diameter, length, and alignment), which collectively alter the biochemical and 
mechanical properties of collagen matrix. These changes potentially regulate cellular behaviors such as 
proliferation and migration93,285. While engineered in vitro systems have aided in understanding the role 
of microarchitecture in the regulation of cell behaviors such as cancer cell invasion and blood vessel 
morphogenesis, there is still lack of understanding about whether fiber thickness influences 
mechanoregulation of cell behaviors94,286. In particular, the role of microstructure of collagen fiber in the 
regulation of ASC phenotype and its resulting effects on angiogenic activity of ECs remain elusive. 
Here, we utilized 3D co-culture scaffold with varying microstructure of collagen fibers to 
investigate our hypothesis that thicker collagen fibrils mechanically stimulate pro-angiogenic potential of 
surrounding progenitor cells, thereby facilitating angiogenic activities of ECs. Our findings suggest that 
microstructural change of collagen fibers is a critical regulator of stem cell fate, providing significant 
implication in cancer, stem cell, and tissue engineering research. 
 
5.4. Materials and methods 
Cell culture 
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Human adipose derived stem cells (ASCs) were maintained in ADSC-GM supplemented by 
growth factors (both from Lonza). Human umbilical vein endothelial cells (HUVECs) (Lonza) were 
cultured in HUVEC-GM containing Bio-Whittaker® medium 199 (M199; Lonza) with Endothelial Cell 
Growth Supplement (Millipore), 2mM Glutamax, 5U/ml heparin, 20% Fetal Bovine Serum (FBS) (Tissue 
Culture Biologicals), 1% penicillin/streptomycin (Gibco). Fn-null mouse embryonic fibroblasts (FN-null 
MEFs) were generously provided by Prof. Denise Hocking, University of Rochester, Rochester, NY) 
were cultured on 50µg/ml of collagen I (Gibco)-coated culture plates under fibronectin- and serum-free 
media using a 1:1 mixture of Cellgro® (Mediatech) and Aim V (Invitrogen). 
 
Fabrication of three-dimensional collagen scaffolds with varying microstructure 
Three-dimensional collagen scaffold fabrication procedure was adopted from our previously 
published protocol182. First, 4-mm-diameter and 200-µm-thick round shape of polydimethylsiloxane 
(PDMS) molds were micro-fabricated using Sylgard® 184 silicone elastomer kit (Dow Corning) and their 
surface was treated by 1% [v/v] poly-ethylenimine (Aldrich) and then 0.1% [v/v] glutaraldehyde (Fischer 
Scientific) to aid the adhesion of collagen to the mold. After the surface treatment, the molds were kept in 
either ice-cold or 37°C to either delay or accelerate collagen fibrillogenesis, which ultimately modulates 
collagen fibril diameter. Collagen was obtained by acid extraction of rat-tail tendon (Pel-Freez 
Biologicals), lyophilized and then reconstituted in 0.1% [v/v] acetic acid at a concentration of 1.5mg/ml 
as previously described287. The reconstituted collagen was neutralized to pH 7.2 by an increment of 0.1N 
and 1N NaOH, and then mixed with ASCs at a density of 2 million cells/ml to produce a final 
concentration of 0.6% collagen suspension. Subsequently, the half of the ASCs-suspended collagen was 
injected to the pre-chilled molds and slowly polymerized by a series of gradual temperature change from 
ice-cold, room temperature to 37°C to create thicker collagen fibrils while the other half was abruptly 
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solidified in pre-warmed molds at 37°C for thinner fibrils. The completely polymerized collagen scaffolds 
containing ASCs were cultured in their growth media for 6 days. 
 
Confocal reflectance microscopy (CRM) analysis of microstructure in collagen scaffold 
To visualize the microarchitecture of collagen scaffolds with cells and its remodeling over time, 
ASCs-embedded collagen scaffolds cultured for 1, 6, and 10 days were briefly washed with ice-cold PBS 
and then fixed with 4% paraformaldehyde (PFA). Confocal reflectance imaging of collagen fibrils was 
performed using Zeiss 710 confocal microscope on a Zeiss Axio Observer Z1 inverted stand with 40x 
water immersion objective. The samples were illuminated by a low intensity of 488nm laser split through 
an 80/20 dichroic beam splitter, and the backscatter light reflected from collagen fibrils were collected by 
a photomultiplier tube. Z-stack images were captured from 5-6 random spots per each sample with 2µm 
intervals.  
 
Scanning electron microscopy (SEM) imaging  
For SEM analysis of the scaffold microarchitecture, ASCs-embedded collagen scaffolds were 
cultured for 1 and 6 days and briefly fixed by 2.5% glutaraldehyde in 0.05 M cacodylate buffer. The fixed 
scaffolds were sequentially dehydrated by a series of ethanol solution (25%, 50%, 75%, 95%, and 100%) 
and dried by a treatment with hexamethyldisilazane (Electron Microscopy Sciences). The dehydrated 
samples were mounted on the conductive carbon adhesive tab (Electron Microscopy Sciences), and then 
coated with gold/palladium alloy in sputter coater (Denton Vacuum, Desk II). Images were captured by 
scanning electron microscopy (Tescan, Mira3 LM) with 40000 magnification. 
 
Image analysis of collagen scaffold microarchitecture  
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The pore size, mean diameter of fibril diameter of collagen and overall collagen content in cold- 
or warm-polymerized scaffolds were analyzed using a custom-built automated algorithm as described 
previously288. Briefly, the images taken by SEM were transformed to black and white binary images by a 
constant threshold throughout the conditions. The pore size was analyzed by an erosion algorithm where 
circular disks with varying size filled the pore areas, and the mean diameter of pore size was determined 
at 50% of total pore area. For fibril diameter, an autocorrelation method was utilized to evaluate the 
diameter of heterogeneously oriented collagen fibrils. 4 images per sample were analyzed. (n = 3) 
 
Dynamic Mechanical Thermal Analysis (DMTA) of 3D collagen scaffolds 
 The compressive moduli of collagen scaffolds were measured by dynamic mechanical thermal 
analysis (DMTA) as previously described177. Collagen scaffolds were freshly prepared in PDMS micro-
wells and kept submerged in PBS. For the test, gels were carefully taken out from the micro-well. Then 
the gels were placed between the DMTA parallel plates, and fully immersed in PBS in a standard 
submersion-compression clamp configuration at room temperature (25oC). Given 10% pre-strain 
(0.001N), which prevented slippage of a sample during the test, the compressive tests were run on each 
sample under the controlled force up to 0.1N. The rate of force application was kept constant at 0.01 
N/min in all tests. The force F (force sensitivity of 0.001 N) and thickness L (distance resolution of 0.05 
µm) were measured simultaneously and converted into engineering stress-strain plots as follows: strain, 
=(Lo-L)/Lo (where Lo is the initial thickness and L the thickness of compressed sample) and stress, 
=F/Ao (where F is the applied force, and Ao the initial surface area). Young’s modulus, E, was the slope 
of the stress-strain curve,  = E  in the low-strain (5 - 20 %) elastic regime and the mean of Young’s 
modulus [E] was obtained from four different samples. (n = 4) 
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Characterization of ASCs cultured in cold- vs. warm-cast collagen scaffolds 
To investigate whether the micro-scale difference in collagen fibrils influence ASCs’ phenotype, 
ASCs cultured in either cold- or warm-templated collagen scaffolds for 6 days were fixed and analyzed 
for myofibroblastic characteristics including alpha-smooth muscle actin (α-SMA) expression and 
fibronectin deposition by immunofluorescence and Western blot. For the fluorescent immunostaining, the 
fixed cells were permeabilized in 0.05% Triton X-100 (VWR) in PBS (PBS-X), blocked in 1% BSA 
(Fischer Scientific) in PBS, and then incubated with primary antibodies of α-SMA (Abcam) and Fn 
(Invitrogen) in 0.05% PBS-X overnight at 4°C. Then the samples were labeled by AlexaFluor 488 
conjugated secondary antibody for α-SMA, and Fn, Alexa Fluor 568 Phalloidin for cytoskeleton, and 
counterstained with 4',6-diamidino-2-phenylindole (DAPI). For image analysis, 5 to 6 areas per stained 
sample were randomly selected and imaged by a Zeiss 710 confocal with 25x0.8 water immersion 
objective. The average positive pixel intensity above a constant threshold was calculated using Image J 
(NIH) and then normalized to the number of cells (n = 3).  
 
Analysis of Fn conformation in 3D collagen scaffolds via FRET 
ASCs in the cold- vs. warm-polymerized collagen scaffolds were pre-cultured for 3 days to render ASCs 
to deposit their own Fn matrix. 50 µg/mL of human plasma Fn consisting of 8% FRET-labeled and 92% 
unlabeled-Fn was supplemented and cultured for up-to 3 days223. Collagen scaffolds were fixed on day 1, 
2, and 3 after FRET incorporation and then imaged using a Zeiss 710 confocal microscope with a 40x 
water immersion objective at 2m intervals. FRET-labeled Fn in the matrices was excited by a low laser 
intensity (10%) through the 488 nm channel to prevent photobleaching, and the signals from both the 
donor (514-526 nm) and acceptor (566-578nm) channels were collected. For FRET image analysis, a 
strict threshold was set by averaging the highest signals from cell and fibronectin fibril-free areas in each 
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image to obtain concrete positive signals excluding autofluorescence from the underlying collagen. FRET 
intensity was obtained by calculating the ratio of acceptor to donor intensity through MATLAB 
(MathWorks, Inc.) as previously described224. 5 Z-stacks per sample, and three samples per condition 
were analyzed to determine the mean and standard deviation of the FRET intensities, and the histogram 
plots were generated to indicate FRET intensity at each representative location (n = 3). Finally, the 
obtained FRET intensity was compared to the pre-obtained calibration curves for the FRET intensity of 
chemically denatured dual-labeled Fn and its corresponding circular dichroism spectra 95,97. Similarly, the 
strain of Fn fiber relative to the FRET intensity can be obtained by referencing a pre-obtained calibration 
curve of the FRET intensity as a function of real fiber strain95. 
 
Evaluation of pro-angiogenic factor secretion 
To collect the pro-angiogenic factors secreted by ASCs in response to collagen fibrillar structure, 
ASCs cultured in collagen scaffolds for 6 days were incubated with DMEM/F12 (Gibco) with 1% FBS, 
and 1% penicillin/streptomycin for 24 hours. The media containing the ASCs secreted factors were 
collected, and the levels of vascular endothelial cell growth factor (VEGF) and interleukin-8 (IL-8) in the 
media were evaluated by VEGF and IL-8 ELISA duo set (R&D), respectively. The DNA content was 
extracted from the cells lysed in Caron’s buffer (25mM Tris-HCl, 0.4M NaCl, 0.5% SDS), and measured 
by QuantiFluor® dsDNA System (Promega) following the manufacturer’s protocols to normalize the 
VEGF and IL-8 levels. Each condition had three samples and each experiment was repeated three times to 
determine the statistical difference. (n = 3)  
 
Endothelial cell sprouting assay  
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To evaluate the impact of the differences in VEGF and IL-8 concentration on the pro-angiogenic 
activity of endothelial cells, HUVECs were seeded on top of the ASCs-encapsulated cold vs. warm-
templated collagen scaffolds. HUVECs were seeded on top of the collagen scaffolds at a density of 300 
cells/mm2 of the micro-well surface and were left to adhere for an hour. Subsequently, HUVEC invasion 
media containing HUVEC-GM, 1% [v/v] L-ascorbic acid (50 µg/mL; Acros Organics, Morris Plains, NJ), 
and 0.16% [v/v] tetradecanoyl phorbol acetate (50 ng/mL; Cell Signaling Technology, Inc., Danvers, 
MA) was added, and cultured for 4 days. For VEGF and IL-8 inhibition study, 1µg/ml of VEGF and IL-8 
neutralizing antibodies (both from R&D) were supplemented in the invasion media and cultured for the 
same period of time. The resulting HUVEC sprouting in response to the ASC-derived pro-angiogenic 
factors were assessed by confocal microscope imaging the immunoflurescently labeled HUVECs by their 
surface marker, CD31 (Sigma-Aldrich). 5 to 6 top-to-bottom images per sample were obtained by Zeiss 
710 confocal microscope with a 25×/0.8 water immersion objective at 5µm intervals. HUVEC sprouts, 
which exceed a length of 15µm, were manually counted throughout the Z-stack images. The average 
number of sprouts per condition was obtained from the counts of three samples in each experiment and 
the experiment was triplicated in a consistent manner. (n = 3) 
 
Analysis of the stiffness-mediated effect on ASCs’ pro-angiogenic factor secretion 
To see whether the differences in the pro-angiogenic factor secretions from ASCs is mediated by 
the local scale of stiffness, ASCs in cold or warm-polymerized collagen scaffolds were cultured with 
Y27632 Rho/ROCK inhibitor (Tocris) which blocks Rho-mediated stress fiber formation and contraction 
(Ref). 30μM of Y27632-supplemented growth media (DMEM/F12 with 10% FBS and 1% antibiotics) 
were added to the cells every other day for 6 days. For the analysis of VEGF and IL-8 by ELISA, the 
media containing ASCs-derived factors was collected as explained above. To assess the response of 
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HUVECs to the Y27632-mediated changes of pro-angiogenic factors, HUVEC sprouting assay was 
performed after the Y27632 treatment for 6 days. 
 
Statistical analysis 
Student’s t-tests and ANOVA were used to determine statistical difference between two 
conditions and among multiple conditions, respectively. For ANOVA, post-hoc pairwise comparisons 
were determined by Tukey’s test. Two-sided testing was performed for each analysis and a P-value less 
than 0.05 was considered statistically significant. All tests were performed on Microsoft Exel and 
GraphPad Prism 5©. Unless otherwise noted, values are reported as the mean with error bars indicating 
standard deviations.  
 
5.5. Results  
Fabrication of collagen scaffolds with two different micro-architectures 
To understand the impact of collagen fiber microstructures in a 3D scaffold on cellular behaviors, 
we utilized a previously-established micro-well model289. In this model, cell-suspended collagen solution 
was polymerized within each micro-scale cavity (4mm-diameter and 200µm in depth) patterned on a 
PDMS mold. This micro-well format aids in handling a compliant collagen scaffold and prevents 
contraction of the collagen scaffold, which binds to the walls of the micro-well during the culture period. 
To generate two different collagen fibrillar structures, we altered the polymerization temperature, which 
regulated lateral growth of collagen microfibrils and consequently fibrillar thickness290,291. As shown in 
Fig. 5.1A, solubilized collagen in acetic acid was first neutralized to pH 7.2-7.4 and mixed with the media 
containing 2x106 ASCs. To ensure that other parameters (pH, salts and cell density) were kept identical, 
half of the prepared collagen solution was quickly polymerized in pre-warmed micro-wells at 37 °C, 
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Fig. 5.1. Fabrication of collagen scaffolds with two different micro-architectures. (A) Cell-containing 
collagen suspension was prepared, and divided into half. The half of the suspension was injected to the pre-
chilled molds and slowly polymerized by a gradual increase of temperature from ice-cold, room temperature to 
37°C to create thicker collagen fibers. The other half was solidified in pre-warmed molds at 37°C to construct 
thinner collagen fibers. (B) After the polymerization, microarchitecture of a warm- (left) and cold-cast (right) 
collagen fibrils were visualized by confocal-microscope imaging. 
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while fibrillogensesis of the other half was prolonged by polymerizing collagen at initially cold 
temperature (4°C) for 20 minutes and gradually increasing the temperature to 20 °C for 20 minutes, and 
finally up to 37°C. The fully polymerized collagen scaffolds were then cultured in the growth media for 
the following analysis. Here we named a collagen scaffold casted at 37 °C as ‘a warm-cast’ scaffold and 
those casted initially at 4°C as a ‘cold-cast’ scaffold. The 3D architectures of the collagen scaffolds were 
visualized by confocal reflectance microscope (CRM) to determine whether altered polymerization 
temperature changed the interior architecture of collagen scaffolds (Fig. 5.1B).  
 
Characteristics of initial and remodeled collagen scaffold microarchitectures  
Since ASCs actively remodel their ECM, we assessed structural features of the scaffolds at day 1 
and day 6. For this, the cell-embedded scaffolds were cultured, harvested after each time point and 
imaged by CRM, as well as by scanning electron microscope (SEM) (Fig. 5.2A). For quantification, we 
utilized SEM images due to their higher resolution than CRM images at a nanometer scale as well as 
capacity to visualize collagen fibers at different angle287,288. Also, we quantified collagen fiber diameter 
and pore size from SEM using a custom-built algorithm288. In accordance with CRM observations and 
previously reported data, collagen fibrillar thickness changed as a function of cross-linking temperature291. 
The initial mean diameters of collagen fibrils (170.8 ± 5.9 nm) in the cold-cast scaffolds were 
significantly larger than those of warm cast scaffolds (129 ± 10.3 nm).  
In addition, the pore size of cold-cast scaffolds was relatively larger (271.5 ± 16.4 nm) than that 
of warm-cast scaffolds (148.3 ± 10.8 nm). Finally, fiber linearity was assessed by calculating the ratio of 
the shortest length over the full length. Interestingly, collagen fibers in cold-cast scaffolds were more 
linear than those in warm-cast scaffolds on day 1. Therefore, cold-cast gels were characterized by 
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relatively thicker, straighter fibers and larger void spaces, whereas warm-cast gels exhibited smaller pores 
within a denser mesh of thinner, coiled/tortuous fibrils (148.3 ± 10.8 nm).  
 
  
 
 
Fig. 5.2. Characteristics of initial and remodeled collagen scaffold microarchitectures. (A) The initial 
(day1) and ASC-remodeled (day6) interior architecture of warm- and cold-cast scaffolds were visualized by 
confocal reflectance microscope (CRM) and scanning electron microscope (SEM) imaging (Scale bars = 50 μm 
for CRM and 1 μm for SEM). (B) SEM image analysis indicated that the mean diameters of collagen fibers in 
cold-cast scaffolds remained greater than those of warm-cast scaffolds throughout the culture. (C) Larger pore 
size in cold-cast scaffolds significantly decreased, while the smaller size of pores in a warm-cast scaffold 
moderately increased over time. (D) Collagen fibrils in cold-cast scaffolds linearized over time, whereas only an 
insignificant change was noted in warm-cast scaffolds. p < 0.05, and p < 0.05 indicate the difference 
between two conditions and from all other conditions, respectively. 
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 The trend to thicker fibers in cold-cast remained throughout the culture; however, the cold-cast 
conditions exhibited a broader range of fiber diameters (± 21.1 nm) on day 6 as compared to that on day 1  
(± 6 nm) (Fig. 5.2B). Interestingly, after 6 days the pore size in cold-cast scaffolds significantly decreased, 
whereas it remained similar in a warm-cast scaffold (203.8 ± 9.2 nm and 194.5 ± 11.24 nm, respectively). 
Over this interval collagen fiber linearity increased in cold-cast scaffolds, whereas no significant 
difference was noted in warm-cast scaffolds (Figs. 3.2C and D). Since ASC-free collagen scaffolds 
maintained pore size and fibril linearity during the culture period (Fig. 5.3), our results suggest that these 
micro-structural changes were mediated by ASCs over time. These changes are considered indicators of 
increased cellular contractility93,177, and has been seen in wound closure in vivo and fibroblast-embedded 
collagen scaffolds in vitro. Because the increased pulling force of cells is mediated in part by enhanced 
expression of α-SMA stress fibers196,292, we next investigated changes in α-SMA levels of ASC in 
response to the different collagen fiber structure of the scaffolds.  
 
 
 
Fig. 5.3. Microarchitecture of collagen scaffolds in absence of ASCs. SEM image analysis indicated that the 
mean pore size of both warm and cold-cast scaffolds did not significantly change over time in the absence of 
ASCs. 
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Fig. 5.4. Phenotypic changes of ASCs in response to collagen fiber thickness. (A) and (B) 
Immunofluorescence (IF) image analyses indicate that ASC-embedded cold-cast gels contained a larger 
population of α-SMA positive ASCs compared to those cultured in warm-cast scaffolds. Also, desmin positive 
cells were not associated with α-SMA positive cells. (C) A histogram and a box-and-whisker plot of FRET 
analysis show FRET intensity [Acceptor/Donor] obtained from a representative FRET image of each condition 
and the average of multiple FRET analysis per condition, respectively. Also, color-coded FRET image visualizes 
the relative conformational change of Fn by color spectrum from red (compact form) to blue (unfolded form). 
FRET analysis indicates that matrices deposited by ASCs cultured in cold-cast gels consisted of yellow to lighter 
blue-colored Fn fibers, which indicates a lower FRET intensity and thus, partially unfolded Fn. On the other 
hand, the matrices deposited by ASCs cultured in warm-cast gels contained red and orange colored Fn fibers 
indicating higher FRET intensity and thus, folded Fn. Scale bar =50 μm, p < 0.05 
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Phenotypic changes of ASCs in response to the collagen fiber thickness 
First, to evaluate ASC contractility, α-SMA expression level was assessed via 
immunofluorescence (IF) after 6-day culture either in cold-cast or warm-cast scaffolds. Because α-SMA 
is a marker of pericytes, smooth muscles cell, and myofibroblastic differentiation, we also stained for 
desmin, to identify the phenotype of the ASCs. Interestingly, our analysis indicates that ASCs cultured in 
a cold-cast scaffold exhibited increased expression of α-SMA protein while a pericytes marker, desmin 
positive cells were rare (Figs. 5.4A and B). This suggests that ASCs developed myofibroblastic 
phenotype in response to the thicker collagen fibers in cold-cast scaffolds, and this contractile cell 
population may further contribute to matrix remodeling by contraction, degradation, or deposition of 
ECM. This result is consistent with our previous study showed that ASCs develop a myofibroblastic 
phenotype in response to tumor-derived soluble factors177.  
In addition to collagen microarchitecture, fibronectin is another indicator of increased cellular 
contractility and Fn conformational change has been correlated with increased stiffness of Fn fiber, so we 
assessed fibronectin conformational change via FRET technique31,97.   The histogram of FRET intensities 
obtained from a representative region of a cold-cast scaffold shifted to the left relative to that from a 
warm-cast scaffold, indicating that Fn fibers were more unfolded in cold-cast gels (Fig 5.4C). The 
corresponding FRET images visualize the Fn conformation of the representative region by a color 
spectrum, showing the matrix containing more low FRET Fn fibers in a cold-cast is colored by yellow to 
light blue while that with higher FRET Fn fibers in a warm-cast represents by orange and yellow. The 
whisker and box plot shows the compiled FRET intensities of Fn fibers in collagen scaffolds casted at 
cold temperature were significantly lower than those from warm-cast scaffolds, which implies that ASCs 
in cold-cast scaffolds deposited matrices containing partially unfolded and stiffer Fn fibers, whereas the 
Fn fibers in the matrices deposited by ASCs in warm-cast scaffolds were more compact and relaxed. In 
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addition, no differences were observed in FRET intensities of Fn fibers in the matrices deposited by ASCs 
cultured in cold- vs. warm-cast scaffolds when they were incubated with FRET-labeled Fn only for short 
periods of time (24 hours and 48 hours) (Figs. 5.5A and B), so we ensured that the difference of FRET 
intensities between two conditions in Fig. 5.4C was not associated with the auto-fluorescence of collagen 
fibers. These results altogether suggest that ASCs cultured in cold-cast scaffolds exhibit greater 
contractility and deposit stiffer fibers, thereby ultimately generating a stiffer microenvironment as 
compared to those cultured in warm-cast scaffolds.  
 
 
Fig. 5.5. FRET intensity of Fn in the matrices deposited by ASCs in response to collagen fibers. (A) and 
(B) FRET intensities of Fn in the matrices deposited by ASCs cultured in cold-cast scaffolds were not 
significantly different from those by ASCs cultured in warm-cast scaffolds when ASCs were incubated with 
FRET-labeled Fn for 24 hours and 48 hours.  (Scale bar =50 μm).  
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Altered pro-angiogenic potential of ASCs by change in collagen fiber thickness 
Next, we investigated if changes in fiber thickness of a collagen scaffold influence pro-
angiogenic potential of ASCs. Media was collected from ASCs cultured in either a cold or a warm-cast 
scaffold for 6 days and their VEGF and IL-8 secretion levels were assessed by ELISA. In general, the 
levels of IL-8 secreted by ASCs cultured in collagen scaffolds are much greater than the levels of VEGF, 
which is similar to the previous study showing that IL-8 but not VEGF secretion was significantly up-
regulated in 3D context as compared to 2D294. More interestingly, ASCs cultured in a cold-cast scaffold 
secreted greater amounts of VEGF and IL-8 in response to the thicker collagen fibers than those cultured 
in warm-cast scaffolds with thinner fibers and smaller pores (Fig. 5.6A). 
To determine the functional consequences of altered pro-angiogenic signaling of ASCs in 
response to the collagen fiber structure, an endothelial cell invasion assay was performed using human 
umbilical vein endothelial cells (HUVECs). A monolayer of HUVECs was seeded on top of cold- or 
warm-cast scaffolds, which were pre-cultured with and without ASCs for 6 days. After 4 days, the 
number of HUVEC sprouts was quantified by confocal imaging analysis (Fig 5.6B). Our quantification 
revealed that the presence of ASCs significantly promoted HUVEC invasion in both cold- and warm-cast 
scaffolds.. However, the number of HUVEC invasions was much greater in cold-cast gels, in the presence 
or absence of ASCs, suggesting that matrix architecture may also play an important role in regulating 
angiogenic activities of HUVECs (Fig. 5.6C). 
To distinguish ASC soluble factor signaling from matrix structural effects, we inhibited VEGF or/and IL-
8 either alone or in combination while co-culturing a monolayer of HUVECs with embedded ASCs in the 
bulk of scaffolds. Our quantification of HUVEC sprouts showed that the presence of VEGF or/and IL-8 
neutralizing antibody alone or together offset HUVEC sprouting in ASC-embedded cold-cast scaffolds, 
while there was no significant effect of VEGF and IL-8 neutralizing antibodies in ASC-embedded warm-
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cast scaffolds (Fig. 5.7). Therefore, the increased angiogenic activity of HUVECs in cold-cast scaffolds 
was primarily mediated by enhanced pro-angiogenic signaling of ASC in response to thicker fibers. Since 
α-SMA-mediated contractility and pro-angiogenic behaviors of ASCs changed concomitantly in response 
to the changes in the architecture of collagen scaffolds, we examined whether the two behavioral changes 
(α-SMA-mediated contractility and pro-angiogenic behaviors of ASCs) were linked.  
 
 
Fig. 5.6. Altered pro-angiogenic potential of ASCs by change in collagen fibrillar thickness. (A) ELISA 
analysis indicates that ASCs secreted higher amounts of VEGF and IL-8 in response to thicker fibrils in cold-cast 
gels.  (B) To investigate the functional impact of the enhanced VEGF and IL-8 levels from ASCs cultured in 
cold-cast gels, an endothelial cell invasion assay was performed. Cold- and warm-cast gels were prepared with 
and without ASCs and cultured for 6 days and human umbilical vein endothelial cells (HUVECs) were seeded 
atop the gels. After 4 days, HUVECs were immunofluorescently labeled with antibody against CD31 and traced 
by confocal imaging analysis to quantify the number of HUVEC sprouts greater than 10 μm in length. (C) The 
presence of ASCs promoted HUVEC invasion in both cold- and warm-cast scaffolds, but to a greater extent in 
cold-cast scaffolds. In the absence of ASCs, HUVEC sprouting was still higher in cold-cast scaffolds than warm-
cast scaffolds, yet the difference was insignificant. (Scale bar =50 μm), p < 0.05, and p < 0.05 indicate the 
difference from warm-cast and all other conditions, respectively. 
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ROCK-mediated changes in pro-angiogenic potential of ASCs in response to collagen fibers 
To understand whether the pro-angiogenic potential of ASCs is regulated by actomyosin 
contractility in response to collagen fiber structure, angiogenic factor secretion was assessed after treating 
with Y27632, a Rho-associated protein kinase (ROCK) inhibitor in warm- and cold-cast gels. This 
inhibitor blocks actin polymerization, thereby constraining cellular contraction295. Our ELISA analysis 
indicates that the effect of matrix structure on VEGF and IL-8 secretion was abolished by the inhibition of 
 
Fig 5.7. Effects of ASC-derived pro-angiogenic factors on HUVEC sprouting. (A) HUVECs were cultured 
on the top of both cold- and warm-cast collagen scaffolds with VEGF and/or IL-8 neutralizing antibodies for 4 
days and analyzed for their invasion. In ASC-embedded cold-cast collagen scaffolds, HUVEC invasion was 
significantly inhibited with the addition of VEGF and IL-8 antibodies individually and together, whereas the 
inhibition of VEGF and IL-8 had no effect on HUVEC invasion in ASC-embedded warm-cast scaffolds. p < 
0.05 indicates significant difference from all other conditions, respectively. 
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ROCK-mediated contractility. In the presence of Y27632, the levels of VEGF and IL-8 from ASCs 
cultured in cold-cast scaffolds were not significantly different from warm-cast gels (Fig. 5.8). Therefore, 
increased ROCK-mediated contractility of ASCs in the cold-cast scaffolds contributed to enhancing pro-
angiogenic potential of ASCs. 
  
5.6. Discussion 
Microstructure of collagen fiber has emerged as a critical regulator of tissue and cellular behavior, 
yet its role in modulating the pro-angiogenic potential of ASCs has not been explored. In this study, ASCs 
exhibited greater α-SMA-mediated contractility and enhanced pro-angiogenic behaviors in response to 
thicker collagen fibers and larger pore structures. The enhanced pro-angiogenic signaling of ASCs 
consequently promoted HUVEC sprouting, and this change was regulated by ROCK-mediated 
contractility of ASCs in response to tissue architecture.  
 
Fig. 5.8. ROCK-mediated changes in pro-angiogenic potential of ASCs in response to collagen fibers. (A) 
ELISA analysis of the media collected from ASCs cultured in both collagen scaffolds with and without Y-27632 
indicates that VEGF and IL-8 secretion of ASCs cultured in cold-cast gels was significantly lowered with the 
disruption of ROCK-mediated cellular contractility. However, supplementing Y-27632 did not modulate the 
secretion of VEGF and IL-8 from ASCs cultured in warm-cast gels. p < 0.05, and p < 0.05 indicate the 
difference from warm-cast and all other conditions, respectively. 
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For this study, we utilized 3D micro-sized collagen scaffolds with varying fiber thickness. 
Miniaturized tissue engineering models such as our micro-fabricated 3D scaffolds have great advantages 
with i) their efficacy to control homogeneity within the system, and ii) ability to recapitulate the cell-scale 
microenvironment296,297. For example, micro-scale hydrogels can prevent gradients of oxygen and 
nutrients that otherwise result from diffusion-limited transport in 3D, thereby controlling for confounding 
effects of hypoxia at the interior of the scaffold134 298. However, due to the efficient heat transfer rate in 
miniaturized systems, temperature-controlled cross-linking to tune the collagen fiber microstructure is 
challenging299,300.  
Temperature is a critical determinant of collagen assembly rate and consequently fiber 
microstructure93. In particular, the nucleation rate controls the lateral growth of collagen microfibrils and 
therefore fiber diameter92. Thus, we achieved thicker fibers in cold-cast scaffolds by delaying fiber 
nucleation at lower temperatures, while collagen was quickly polymerized for thinner fibers in a warm-
cast scaffold (Fig. 5.1A). Although pH can also modify fiber length, diameter, and cross-linking, here we 
decided to use temperature-mediated method due to greater experimental precision92.  
We observed that ASCs exhibited an enhanced contractile phenotype, characterized by increased 
α-SMA stress fibers and increased Fn unfolding, when they were cultured in cold-cast gels as compared 
to those cultured in scaffolds of thinner fibers and smaller pores. In addition, previous reports indicated 
that actin stress fibers and cell viability of fibroblasts were enhanced when they were cultured in collagen 
scaffolds with thicker fibers, and a similar trend was also observed from fibroblasts cultured in 
fibronectin-coated synthetic polymer network with varying thickness299,301. Our findings including others 
imply that changes in fiber thickness from 10-2 (for ECM fibers) to 10 μm (for synthetic fibers) could alter 
biophysical signals to surrounding cells. The fiber diameter-mediated impact on cell contractility might 
not be ligand (i.e. collagen or fibronectin)-specific but more universal topological or physical cues.  
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In addition, our studies using Fn-null mouse embryonic fibroblasts (MEFs) showed that MEFs which do 
not produce fibronectin similarly responded to thicker collagen fibers secreting a higher level of VEGF 
while the levels of matrix-bound VEGF were not significantly different  (Figs. 5.9A and B). This data 
suggests that cells can response to the collagen-derived physical cues in the absence of Fn. However, in 
the presence of Fn, Fn-null MEFs cultured in cold-cast scaffolds secreted less VEGF, and their matrix-
bound VEGF was also lowered. However, the secretion of VEGF from Fn-nul MEFs cultured in warm-
cast scaffolds did not change much by the supplemented Fn, but their matrix-bound VEGF was similarly 
 
  
Fig. 5.9. VEGF secretion of Fn-null MEFs in absence and presence of Fn. (A) Fn-null MEFs secreted a 
higher level of VEGF in response to thicker collagen fibers as similar to ASCs cultured in cold-cast scaffolds. 
(B) The levels of matrix-bound VEGF were not significantly different. (C) The presence of Fn lowered the 
VEGF secretion of Fn-null MEFs cultured in cold-cast scaffolds while the levels of VEGF secreted from Fn-
MEFs cultured in warm-cast scaffolds did not change by the supplemented Fn. (D) Matrix-bound VEGF was 
lowered by the supplemented Fn in Fn-MEFs cultured in both cold- and warm-cast scaffolds. p < 0.05, and 
p < 0.05 indicate the difference from warm-cast without Fn and cold-cast with Fn, respectively. 
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lowered as in the presence of Fn. Therefore, more studies are required to understand the response of Fn-
null MEFs to the collagen fibers in presence of Fn.  
In addition to matrix topography, increased cell contractility in cold-cast scaffolds might be a 
physical response against to the fibers with higher tensile strength. Increased actomyosin contractility is a 
typical response to maintain tensional balance against a stiff microenvironment90, and previous reports 
correlate fiber thickness with increase tensile strength of collagen fiber at low strain rate302,303. In addition, 
at a cellular level, much smaller force might matter according to their size of cells and ECM fibers as 
previous studies stated single cell traction force and force required to deform ECM fibers range from 
pico- to nano-Newton304,305. Interestingly, our mechanical testing on the cell-free collagen scaffolds of 
thicker vs. thinner fibers on day 1 indicated that the average of Young’s modulus [E] between cold-cast 
gels was moderately higher with a broader variation that warm-cast gels at low strain rate (5% - 20%), but 
 
 
Fig. 5.10. Elastic moduli of ASC-free collagen scaffolds. Stress-strain profile of cell-free collagen scaffolds 
was measured via DMTA and Young’s modulus (E) was calculated at low-strain (5–20%) elastic regime. The 
mean Young’s modulus (E) of cold-cast scaffolds was not different from that of warm-cast scaffolds although it 
had a much broader range. Young’s modulus (E) was calculated from the slope of the stress-strain curve, σ =Eε. 
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no significant difference was observed (Fig. 5.10). This might be because the concomitant changes in 
pore size and volume fraction of fibers in cold-cast scaffolds could mask fiber diameter-mediated effects92, 
or because our apparatus detected bulk compression rather than localized compression on individual 
matrix components. However, as evidence from the FRET analysis suggests that scaffolds containing 
unfolded Fn may exhibit higher stiffness, as observed in matrix deposited by ASCs in cold-cast gels. 
An increased expression of α-SMA in the absence of desmin suggests that ASCs adopted a 
contractile myofibroblastic phenotype in cold-cast scaffolds. This differentiation corresponded with 
increased collagen linearity, decreased pore size, and unfolded Fn conformation (Fig. 5.2C, 5.2D, and 
5.3C), all typical of myofibroblast remodeling186. In addition, collagen fiber linearity and Fn elongation 
collectively contribute to matrix stiffening, which functions as a positive feedback loop of 
myofibroblastic differentiation306,307. Therefore, increased α-SMA positive cell population of ASCs might 
be initiated by predetermined thicker collagen fibers, but could be maintained or further enhanced by their 
own remodeled matrices later on. 
In addition, the myofibroblastic ASCs in cold-cast scaffolds secreted higher levels of VEGF and 
IL-8 than ASCs in warm-cast gels61, and this change was abrogated by ROCK-inhibition (Fig. 5.5A and 
5.7A). Upon mechanical stimulation, cells develop a contractile phenotype and modulate the activity of 
small GTPase Rho and its effector ROCK. This signaling axis governs integrin-mediated focal adhesion 
maturation, actin cytoskeleton organization, and cell morphology304. In addition, other studies have shown 
that stiff substrates and high tensile stress stimulated VEGF and IL-8 signaling308-310. In our system, 
increased cellular contractility and matrix comprising the thicker and linearized collagen fibers with 
partially unfolded Fn collectively generated a tensional microenvironment, which could trigger VEGF 
and IL-8 signaling. This result might also be explained by Fn conformational changes, which might 
reduce the affinity of α5β1 integrin with the synergy site and downstream VEGF signaling284.  
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Finally, our data confirmed that VEGF and IL-8 contributed to enhancing HUVEC sprouting in 
cold-cast scaffolds, showing that the enhanced HUVEC sprouting in cold-cast scaffolds was eliminated in 
presence of VEGF and IL-8 antibodies (Fig. 5.5 and 5.6A). As one of the most clinically and 
experimentally well-established angiogenic factors, VEGF aids in EC proliferation, migration, and 
organization51. Also, IL-8 stimulates EC actin polymerization, proliferation, and migration through 
CXCR-1/2 and epidermal growth factor receptor311. Moreover, a synergistic effect of VEGF and IL-8 has 
been noted as IL-8 stimulated autocrine VEGF signaling of ECs312. In addition, there might be a direct 
effect of matrix microarchitecture on EC sprouting313,314, which might explain the enhanced HUVEC 
sprouting in cold-cast scaffolds even when ASCs were absent (Fig. 5.5C). However, in the presence of 
ASCs, despite the comparable pore sizes in both scaffolds, the difference of HUVEC sprouting between 
cold-cast and warm-cast gels was much greater relative to the difference in the absence of ASCs, which 
suggests the significant pro-angiogenic signaling of ASCs. Taken together, our study suggests the 
phenotypic change of ASCs to myofibroblastic cells and the resulting matrix remodeling and pro-
angiogenic activities lead to the promotion of HUVEC sprouting. 
Based on our findings, several future studies will be beneficial for i) understanding of 
mechanoregulation of angiogenic collaboration of stromal cells with ECs and ii) developing useful 
therapeutic and tissue engineering approaches. First, it has not been well understood if the microstructural 
changes of collagen fibers in 3D scaffolds regulate specific integrin engagement and clustering, thereby 
modulating cellular behaviors. Previous studies indicated that cells preferentially utilize α2β1 to interact 
with fibrillar collagen and this preferential interaction regulates cell projection, thereby changing α-SMA 
expression and contractility315. In addition, it has been noted that cells cultured on the stiff substrate 
initially utilized α2β1 but later switched to αvβ3 integrin while thickening collagen fibers and developing α-
SMA stress fibers316. Also, increasing number of studies indicates that mechanical stimuli and spatial 
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presentation of ECM ligand are critical for integrin activation, clustering, and signaling113,317. Therefore, 
investigating whether microstructural changes of collagen fibers play a role in the preferential 
engagement and clustering of integrin, which ultimately influences cellular behaviors, will aid in 
understanding the mechanism underlying our findings. For this, high-resolution visualizing techniques are 
needed to detect the localized focal adhesion and integrin clustering in 3D constructs113.  
In addition, matrix metalloproteinases (MMPs) are important for blood vessel sprouting and 
morphogenesis318. Previous studies indicated that matrix mechanical cues can trigger progenitor cell-
mediated matrix degradation via MMPs and facilitate blood vessel sprouting272. Thus, MMP-mediated 
effects may contribute to the observations in this study and should be explored further. Moreover, 
provisional ECM components other than type I collagen and fibronectin are involved in the angiogenic 
process318. For example, fibrin and proteoglycans (i.e. glycosaminoglycan) are known to modulate the 
biochemical and physical properties of matrix, which may trigger different cellular responses as compared 
to those cultured in only collagen I-based matrix319,320. Therefore, simplicity of our in vitro model might 
be a caveat to fully understanding the complex angiogenic process in vivo. However, since collagen fiber 
structure can be also modulated by the other ECM macromolecules, the optimization of this system is 
required to properly regulate the microstructure of collagen fibers321.  
In conclusion, we proposed that microstructural change of collagen fibrils is a critical regulator in 
governing the pro-angiogenic potential of ASCs with implications for stem cell, regenerative medicine, 
and cancer research. 
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CHAPTER 6 
 
CONCLUSION 
 
 
6.1. Summary 
My doctoral research investigated the pro-tumorigenic potential of adipocytes and adipose 
stromal vascular cells (ASVCs), which include adipose-derived stem cells (ASCs). The pro-tumorigenic 
potential of these cells are significantly amplified during obesity, which is a risk factor for cancer. In 
particular, the four questions proposed in section 1.6 were examined utilizing various physical 
oncological approaches: 1) and 2) do ASCs and adipocytes in adipose tissue potentially acquire 
myofibroblastic features in response to tumor-derived cues, thereby consequently participating in ECM 
remodeling and angiogenesis, 3) does obesity, a risk factor for cancer, predetermine the pro-tumorigenic 
potential of adipose tissue, which potentially promotes tumor malignancy, and 4) do structural changes of 
collagen fibers as seen during tumorigenesis and obesity potentially regulate stromal cell behaviors. The 
following subsections will briefly revisit the answers to these questions, as discussed in each of the 
corresponding chapters. Following this, there will be a discussion on work that needs to be completed to 
fully draw the link between all of these various signals and then finally a discussion on how our findings 
can be utilized in practical therapies for breast cancer.   
 
Cancer-activated ASCs promote breast tumor progression 
It has been reported that the majority of myofibroblastic cells in tumor stroma are emanated 
primarily from peri-tumoral adipose tissue but not from bone-marrow mesenchymal stem cells322. 
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However, whether ASCs in mammary adipose tissue contribute to enlarging the myofibroblast population 
during breast tumorigenesis was previously unknown.  
The findings in chapter 2 showed that in the presence of soluble factors from MDA-MB231 
breast cancer cell line, ASCs exhibited myofibroblastic features including highly contractile, proliferative, 
pro-fibrotic, and pro-angiogenic features while losing adipogenic potential (Figs. 2.1 and 2.2). The 
myofibroblastic ASCs then deposited and contracted abundant ECM components (collagen and 
fibronectin) with enhanced α-SMA-mediated contractility, which collectively contributed to increasing 
stiffness of their surrounding area (Fig. 2.4). The increased stiffness in turn provides positive feedback to 
enhance the myofibroblastic features of ASCs together with tumor-derived factors (TGF-β and IL-8) 
(Figs. 2.4 and 2.5). Interestingly, the growth and alignment of ASCs cultured on the stiffer substrates 
were progressively enhanced along the malignancy of cancer cells from which we collected tumor-
derived factors. Finally, we showed that implanted ASCs with breast cancer cells in vivo indeed promote 
tumor desmoplasia, leading to increased tumor stiffness, angiogenesis, and ultimately tumor growth (Fig. 
2.9). Although our studies show that tumor explants grown with co-implanted ASCs exhibited enhanced 
α-SMA levels and other desmoplastic features, further study will be helpful to confirm the origin of the 
enhanced α-SMA positive cells in the tumor explants. Since it is possible that circulating or host 
progenitor cells in mouse adipose tissue might be recruited and become a part of the myofibroblastic cell 
population by enhanced chemokine from both cancer cells and possibly extra human ASCs323, further in 
vivo studies to support the concept of myofibroblastic differentiation of implanted human ASCs will 
complement our findings.  
In addition, while other in vivo studies suggest that implanted adipose progenitor cells are more 
associated with blood vessels during tumorigenesis, our studies indicate the enhanced α-SMA levels are 
not associated with desmin levels, which are pericytic or smooth muscle cells161. To resolve this 
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discrepancy, it needs to be understood how the lineage commitment of ASCs between myofibroblastic 
and pericytic or smooth muscle cell lineage was precisely regulated in vivo. Understanding the ways to 
adequately control ASC fate will be beneficial for not only cancer therapeutic but also for tissue 
engineering approaches.  
Lastly, while we reported that the phenotypic changes of ASCs into myofibroblastic cells from 
tumor-derived cues of a series of cancer cells, we have not shown whether this ASC-mediated tumor 
stroma remodeling can similarly modulate various subtypes of breast cancer. Since each subtype of breast 
cancer as we reviewed in section 1.2 exhibits quite unique characteristics, further studies to ensure 
whether these cancer-activated ASCs-mediated effects are also applicable to other subtypes will be 
beneficial. 
 
Cancer-activated adipocytes increase the myofibroblastic cell population, thereby 
stimulating ECM remodeling and angiogenesis 
Since we observed that the number and size of adipocytes are significantly reduced in mouse and 
human tumors (Fig. 3.1), we also assessed whether cancer-activated adipocytes could also contribute to 
tumor stroma remodeling in a way similar to that of ASCs, given their potential of dedifferentiating into 
ASC-like cells85. Our findings indicate that adipocytes cultured in both 2D and 3D in vitro systems lost 
their adipogenic features (Figs. 3.2 and 3.4) but acquired myofibroblastic features in response to tumor-
derived factors from MDA-MB231 (Figs. 3.3 and 3.4). Similar to TCM-treated ASCs as seen in chapter 2, 
a larger quantity if α-SMA, Fn, and collagen proteins were detected in TCM-treated adipocytes.  In 
addition, tumor-derived factors stimulated pro-angiogenic signaling of adipocytes, thereby promoting 
endothelial cell sprouting. 
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 Although we observed the proportional change of adipocyte population (i.e. from adipogenic into 
myofibroblastic population), we have not specifically examined the trans-differentiation of a single 
adipocyte. One could think there might be a specific subset of adipocytes, which can be trans-
differentiated into myofibroblastic cells and then proliferate while the majority of adipocytes might 
undergo apoptosis and consequently reduce lipid content in response to tumor-derived factors. Therefore, 
further investigation is required to confirm the trans-differentiating potential of adipocytes into 
myofibroblastic cells as well as to understand the specific molecular signaling responsible for adipocyte-
myofibroblasts. 
 
Obesity-associated interstitial ECM remodeling promotes tumor malignancy 
In chapter 4, we assessed whether the functional significance of obesity-associated interstitial 
fibrosis predisposes adipose tissue to enhance mammary tumorigenesis. First, our histological analysis of 
clinical breast cancer samples suggests that obese patients exhibit an increased degree of desmoplasia. 
Also, our analysis of mammary fat tissue from both genetic and diet-induced mouse models of obesity 
showed that the fibrotic changes in mammary microenvironment occurred even before tumorigenesis, 
suggesting the fibrotic predisposition of obese mammary tissue is inherently greater than that of its lean 
counterpart (Fig. 4.1). Our findings also show that ASVCs isolated from the adipose tissue of obese mice 
contained more myofibroblastic cells, secreted a higher level of SDF-1, and deposited stiffer matrices 
containing thicker and aligned collagen and more unfolded Fn as compared to ASVCs from lean mice. 
This confirms that the enhanced interstitial fibrosis in mammary adipose tissue is due to the distinct cell 
composition in adipose tissue from obese mice (Figs. 4.3 and 4.5).  
Collectively, it seems as if both biochemical and physical cues derived from obesity-mediated 
ASVCs promote breast tumorigenesis as our data shows that i) obesity-associated ASVCs potentially 
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stimulate the recruitment of MDA-MB231 breast cancer cells through SDF-1/CXCR4 signaling, and that 
ii) stiffer matrices deposited by obesity-associated ASVCs enhanced the cancer cell growth in a 
Rho/ROCK signaling-dependent manner (Figs. 4.7 and 4.8). Furthermore, cancer stem cell transcription 
factor NANOG activity, a poor prognostic marker of tumors, was also enhanced by the physicochemically 
active matrices deposited by obesity-associated ASVC (Fig. 4.9). Taken together, our findings imply that 
obesity-associated adipose tissue, which contains a larger population of myofibroblastic cells, can 
potentially generate a physicochemical microenvironment, which may favor breast tumorigenesis. 
Our rigorous analysis of adipose tissues from different locations (mammary, subcutaneous, vs. 
visceral) as well as from ovary intact vs. ovariectomized mice suggests that enhanced interstitial fibrosis 
is a universal feature of obesity-associated adipose tissue (Figs. 4.2, 4.4 and 4.6), implying a possible link 
between obesity-associated fibrosis and other types of cancer (i.e. prostate and colorectal cancer) 
associated with different adipose depots.  
In addition, our study also indicated that caloric restriction lowered interstitial fibrosis, suggesting 
that obesity indeed modulates interstitial fibrosis (Fig. 4.11). However, previous studies also indicate that 
caloric restriction concomitantly lowers inflammation level and estrogen synthesis in obese individuals324. 
Therefore, further studies need to be performed to understand the etiology of predisposition of interstitial 
fibrosis in obesity-associated mammary stroma. Conventional classification of obesity by body mass 
index might not accurately reflect the metabolic and inflammation status of individuals, which is more 
strongly correlated with enhanced pro-fibrotic features. Therefore, delicate stratification of obesity by the 
metabolic status and inflammation of individuals will aid in understanding the specific molecular 
mechanism underlying the enhanced pro-fibrotic potential of obesity-associated adipose tissue.  
 
Collagen fiber microstructure regulates the pro-angiogenic potential of ASCs. 
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As we observed the dynamics in matrix remodeling during tumorigenesis and obesity (Chapters 1 
and 3), we decided to further investigate whether the microstructural changes of collagen fibers provide a 
feedback mechanism for regulating the phenotype of ASCs in Chapter 5. For this study, we leveraged a 
tissue engineering model: ASC-incorporated 3D collagen scaffolds with varying fiber microstructures 
(Fig. 5.1). The findings of this study indicate that ASCs alter their behaviors in response to changes in the 
fiber microstructure thickness and in turn act to remodel their surrounding matrices. In addition, through 
the use of co-culture 3D models with human umbilical vein endothelial cells (HUVECs), we assessed the 
pro-angiogenic potential of the ASCs and found that they are also altered by the fiber microstructure. 
Finally, we investigated whether changes in the microstructure of collagen fibers regulate cell behaviors 
in a mechanoregulation-dependent manner. 
It was observed that at an early point, the predetermined collagen matrix in scaffolds might 
dominantly affect the ASCs’ behaviors. However, as ASCs begin to deposit more and more of their own 
Fn matrices in response to the microstructure of collagen fibers, these Fn matrices may play an increasing 
role in regulating the pro-angiogenic potential of ASCs while mediating the engagement with specific 
integrin of ASCs91. Thus, understanding the roles of the deposited Fn matrix in modulating the ASCs’ 
behaviors will complement our findings. 
We also attempted to assess changes in the mechanical properties of collagen scaffolds as a 
function of collagen fiber diameter yet the concomitant changes of pore size with fiber diameter in the 
collagen construct complicated this analysis. To overcome this limitation, computational modeling 
approaches have been utilized to dissect the role of each physical parameter in modulating mechanical 
properties of the biological construct, but experimental verification has not yet been presented. As such, it 
will be necessary to devise more effective and precise measurement methods to separately isolate the 
effects of collagen fiber diameter. 
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In conclusion, the findings of my doctoral work suggest that during prolonged exposure of 
obesity and tumor development, host stromal cells lose their phenotypic and functional integrity while 
differentiating into myofibroblastic cells, which are the main cellular mediators to alter mammary stroma 
structure through ECM remodeling and pro-angiogenic activities. The ECM remodeling in turn provides 
positive feedback to increase the myofibroblastic cell population. Consequently, the perturbed mammary 
microenvironment favors tumor progression. 
I believe our findings herein are broadly applicable for not only cancer and stem cell research but 
also for obesity-mediated metabolic diseases and tissue engineering. Our findings highlight that 
 
Fig. 6.1. Adipose tissue and its role in modulating the mammary microenvironment 
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maintaining phenotypic and functional integrity of host stromal cells is critical for preventing breast 
cancer progression and developing adequate cancer therapy. In addition, our findings call for exercising 
extra caution when considering the use of adipose tissue for tissue regenerative medicine, since the health 
conditions of both the tissue donor and recipients can possibly modulate the characteristics of adipose 
tissue. Moreover, our findings suggest that during obesity, the seemingly negligible interstitial fibrosis 
plays an equally significant role in promoting tumor malignancy as does dysfunctional adipocytes. Our 
studies also show that matrix changes at the micro-scale such as the microstructural changes of collagen 
fibers can also induce cellular phenotypic changes. As a side note, I believe other tissue engineers can 
benefit from our model system due to the difficulty to precisely control the microstructure of collagen 
fibers in vivo. However, as stated, several future studies will be beneficial for advancing our 
understanding of these diseases and consequently developing more nuanced and effective therapeutic 
approaches. 
 
6.2. Future directions  
This body of work suggests several causative factors for tumor progression, the understanding of 
which will aid in investigating specific mechanisms underlying the assessed links and ultimately 
developing better therapeutic approaches for cancer and other associated diseases. In addition, the 
combination of an appropriate in vitro platform as well as mouse models of human diseases presented in 
the course of this work are expected to guide the medical research community towards a comprehensive 
understanding of complex human diseases and ultimately aid in evaluating the therapeutic methods to 
tackle these diseases as well. In order to achieve these goals, however, there is still a significant amount 
of research that needs to be done. Some of these points were briefly outlined in the previous subsections 
of this chapter. The following subsection expands upon these aforementioned experiments with greater 
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detail and also introduces some other broader work that needs to be performed to translate these research 
findings to practical therapeutic methods. 
 
Mechanism underlying possible trans-differentiation of adipocytes 
Since the phenotypic and functional integrity of adipocytes are known to be responsible not only 
for cancer but also for a variety of other metabolic disease progressions, investigation of the specific 
molecular mechanism underlying adipocyte conversion is important in developing preventative care and 
treatments for such diseases250. Specifically, soluble factors responsible for adipogenesis and 
myofibroblast differentiation such as BMPs, IL-1β, TGF-β, and IL-8 may provides clues for adipocyte 
conversion, so they should be investigated in further detail48,194. Therefore, a first step is to develop an 
understanding of these aforementioned factors and their underlying signaling mechanisms will guide 
finding a potential regulator of adipocyte trans-differentiation. The next step would be to understand 
whether those signaling mechanisms regulate the conversion of adipocytes to myofibroblasts in a simply 
reversed-signaling cascade or via completely different routes. 
In addition, ECM-mediated biophysical cues may also contribute to the adipocyte trans-
differentiation as we have previously discussed in chapter 3. Previous studies indicate that mechanical 
stimuli (i.e. stretching) regulate adipogenesis through an ERK-mediated pathway as similar to 
biochemical cues (i.e. TNF-α)195,204. Also, morphological changes of adipocytes and subsequent actin 
cytoskeleton reorganization regulate cell fate via RhoA-mediated signaling187. However, how physical 
cues precisely regulate this process has not been well understood. In particular, similar to previous work 
indicating that collagen and adipocyte size are correlated250, our microscopic image analysis on the 
picrosirius red stained tumor sections showed that the size of adipocytes is positively correlated with the 
proximity of collagen fibers (data not shown). The morphological changes of adipocytes in a close 
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proximity of collagen fibers suggest that the surrounding thicker collagen matrix might  physically entrap 
the adipocytes and then reduce their size by mechanical stimuli71. Certainly more investigation on the link 
between ECM remodeling and adipocyte trans-differentiation needs to be done and this study will be also 
applicable for understanding of mechanism underlying obesity-associated fibrosis, which will be 
discussed in the following section. 
 
Mechanism underlying the enhanced obesity-associated fibrosis 
Although the process of fibrosis is relatively well understood, how obesity-associated interstitial 
fibrosis is stimulated remains unclear250. Fibrosis has been explained as a function of macrophage 
recruitment and the resulting high levels of inflammatory cytokine, but during obesity inflammation may 
not be an initiator of fibrosis since previous studies indicate that inflammatory cells are recruited at a later 
stage of obesity, so they may be responsible for progression rather than initiation of fibrosis250. Thus, 
other possibilities have been proposed in the literature including 1) hypoxia, and 2) a self-governing 
process of adipocytes to physically constrain their abnormal expansion by ECM fibers71,265,269. The 
proposed mechanisms may be linked and complement each other but even so, it still needs to be 
understood how these mechanisms (e.g., crosstalk between inflammatory cells and adipocytes, or 
adipocytes and surrounding stromal cell-mediated ECM deposition) are precisely regulated. 
Understanding this mechanism will aid in developing therapeutic approaches for obesity-associated 
cancer as well as other obesity-associated diseases given the strong association between fibrosis and 
adipocyte metabolic function. 
 
Link between obesity-associated fibrosis and preferential development of breast cancer 
subtype 
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Based on our findings in chapter 4, understanding whether obesity preferentially encourages the 
development of a specific subtype of breast cancer and if the preferential development is mediated 
through fibrosis-mediated mechanosignaling will prove useful in diagnosing breast cancer subtype and 
predicting clinical outcomes. For this study, thorough classification is a prerequisite since all other risk 
factors such as age, menopausal status, family history, smoking, dense breast tissue, etc. could potentially 
influence the development of a specific subtype of breast cancer325. In addition, due to the heterogeneity 
of tumor, a large number of samples will be required to obtain a meaningful relationship. 
 
Angiogenesis and blood vessel morphogenesis during obesity 
Despite enhanced fibrosis during obesity, delayed wound healing in obese and diabetic patients 
has been problematic, and it is speculated that this might be partially due to formation of dysfunctional 
blood vessels, which also pose difficulties for cancer therapy214,250. In particular, obesity-associated 
adipose tissue has been observed to reduce capillary density as well as larger but dysfunctional vessels, 
which possibly prevent wound healing by inhibiting the adequate recruitment of inflammatory cells as 
well as delivery of their factors71,250. Therefore, how blood vessel morphogenesis is regulated during 
obesity and how the dysfunctional blood vessels also contribute to tumor progression needs to be 
understood. 
In particular, it remains unclear whether ECM remodeling (i.e., collagen fiber structure) during 
obesity may influence blood vessel morphogenesis. For this study, the collagen scaffolds developed as a 
part of our work might be helpful in interrogating the role of collagen fiber microstructure in regulating 
vascular morphogenesis. Although we were not able to detect the morphogenic difference of HUVEC 
sprouting due to the short period of HUVEC culture in our system in chapter 5, understanding the role of 
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the collagen fiber microstructure on blood vessel morphogenesis will aid in developing effective therapies 
for cancer as well as obesity-associated wound healing and hypertension in multiple organs326.  
 
Molecular mechanism underlying the mechanoregulation of cancer stem cell 
The cancer cell heterogeneity and cancer stem cell population have been recognized as key 
factors of the driving force necessary to maintain the heterogeneous cancer cell population262. 
Furthermore, clinical studies show that cancer stem cell populations have been correlated with high 
resistance to available cancer therapies, poor clinical outcomes, and recurrence of specific types of 
cancer327. Nevertheless, the mechanisms underlying the origin of cancer stem cells and the precise 
maintenance of their populations among the heterogeneous tumor mass are not well understood. However, 
since the maintenance of normal stem cells – which are also believed to be source of cancer stem cells – 
are known to be regulated by their surrounding microenvironment, it may be possible that the tumor 
microenvironment provides cancer stem cell with a favorable niche257. In particular, the 
mechanoregulation of cancer stem cell maintenance in fibrotic microenvironments might be one of the 
possible mechanisms, as our studies also suggest that obesity-associated fibrosis possibly contributes to 
cancer stem cell maintenance in chapter 4. More detailed studies, however, need to be performed to fully 
verify this mechanism. 
 
Therapeutic approaches 
Based on our understanding of partially successful cancer therapies that are currently being used, 
there may not be a single silver bullet therapy for treating cancer. It is more likely that a combination of 
targeting oncogenes as well as normalizing the unbalanced tumor microenvironment may be the optimal 
approach for cancer therapy. Based on our findings, several possible therapeutic approaches to normalize 
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the microenvironment can be suggested and precise control of the normalization will be a key factor in 
the effectiveness of these proposed therapeutic approaches to combat cancer.  
First, the precise regulation of phenotypic and functional integrity of the implanted cells for tissue 
is a critical determining factor for safe tissue regeneration, in particular for breast reconstruction after 
mastectomy. Given that ASCs as well as adipocytes can be a source of pro-tumorigenic mediators, ways 
to control the undesirable differentiation of these cells after implantation will be essential. Therefore, 
incorporating specific factors to control their differentiation or accurate design of cell carriers for 
implantation might be an option.  
Second, the findings from this dissertation emphasize that fibrosis and consequent tumor stiffness 
exacerbate tumor progression as previous studies suggested123. Accordingly, several therapeutic 
approaches to target matrix remodeling (i.e. heparanase inhibitor) or cancer-activated fibroblasts (i.e. FGF 
receptor inhibitor) were introduced10. Also, anti-fibrotic therapies using factors such as TGF-β and PPAR-
γ might be considered250. However, a detailed investigation into the adequate treatment (i.e. timing and 
dosage) and the potential side effects of such treatments will need to be conducted.  
As we have demonstrated through our studies, obesity-associated alteration in the mammary 
microenvironment is a critical factor for tumor progression. Thus, for obese cancer patients, weight loss 
through dietary intervention and exercise has been recommended since weight loss has been known to 
lead to lower chronic inflammation and estrogen synthesis108,328. However, a clear understanding of the 
impacts of acute weight loss on clinical outcomes of obese patients still needs to be established. Even still, 
the importance of proper homeostasis of our bodies including a well-regulated weight cannot be 
overstated. 
Since current studies indicate that not only obesity but also lipodystrophy (i.e., loss of fat) may 
create a similar pathological microenvironment including chronic inflammation and the resulting fibrosis, 
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simple weight loss may not be the only solution for preventing breast cancer328. Rather, the effective 
control of chronic inflammation may play a critical role in regulating disease development. Therefore, 
pharmacological anti-inflammatory approaches such non-steroidal anti-inflammatory drugs, 
corticosteroids, and statins might be another option but careful timing of administration, dosage-control 
and regular medical check-ups for inflammation level are required329. 
Lastly, predisposed interstitial fibrosis might possibly be utilized as a diagnostic tool in the future, 
although much work is needed before it can be applied in practice. Specifically, it is not well understood 
if a specific risk factor for breast cancer (e.g., menopausal status, obesity, etc.) can be directly and 
uniquely mapped to a specific alteration to the tumor stroma structure in such a manner as to be used as a 
diagnostic marker. Certainly, more investigation is required to understand the characteristics of mammary 
tumor stroma in conjunction with breast cancer risk factors and the resulting impact on tumor malignancy 
and recurrence. 
 In conclusion, this dissertation emphasizes the significance of maintaining structural and 
functional integrity both at the cell and tissue levels since their compromised balance leads to the 
development and progression of breast cancer. More generally though, this work highlights that for any 
disease, it is important to discover ways to maintain this structural and functional integrity in healthy 
individuals for prevention and/or ways to recover it in sick patients for effective therapy. As such, it is my 
privilege to have completed the ground work in not only the field of cancer, but also in the broader 
spectrum of diseases closely linked to obesity. It is my hope that this work will continue to be pursued 
and applied for the successful treatment of many valuable lives. 
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